[1]		P04406	G3P_HUMAN	GAPDH	15	68.1	9.97	7.3e-18	871.1246	3	1.7	VIHDNFGIVEGLMTTVHAITATQK	VIHDNFGIVEGLM(Oxidation)TTVHAITATQK	Oxidation@175	24	V20130429-12_FTMSms2hcd	61.686	163	186	53.9	7.3e-18	1.3e-20	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	15	68.1	9.97	7.3e-18	765.0156	3	-0.29	WGDAGAEYVVESTGVFTTMEK	WGDAGAEYVVESTGVFTTM(Oxidation)EK	Oxidation@105	21	V20130429-12_FTMSms2hcd	53.539	87	107	52.3	7.3e-17	7.3e-20	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	15	68.1	9.97	7.3e-18	845.4095	3	0.79	IKWGDAGAEYVVESTGVFTTMEK	IKWGDAGAEYVVESTGVFTTM(Oxidation)EK	Oxidation@105	23	V20130429-12_FTMSms2hcd	53.781	85	107	51.4	2.0e-16	1.9e-19	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	15	68.1	9.97	7.3e-18	756.0605	3	-0.57	LTGMAFRVPTANVSVVDLTCR	LTGM(Oxidation)AFRVPTANVSVVDLTCR	Oxidation@231	21	V20130429-12_FTMSms2hcd	52.486	228	248	52.7	5.0e-16	7.3e-19	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	15	68.1	9.97	7.3e-18	865.7939	3	2.8	VIHDNFGIVEGLMTTVHAITATQK	VIHDNFGIVEGLMTTVHAITATQK		24	V20130429-12_FTMSms2hcd	70.903	163	186	52.8	1.6e-15	3.6e-18	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	15	68.1	9.97	7.3e-18	681.8240	2	1.1	VVDLMAHMASKE	VVDLM(Oxidation)AHM(Oxidation)ASKE	Oxidation@328;Oxidation@331	12	V20130429-12_FTMSms2hcd	16.162	324	335	44.5	1.6e-14	2.1e-17	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	15	68.1	9.97	7.3e-18	882.4067	2	2.1	LISWYDNEFGYSNR	LISWYDNEFGYSNR		14	V20130429-12_FTMSms2hcd	49.466	310	323	56.5	3.9e-14	4.3e-17	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	15	68.1	9.97	7.3e-18	1004.7288	4	1.3	AAFNSGKVDIVAINDPFIDLNYMVYMFQYDSTHGK	AAFNSGKVDIVAINDPFIDLNYM(Oxidation)VYM(Oxidation)FQYDSTHGK	Oxidation@43;Oxidation@46	35	V20130429-12_FTMSms2hcd	69.251	21	55	40.6	2.2e-13	2.6e-16	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	15	68.1	9.97	7.3e-18	966.8702	5	6.2	QASEGPLKGILGYTEHQVVSSDFNSDTHSSTFDAGAGIALNDHFVK	Q(Gln->pyro-Glu)ASEGPLKGILGYTEHQVVSSDFNSDTHSSTFDAGAGIALNDHFVK	Gln->pyro-Glu@264	46	V20130429-12_FTMSms2hcd	62.712	264	309	36.6	2.8e-13	4.9e-16	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	15	68.1	9.97	7.3e-18	1009.9802	4	1.0	GILGYTEHQVVSSDFNSDTHSSTFDAGAGIALNDHFVK	GILGYTEHQVVSSDFNSDTHSSTFDAGAGIALNDHFVK		38	V20130429-12_FTMSms2hcd	53.046	272	309	40.5	2.1e-12	2.3e-15	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	15	68.1	9.97	7.3e-18	681.0414	3	0.97	LVINGNPITIFQERDPSK	LVINGNPITIFQERDPSK		18	V20130429-12_FTMSms2hcd	52.270	67	84	43.0	1.1e-10	3.1e-13	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	15	68.1	9.97	7.3e-18	737.3909	2	1.0	VPTANVSVVDLTCR	VPTANVSVVDLTCR		14	V20130429-12_FTMSms2hcd	43.198	235	248	55.7	6.0e-10	9.6e-13	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	15	68.1	9.97	7.3e-18	706.3987	2	-0.16	GALQNIIPASTGAAK	GALQNIIPASTGAAK		15	V20130429-12_FTMSms2hcd	38.836	201	215	33.1	4.6e-8	1.2e-10	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	15	68.1	9.97	7.3e-18	362.7097	4	1.0	LEKPAKYDDIKK	LEKPAKYDDIKK		12	V20130429-12_FTMSms2hcd	14.079	249	260	35.7	5.6e-8	1.7e-10	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	15	68.1	9.97	7.3e-18	403.2191	2	-0.73	VGVNGFGR	VGVNGFGR		8	V20130429-12_FTMSms2hcd	22.150	6	13	36.0	1.0e-5	1.9e-8	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2]		P68104	EF1A1_HUMAN	EEF1A1	12	38.3	9.84	1.3e-17	990.7953	3	1.1	SGDAAIVDMVPGKPMCVESFSDYPPLGR	SGDAAIVDM(Oxidation)VPGKPM(Oxidation)CVESFSDYPPLGR	Oxidation@404;Oxidation@410	28	V20130429-12_FTMSms2hcd	49.920	396	423	54.9	1.3e-17	1.1e-20	2	50141.3	HUMAN	Elongation factor 1-alpha 1
[2]		P68104	EF1A1_HUMAN	EEF1A1	12	38.3	9.84	1.3e-17	794.9443	2	0.48	THINIVVIGHVDSGK	THINIVVIGHVDSGK		15	V20130429-12_FTMSms2hcd	81.617	6	20	43.4	1.1e-16	2.5e-19	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[2]		P68104	EF1A1_HUMAN	EEF1A1	12	38.3	9.84	1.3e-17	897.4929	3	0.64	THINIVVIGHVDSGKSTTTGHLIYK	THINIVVIGHVDSGKSTTTGHLIYK		25	V20130429-12_FTMSms2hcd	37.817	6	30	49.5	4.4e-15	1.8e-17	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[2]		P68104	EF1A1_HUMAN	EEF1A1	12	38.3	9.84	1.3e-17	813.9069	2	1.3	TIEKFEKEAAEMGK	TIEKFEKEAAEM(Oxidation)GK	Oxidation@49	14	V20130429-12_FTMSms2hcd	21.567	38	51	49.0	1.3e-13	1.6e-16	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[2]		P68104	EF1A1_HUMAN	EEF1A1	12	38.3	9.84	1.3e-17	1307.7008	3	2.3	DGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK	DGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK		36	V20130429-12_FTMSms2hcd	74.193	220	255	41.6	9.1e-13	3.7e-15	2	50141.3	HUMAN	Elongation factor 1-alpha 1
[2]		P68104	EF1A1_HUMAN	EEF1A1	12	38.3	9.84	1.3e-17	1013.0493	4	0.34	KDGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK	KDGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK		37	V20130429-12_FTMSms2hcd	69.947	219	255	49.8	5.8e-12	3.1e-14	2	50141.3	HUMAN	Elongation factor 1-alpha 1
[2]		P68104	EF1A1_HUMAN	EEF1A1	12	38.3	9.84	1.3e-17	844.4669	3	2.8	VETGVLKPGMVVTFAPVNVTTEVK	VETGVLKPGM(Oxidation)VVTFAPVNVTTEVK	Oxidation@276	24	V20130429-12_FTMSms2hcd	51.189	267	290	42.9	1.4e-11	5.6e-14	2	50141.3	HUMAN	Elongation factor 1-alpha 1
[2]		P68104	EF1A1_HUMAN	EEF1A1	12	38.3	9.84	1.3e-17	956.8228	3	15	NMITGTSQADCAVLIVAAGVGEFEAGISK	NM(Oxidation)ITGTSQADCAVLIVAAGVGEFEAGISK	Oxidation@102	29	V20130429-12_FTMSms2hcd	77.272	101	129	36.6	6.0e-11	8.6e-14	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[2]		P68104	EF1A1_HUMAN	EEF1A1	12	38.3	9.84	1.3e-17	741.8959	4	5.4	DGNASGTTLLEALDCILPPTRPTDKPLR	DGNASGTTLLEALDCILPPTRPTDKPLR		28	V20130429-12_FTMSms2hcd	70.436	220	247	36.7	2.9e-10	7.1e-13	2	50141.3	HUMAN	Elongation factor 1-alpha 1
[2]		P68104	EF1A1_HUMAN	EEF1A1	12	38.3	9.84	1.3e-17	560.8031	2	-0.69	STTTGHLIYK	STTTGHLIYK		10	V20130429-12_FTMSms2hcd	17.753	21	30	37.6	3.0e-8	5.3e-11	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[2]		P68104	EF1A1_HUMAN	EEF1A1	12	38.3	9.84	1.3e-17	513.3088	2	0.12	IGGIGTVPVGR	IGGIGTVPVGR		11	V20130429-12_FTMSms2hcd	31.175	256	266	40.1	9.6e-7	7.2e-9	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[2]		P68104	EF1A1_HUMAN	EEF1A1	12	38.3	9.84	1.3e-17	457.7868	2	-0.68	QTVAVGVIK	QTVAVGVIK		9	V20130429-12_FTMSms2hcd	26.577	431	439	28.2	4.5e-5	1.3e-7	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[2-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	12	38.3	9.84	1.3e-17	990.7953	3	1.1	SGDAAIVDMVPGKPMCVESFSDYPPLGR	SGDAAIVDM(Oxidation)VPGKPM(Oxidation)CVESFSDYPPLGR	Oxidation@404;Oxidation@410	28	V20130429-12_FTMSms2hcd	49.920	396	423	54.9	1.3e-17	1.1e-20	2	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[2-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	12	38.3	9.84	1.3e-17	794.9443	2	0.48	THINIVVIGHVDSGK	THINIVVIGHVDSGK		15	V20130429-12_FTMSms2hcd	81.617	6	20	43.4	1.1e-16	2.5e-19	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[2-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	12	38.3	9.84	1.3e-17	897.4929	3	0.64	THINIVVIGHVDSGKSTTTGHLIYK	THINIVVIGHVDSGKSTTTGHLIYK		25	V20130429-12_FTMSms2hcd	37.817	6	30	49.5	4.4e-15	1.8e-17	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[2-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	12	38.3	9.84	1.3e-17	813.9069	2	1.3	TIEKFEKEAAEMGK	TIEKFEKEAAEM(Oxidation)GK	Oxidation@49	14	V20130429-12_FTMSms2hcd	21.567	38	51	49.0	1.3e-13	1.6e-16	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[2-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	12	38.3	9.84	1.3e-17	1307.7008	3	2.3	DGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK	DGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK		36	V20130429-12_FTMSms2hcd	74.193	220	255	41.6	9.1e-13	3.7e-15	2	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[2-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	12	38.3	9.84	1.3e-17	1013.0493	4	0.34	KDGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK	KDGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK		37	V20130429-12_FTMSms2hcd	69.947	219	255	49.8	5.8e-12	3.1e-14	2	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[2-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	12	38.3	9.84	1.3e-17	844.4669	3	2.8	VETGVLKPGMVVTFAPVNVTTEVK	VETGVLKPGM(Oxidation)VVTFAPVNVTTEVK	Oxidation@276	24	V20130429-12_FTMSms2hcd	51.189	267	290	42.9	1.4e-11	5.6e-14	2	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[2-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	12	38.3	9.84	1.3e-17	956.8228	3	15	NMITGTSQADCAVLIVAAGVGEFEAGISK	NM(Oxidation)ITGTSQADCAVLIVAAGVGEFEAGISK	Oxidation@102	29	V20130429-12_FTMSms2hcd	77.272	101	129	36.6	6.0e-11	8.6e-14	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[2-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	12	38.3	9.84	1.3e-17	741.8959	4	5.4	DGNASGTTLLEALDCILPPTRPTDKPLR	DGNASGTTLLEALDCILPPTRPTDKPLR		28	V20130429-12_FTMSms2hcd	70.436	220	247	36.7	2.9e-10	7.1e-13	2	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[2-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	12	38.3	9.84	1.3e-17	560.8031	2	-0.69	STTTGHLIYK	STTTGHLIYK		10	V20130429-12_FTMSms2hcd	17.753	21	30	37.6	3.0e-8	5.3e-11	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[2-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	12	38.3	9.84	1.3e-17	513.3088	2	0.12	IGGIGTVPVGR	IGGIGTVPVGR		11	V20130429-12_FTMSms2hcd	31.175	256	266	40.1	9.6e-7	7.2e-9	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[2-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	12	38.3	9.84	1.3e-17	457.7868	2	-0.68	QTVAVGVIK	QTVAVGVIK		9	V20130429-12_FTMSms2hcd	26.577	431	439	28.2	4.5e-5	1.3e-7	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[2-2]	1	Q05639	EF1A2_HUMAN	EEF1A2	8	27.0	9.34	1.1e-16	794.9443	2	0.48	THINIVVIGHVDSGK	THINIVVIGHVDSGK		15	V20130429-12_FTMSms2hcd	81.617	6	20	43.4	1.1e-16	2.5e-19	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[2-2]	1	Q05639	EF1A2_HUMAN	EEF1A2	8	27.0	9.34	1.1e-16	897.4929	3	0.64	THINIVVIGHVDSGKSTTTGHLIYK	THINIVVIGHVDSGKSTTTGHLIYK		25	V20130429-12_FTMSms2hcd	37.817	6	30	49.5	4.4e-15	1.8e-17	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[2-2]	1	Q05639	EF1A2_HUMAN	EEF1A2	8	27.0	9.34	1.1e-16	813.9069	2	1.3	TIEKFEKEAAEMGK	TIEKFEKEAAEM(Oxidation)GK	Oxidation@49	14	V20130429-12_FTMSms2hcd	21.567	38	51	49.0	1.3e-13	1.6e-16	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[2-2]	1	Q05639	EF1A2_HUMAN	EEF1A2	8	27.0	9.34	1.1e-16	956.8228	3	15	NMITGTSQADCAVLIVAAGVGEFEAGISK	NM(Oxidation)ITGTSQADCAVLIVAAGVGEFEAGISK	Oxidation@102	29	V20130429-12_FTMSms2hcd	77.272	101	129	36.6	6.0e-11	8.6e-14	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[2-2]	1	Q05639	EF1A2_HUMAN	EEF1A2	8	27.0	9.34	1.1e-16	560.8031	2	-0.69	STTTGHLIYK	STTTGHLIYK		10	V20130429-12_FTMSms2hcd	17.753	21	30	37.6	3.0e-8	5.3e-11	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[2-2]	1	Q05639	EF1A2_HUMAN	EEF1A2	8	27.0	9.34	1.1e-16	1032.0503	4	-4.9	KEGNASGVSLLEALDTILPPTRPTDKPLRLPLQDVYK	KEGNASGVS(Phospho)LLEALDTILPPTRPTDKPLRLPLQDVYK	Phospho@224|227|234	37	V20130429-12_FTMSms2hcd	72.610	219	255	24.9	6.2e-7	2.8e-9	1	50470.6	HUMAN	Elongation factor 1-alpha 2
[2-2]	1	Q05639	EF1A2_HUMAN	EEF1A2	8	27.0	9.34	1.1e-16	513.3088	2	0.12	IGGIGTVPVGR	IGGIGTVPVGR		11	V20130429-12_FTMSms2hcd	31.175	256	266	40.1	9.6e-7	7.2e-9	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[2-2]	1	Q05639	EF1A2_HUMAN	EEF1A2	8	27.0	9.34	1.1e-16	457.7868	2	-0.68	QTVAVGVIK	QTVAVGVIK		9	V20130429-12_FTMSms2hcd	26.577	431	439	28.2	4.5e-5	1.3e-7	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[3]		P60709	ACTB_HUMAN	ACTB	12	38.1	12.30	3.6e-22	890.8922	2	2.4	MDDDIAALVVDNGSGMCK	M(Met-loss+Acetyl)DDDIAALVVDNGSGM(Oxidation)CK	Met-loss+Acetyl@1;Oxidation@16	18	V20130429-12_FTMSms2hcd	52.257	1	18	58.5	3.6e-22	4.6e-25	1	41737.1	HUMAN	Actin, cytoplasmic 1
[3]		P60709	ACTB_HUMAN	ACTB	12	38.1	12.30	3.6e-22	800.6564	4	-1.7	TTGIVMDSGDGVTHTVPIYEGYALPHAILR	TTGIVM(Oxidation)DSGDGVTHTVPIYEGYALPHAILR	Oxidation@153	30	V20130429-12_FTMSms2hcd	53.327	148	177	38.3	1.2e-14	1.5e-17	2	41737.1	HUMAN	Actin, cytoplasmic 1
[3]		P60709	ACTB_HUMAN	ACTB	12	38.1	12.30	3.6e-22	977.5383	2	2.5	VAPEEHPVLLTEAPLNPK	VAPEEHPVLLTEAPLNPK		18	V20130429-12_FTMSms2hcd	41.007	96	113	47.6	3.2e-14	8.6e-17	2	41737.1	HUMAN	Actin, cytoplasmic 1
[3]		P60709	ACTB_HUMAN	ACTB	12	38.1	12.30	3.6e-22	895.9498	2	0.23	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-12_FTMSms2hcd	47.647	239	254	43.4	7.0e-14	8.2e-17	10	41737.1	HUMAN	Actin, cytoplasmic 1
[3]		P60709	ACTB_HUMAN	ACTB	12	38.1	12.30	3.6e-22	452.2130	3	0.81	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-12_FTMSms2hcd	11.625	51	62	32.0	2.0e-12	2.5e-15	6	41737.1	HUMAN	Actin, cytoplasmic 1
[3]		P60709	ACTB_HUMAN	ACTB	12	38.1	12.30	3.6e-22	589.3110	2	1.2	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@325	11	V20130429-12_FTMSms2hcd	24.932	316	326	39.9	9.6e-12	1.5e-14	6	41737.1	HUMAN	Actin, cytoplasmic 1
[3]		P60709	ACTB_HUMAN	ACTB	12	38.1	12.30	3.6e-22	505.9213	3	0.12	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-12_FTMSms2hcd	31.055	85	95	27.6	1.4e-10	1.8e-13	9	41737.1	HUMAN	Actin, cytoplasmic 1
[3]		P60709	ACTB_HUMAN	ACTB	12	38.1	12.30	3.6e-22	790.9037	2	-1.3	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@313;Oxidation@325	14	V20130429-12_FTMSms2hcd	23.185	313	326	27.4	2.8e-10	3.7e-13	6	41737.1	HUMAN	Actin, cytoplasmic 1
[3]		P60709	ACTB_HUMAN	ACTB	12	38.1	12.30	3.6e-22	400.2399	3	-0.30	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-12_FTMSms2hcd	35.350	29	39	38.3	8.1e-9	3.0e-11	9	41737.1	HUMAN	Actin, cytoplasmic 1
[3]		P60709	ACTB_HUMAN	ACTB	12	38.1	12.30	3.6e-22	360.6714	2	1.4	CDVDIR	CDVDIR		6	V20130429-12_FTMSms2hcd	16.243	285	290	22.8	0.0018	5.9e-6	3	41737.1	HUMAN	Actin, cytoplasmic 1
[3]		P60709	ACTB_HUMAN	ACTB	12	38.1	12.30	3.6e-22	424.7181	2	-0.64	CDVDIRK	CDVDIRK		7	V20130429-12_FTMSms2hcd	12.093	285	291	12.9	0.033	6.2e-5	3	41737.1	HUMAN	Actin, cytoplasmic 1
[3]		P60709	ACTB_HUMAN	ACTB	12	38.1	12.30	3.6e-22	400.7716	2	0.84	RGILTLK	RGILTLK		7	V20130429-12_FTMSms2hcd	25.663	62	68	15.2	0.089	5.4e-4	10	41737.1	HUMAN	Actin, cytoplasmic 1
[3-1]	1	P63261	ACTG_HUMAN	ACTG1	12	38.1	11.37	1.9e-20	918.9307	2	10	MEEEIAALVIDNGSGMCK	M(Met-loss+Acetyl)EEEIAALVIDNGSGM(Oxidation)CK	Met-loss+Acetyl@1;Oxidation@16	18	V20130429-12_FTMSms2hcd	60.373	1	18	58.5	1.9e-20	2.1e-23	1	41793.2	HUMAN	Actin, cytoplasmic 2
[3-1]	1	P63261	ACTG_HUMAN	ACTG1	12	38.1	11.37	1.9e-20	800.6564	4	-1.7	TTGIVMDSGDGVTHTVPIYEGYALPHAILR	TTGIVM(Oxidation)DSGDGVTHTVPIYEGYALPHAILR	Oxidation@153	30	V20130429-12_FTMSms2hcd	53.327	148	177	38.3	1.2e-14	1.5e-17	2	41793.2	HUMAN	Actin, cytoplasmic 2
[3-1]	1	P63261	ACTG_HUMAN	ACTG1	12	38.1	11.37	1.9e-20	977.5383	2	2.5	VAPEEHPVLLTEAPLNPK	VAPEEHPVLLTEAPLNPK		18	V20130429-12_FTMSms2hcd	41.007	96	113	47.6	3.2e-14	8.6e-17	2	41793.2	HUMAN	Actin, cytoplasmic 2
[3-1]	1	P63261	ACTG_HUMAN	ACTG1	12	38.1	11.37	1.9e-20	895.9498	2	0.23	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-12_FTMSms2hcd	47.647	239	254	43.4	7.0e-14	8.2e-17	10	41793.2	HUMAN	Actin, cytoplasmic 2
[3-1]	1	P63261	ACTG_HUMAN	ACTG1	12	38.1	11.37	1.9e-20	452.2130	3	0.81	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-12_FTMSms2hcd	11.625	51	62	32.0	2.0e-12	2.5e-15	6	41793.2	HUMAN	Actin, cytoplasmic 2
[3-1]	1	P63261	ACTG_HUMAN	ACTG1	12	38.1	11.37	1.9e-20	589.3110	2	1.2	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@325	11	V20130429-12_FTMSms2hcd	24.932	316	326	39.9	9.6e-12	1.5e-14	6	41793.2	HUMAN	Actin, cytoplasmic 2
[3-1]	1	P63261	ACTG_HUMAN	ACTG1	12	38.1	11.37	1.9e-20	505.9213	3	0.12	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-12_FTMSms2hcd	31.055	85	95	27.6	1.4e-10	1.8e-13	9	41793.2	HUMAN	Actin, cytoplasmic 2
[3-1]	1	P63261	ACTG_HUMAN	ACTG1	12	38.1	11.37	1.9e-20	790.9037	2	-1.3	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@313;Oxidation@325	14	V20130429-12_FTMSms2hcd	23.185	313	326	27.4	2.8e-10	3.7e-13	6	41793.2	HUMAN	Actin, cytoplasmic 2
[3-1]	1	P63261	ACTG_HUMAN	ACTG1	12	38.1	11.37	1.9e-20	400.2399	3	-0.30	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-12_FTMSms2hcd	35.350	29	39	38.3	8.1e-9	3.0e-11	9	41793.2	HUMAN	Actin, cytoplasmic 2
[3-1]	1	P63261	ACTG_HUMAN	ACTG1	12	38.1	11.37	1.9e-20	360.6714	2	1.4	CDVDIR	CDVDIR		6	V20130429-12_FTMSms2hcd	16.243	285	290	22.8	0.0018	5.9e-6	3	41793.2	HUMAN	Actin, cytoplasmic 2
[3-1]	1	P63261	ACTG_HUMAN	ACTG1	12	38.1	11.37	1.9e-20	424.7181	2	-0.64	CDVDIRK	CDVDIRK		7	V20130429-12_FTMSms2hcd	12.093	285	291	12.9	0.033	6.2e-5	3	41793.2	HUMAN	Actin, cytoplasmic 2
[3-1]	1	P63261	ACTG_HUMAN	ACTG1	12	38.1	11.37	1.9e-20	400.7716	2	0.84	RGILTLK	RGILTLK		7	V20130429-12_FTMSms2hcd	25.663	62	68	15.2	0.089	5.4e-4	10	41793.2	HUMAN	Actin, cytoplasmic 2
[3-2]	1	P68032	ACTC_HUMAN	ACTC1	8	26.0	7.82	7.0e-14	895.9498	2	0.23	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-12_FTMSms2hcd	47.647	241	256	43.4	7.0e-14	8.2e-17	10	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[3-2]	1	P68032	ACTC_HUMAN	ACTC1	8	26.0	7.82	7.0e-14	452.2130	3	0.81	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-12_FTMSms2hcd	11.625	53	64	32.0	2.0e-12	2.5e-15	6	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[3-2]	1	P68032	ACTC_HUMAN	ACTC1	8	26.0	7.82	7.0e-14	589.3110	2	1.2	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@327	11	V20130429-12_FTMSms2hcd	24.932	318	328	39.9	9.6e-12	1.5e-14	6	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[3-2]	1	P68032	ACTC_HUMAN	ACTC1	8	26.0	7.82	7.0e-14	505.9213	3	0.12	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-12_FTMSms2hcd	31.055	87	97	27.6	1.4e-10	1.8e-13	9	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[3-2]	1	P68032	ACTC_HUMAN	ACTC1	8	26.0	7.82	7.0e-14	790.9037	2	-1.3	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@315;Oxidation@327	14	V20130429-12_FTMSms2hcd	23.185	315	328	27.4	2.8e-10	3.7e-13	6	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[3-2]	1	P68032	ACTC_HUMAN	ACTC1	8	26.0	7.82	7.0e-14	400.2399	3	-0.30	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-12_FTMSms2hcd	35.350	31	41	38.3	8.1e-9	3.0e-11	9	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[3-2]	1	P68032	ACTC_HUMAN	ACTC1	8	26.0	7.82	7.0e-14	1049.8025	3	-17	CPETLFQPSFIGMESAGIHETTYNSIMK	CPETLFQPSFIGM(Oxidation)ESAGIHETTYNSIMK	Oxidation@271=36	28	V20130429-12_FTMSms2hcd	59.170	259	286	14.7	2.0e-5	2.0e-8	4	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[3-2]	1	P68032	ACTC_HUMAN	ACTC1	8	26.0	7.82	7.0e-14	400.7716	2	0.84	RGILTLK	RGILTLK		7	V20130429-12_FTMSms2hcd	25.663	64	70	15.2	0.089	5.4e-4	10	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[3-3]	1	P68133	ACTS_HUMAN	ACTA1	8	26.0	7.82	7.0e-14	895.9498	2	0.23	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-12_FTMSms2hcd	47.647	241	256	43.4	7.0e-14	8.2e-17	10	42051.4	HUMAN	Actin, alpha skeletal muscle
[3-3]	1	P68133	ACTS_HUMAN	ACTA1	8	26.0	7.82	7.0e-14	452.2130	3	0.81	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-12_FTMSms2hcd	11.625	53	64	32.0	2.0e-12	2.5e-15	6	42051.4	HUMAN	Actin, alpha skeletal muscle
[3-3]	1	P68133	ACTS_HUMAN	ACTA1	8	26.0	7.82	7.0e-14	589.3110	2	1.2	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@327	11	V20130429-12_FTMSms2hcd	24.932	318	328	39.9	9.6e-12	1.5e-14	6	42051.4	HUMAN	Actin, alpha skeletal muscle
[3-3]	1	P68133	ACTS_HUMAN	ACTA1	8	26.0	7.82	7.0e-14	505.9213	3	0.12	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-12_FTMSms2hcd	31.055	87	97	27.6	1.4e-10	1.8e-13	9	42051.4	HUMAN	Actin, alpha skeletal muscle
[3-3]	1	P68133	ACTS_HUMAN	ACTA1	8	26.0	7.82	7.0e-14	790.9037	2	-1.3	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@315;Oxidation@327	14	V20130429-12_FTMSms2hcd	23.185	315	328	27.4	2.8e-10	3.7e-13	6	42051.4	HUMAN	Actin, alpha skeletal muscle
[3-3]	1	P68133	ACTS_HUMAN	ACTA1	8	26.0	7.82	7.0e-14	400.2399	3	-0.30	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-12_FTMSms2hcd	35.350	31	41	38.3	8.1e-9	3.0e-11	9	42051.4	HUMAN	Actin, alpha skeletal muscle
[3-3]	1	P68133	ACTS_HUMAN	ACTA1	8	26.0	7.82	7.0e-14	1049.8025	3	-17	CPETLFQPSFIGMESAGIHETTYNSIMK	CPETLFQPSFIGM(Oxidation)ESAGIHETTYNSIMK	Oxidation@271=36	28	V20130429-12_FTMSms2hcd	59.170	259	286	14.7	2.0e-5	2.0e-8	4	42051.4	HUMAN	Actin, alpha skeletal muscle
[3-3]	1	P68133	ACTS_HUMAN	ACTA1	8	26.0	7.82	7.0e-14	400.7716	2	0.84	RGILTLK	RGILTLK		7	V20130429-12_FTMSms2hcd	25.663	64	70	15.2	0.089	5.4e-4	10	42051.4	HUMAN	Actin, alpha skeletal muscle
[3-4]	1	P62736	ACTA_HUMAN	ACTA2	7	23.1	7.82	7.0e-14	895.9498	2	0.23	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-12_FTMSms2hcd	47.647	241	256	43.4	7.0e-14	8.2e-17	10	42009.4	HUMAN	Actin, aortic smooth muscle
[3-4]	1	P62736	ACTA_HUMAN	ACTA2	7	23.1	7.82	7.0e-14	452.2130	3	0.81	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-12_FTMSms2hcd	11.625	53	64	32.0	2.0e-12	2.5e-15	6	42009.4	HUMAN	Actin, aortic smooth muscle
[3-4]	1	P62736	ACTA_HUMAN	ACTA2	7	23.1	7.82	7.0e-14	589.3110	2	1.2	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@327	11	V20130429-12_FTMSms2hcd	24.932	318	328	39.9	9.6e-12	1.5e-14	6	42009.4	HUMAN	Actin, aortic smooth muscle
[3-4]	1	P62736	ACTA_HUMAN	ACTA2	7	23.1	7.82	7.0e-14	790.9037	2	-1.3	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@315;Oxidation@327	14	V20130429-12_FTMSms2hcd	23.185	315	328	27.4	2.8e-10	3.7e-13	6	42009.4	HUMAN	Actin, aortic smooth muscle
[3-4]	1	P62736	ACTA_HUMAN	ACTA2	7	23.1	7.82	7.0e-14	400.2399	3	-0.30	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-12_FTMSms2hcd	35.350	31	41	38.3	8.1e-9	3.0e-11	9	42009.4	HUMAN	Actin, aortic smooth muscle
[3-4]	1	P62736	ACTA_HUMAN	ACTA2	7	23.1	7.82	7.0e-14	1049.8025	3	-17	CPETLFQPSFIGMESAGIHETTYNSIMK	CPETLFQPSFIGM(Oxidation)ESAGIHETTYNSIMK	Oxidation@271=36	28	V20130429-12_FTMSms2hcd	59.170	259	286	14.7	2.0e-5	2.0e-8	4	42009.4	HUMAN	Actin, aortic smooth muscle
[3-4]	1	P62736	ACTA_HUMAN	ACTA2	7	23.1	7.82	7.0e-14	400.7716	2	0.84	RGILTLK	RGILTLK		7	V20130429-12_FTMSms2hcd	25.663	64	70	15.2	0.089	5.4e-4	10	42009.4	HUMAN	Actin, aortic smooth muscle
[3-5]	1	P63267	ACTH_HUMAN	ACTG2	7	23.1	7.82	7.0e-14	895.9498	2	0.23	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-12_FTMSms2hcd	47.647	240	255	43.4	7.0e-14	8.2e-17	10	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[3-5]	1	P63267	ACTH_HUMAN	ACTG2	7	23.1	7.82	7.0e-14	452.2130	3	0.81	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-12_FTMSms2hcd	11.625	52	63	32.0	2.0e-12	2.5e-15	6	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[3-5]	1	P63267	ACTH_HUMAN	ACTG2	7	23.1	7.82	7.0e-14	589.3110	2	1.2	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@326	11	V20130429-12_FTMSms2hcd	24.932	317	327	39.9	9.6e-12	1.5e-14	6	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[3-5]	1	P63267	ACTH_HUMAN	ACTG2	7	23.1	7.82	7.0e-14	790.9037	2	-1.3	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@314;Oxidation@326	14	V20130429-12_FTMSms2hcd	23.185	314	327	27.4	2.8e-10	3.7e-13	6	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[3-5]	1	P63267	ACTH_HUMAN	ACTG2	7	23.1	7.82	7.0e-14	400.2399	3	-0.30	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-12_FTMSms2hcd	35.350	30	40	38.3	8.1e-9	3.0e-11	9	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[3-5]	1	P63267	ACTH_HUMAN	ACTG2	7	23.1	7.82	7.0e-14	1049.8025	3	-17	CPETLFQPSFIGMESAGIHETTYNSIMK	CPETLFQPSFIGM(Oxidation)ESAGIHETTYNSIMK	Oxidation@270=36	28	V20130429-12_FTMSms2hcd	59.170	258	285	14.7	2.0e-5	2.0e-8	4	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[3-5]	1	P63267	ACTH_HUMAN	ACTG2	7	23.1	7.82	7.0e-14	400.7716	2	0.84	RGILTLK	RGILTLK		7	V20130429-12_FTMSms2hcd	25.663	63	69	15.2	0.089	5.4e-4	10	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[3-6]	0	Q6S8J3	POTEE_HUMAN	POTEE	4	4.2	7.82	7.0e-14	895.9498	2	0.23	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-12_FTMSms2hcd	47.647	939	954	43.4	7.0e-14	8.2e-17	10	121364.6	HUMAN	POTE ankyrin domain family member E
[3-6]	0	Q6S8J3	POTEE_HUMAN	POTEE	4	4.2	7.82	7.0e-14	505.9213	3	0.12	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-12_FTMSms2hcd	31.055	785	795	27.6	1.4e-10	1.8e-13	9	121364.6	HUMAN	POTE ankyrin domain family member E
[3-6]	0	Q6S8J3	POTEE_HUMAN	POTEE	4	4.2	7.82	7.0e-14	400.2399	3	-0.30	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-12_FTMSms2hcd	35.350	729	739	38.3	8.1e-9	3.0e-11	9	121364.6	HUMAN	POTE ankyrin domain family member E
[3-6]	0	Q6S8J3	POTEE_HUMAN	POTEE	4	4.2	7.82	7.0e-14	400.7716	2	0.84	RGILTLK	RGILTLK		7	V20130429-12_FTMSms2hcd	25.663	762	768	15.2	0.089	5.4e-4	10	121364.6	HUMAN	POTE ankyrin domain family member E
[3-7]	0	A5A3E0	POTEF_HUMAN	POTEF	4	4.2	7.82	7.0e-14	895.9498	2	0.23	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-12_FTMSms2hcd	47.647	939	954	43.4	7.0e-14	8.2e-17	10	121445.7	HUMAN	POTE ankyrin domain family member F
[3-7]	0	A5A3E0	POTEF_HUMAN	POTEF	4	4.2	7.82	7.0e-14	505.9213	3	0.12	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-12_FTMSms2hcd	31.055	785	795	27.6	1.4e-10	1.8e-13	9	121445.7	HUMAN	POTE ankyrin domain family member F
[3-7]	0	A5A3E0	POTEF_HUMAN	POTEF	4	4.2	7.82	7.0e-14	400.2399	3	-0.30	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-12_FTMSms2hcd	35.350	729	739	38.3	8.1e-9	3.0e-11	9	121445.7	HUMAN	POTE ankyrin domain family member F
[3-7]	0	A5A3E0	POTEF_HUMAN	POTEF	4	4.2	7.82	7.0e-14	400.7716	2	0.84	RGILTLK	RGILTLK		7	V20130429-12_FTMSms2hcd	25.663	762	768	15.2	0.089	5.4e-4	10	121445.7	HUMAN	POTE ankyrin domain family member F
[3-8]	0	Q9BYX7	ACTBM_HUMAN	POTEKP	2	7.2	7.82	7.0e-14	895.9498	2	0.23	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-12_FTMSms2hcd	47.647	239	254	43.4	7.0e-14	8.2e-17	10	42016.6	HUMAN	Putative beta-actin-like protein 3
[3-8]	0	Q9BYX7	ACTBM_HUMAN	POTEKP	2	7.2	7.82	7.0e-14	505.9213	3	0.12	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-12_FTMSms2hcd	31.055	85	95	27.6	1.4e-10	1.8e-13	9	42016.6	HUMAN	Putative beta-actin-like protein 3
[3-9]	0	P0CG38	POTEI_HUMAN	POTEI	3	2.7	5.87	1.4e-10	505.9213	3	0.12	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-12_FTMSms2hcd	31.055	785	795	27.6	1.4e-10	1.8e-13	9	121283.5	HUMAN	POTE ankyrin domain family member I
[3-9]	0	P0CG38	POTEI_HUMAN	POTEI	3	2.7	5.87	1.4e-10	400.2399	3	-0.30	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-12_FTMSms2hcd	35.350	729	739	38.3	8.1e-9	3.0e-11	9	121283.5	HUMAN	POTE ankyrin domain family member I
[3-9]	0	P0CG38	POTEI_HUMAN	POTEI	3	2.7	5.87	1.4e-10	400.7716	2	0.84	RGILTLK	RGILTLK		7	V20130429-12_FTMSms2hcd	25.663	762	768	15.2	0.089	5.4e-4	10	121283.5	HUMAN	POTE ankyrin domain family member I
[3-10]	0	Q562R1	ACTBL_HUMAN	ACTBL2	3	6.1	7.82	7.0e-14	895.9498	2	0.23	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-12_FTMSms2hcd	47.647	240	255	43.4	7.0e-14	8.2e-17	10	42003.6	HUMAN	Beta-actin-like protein 2
[3-10]	0	Q562R1	ACTBL_HUMAN	ACTBL2	3	6.1	7.82	7.0e-14	360.6714	2	1.4	CDVDIR	CDVDIR		6	V20130429-12_FTMSms2hcd	16.243	286	291	22.8	0.0018	5.9e-6	3	42003.6	HUMAN	Beta-actin-like protein 2
[3-10]	0	Q562R1	ACTBL_HUMAN	ACTBL2	3	6.1	7.82	7.0e-14	424.7181	2	-0.64	CDVDIRK	CDVDIRK		7	V20130429-12_FTMSms2hcd	12.093	286	292	12.9	0.033	6.2e-5	3	42003.6	HUMAN	Beta-actin-like protein 2
[3-11]	0	P0CG39	POTEJ_HUMAN	POTEJ	2	1.7	4.80	1.4e-10	505.9213	3	0.12	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-12_FTMSms2hcd	31.055	748	758	27.6	1.4e-10	1.8e-13	9	117391.0	HUMAN	POTE ankyrin domain family member J
[3-11]	0	P0CG39	POTEJ_HUMAN	POTEJ	2	1.7	4.80	1.4e-10	400.7716	2	0.84	RGILTLK	RGILTLK		7	V20130429-12_FTMSms2hcd	25.663	725	731	15.2	0.089	5.4e-4	10	117391.0	HUMAN	POTE ankyrin domain family member J
[4]		P68371	TBB4B_HUMAN	TUBB4B	11	36.9	8.27	1.1e-14	933.4544	3	1.9	SGPFGQIFRPDNFVFGQSGAGNNWAK	SGPFGQIFRPDNFVFGQSGAGNNWAK		26	V20130429-12_FTMSms2hcd	61.271	78	103	47.1	1.1e-14	1.0e-17	5	49831.5	HUMAN	Tubulin beta-4B chain
[4]		P68371	TBB4B_HUMAN	TUBB4B	11	36.9	8.27	1.1e-14	677.3528	3	3.1	MSATFIGNSTAIQELFKR	M(Oxidation)SATFIGNSTAIQELFKR	Oxidation@363	18	V20130429-12_FTMSms2hcd	55.992	363	380	38.1	9.1e-14	1.2e-16	3	49831.5	HUMAN	Tubulin beta-4B chain
[4]		P68371	TBB4B_HUMAN	TUBB4B	11	36.9	8.27	1.1e-14	818.9185	2	-0.44	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-12_FTMSms2hcd	51.611	263	276	43.0	2.7e-13	3.3e-16	9	49831.5	HUMAN	Tubulin beta-4B chain
[4]		P68371	TBB4B_HUMAN	TUBB4B	11	36.9	8.27	1.1e-14	883.4559	2	1.8	EIVHLQAGQCGNQIGAK	EIVHLQAGQCGNQIGAK		17	V20130429-12_FTMSms2hcd	29.797	3	19	42.3	5.1e-12	6.8e-15	6	49831.5	HUMAN	Tubulin beta-4B chain
[4]		P68371	TBB4B_HUMAN	TUBB4B	11	36.9	8.27	1.1e-14	889.7793	3	4.4	LTTPTYGDLNHLVSATMSGVTTCLR	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLR	Oxidation@233	25	V20130429-12_FTMSms2hcd	60.063	217	241	38.2	6.8e-12	7.7e-15	5	49831.5	HUMAN	Tubulin beta-4B chain
[4]		P68371	TBB4B_HUMAN	TUBB4B	11	36.9	8.27	1.1e-14	696.3642	3	0.62	GHYTEGAELVDSVLDVVRK	GHYTEGAELVDSVLDVVRK		19	V20130429-12_FTMSms2hcd	57.975	104	122	43.0	2.6e-11	3.6e-14	5	49831.5	HUMAN	Tubulin beta-4B chain
[4]		P68371	TBB4B_HUMAN	TUBB4B	11	36.9	8.27	1.1e-14	668.3527	2	0.32	IMNTFSVVPSPK	IM(Oxidation)NTFSVVPSPK	Oxidation@164	12	V20130429-12_FTMSms2hcd	36.212	163	174	32.1	2.6e-11	4.2e-14	4	49831.5	HUMAN	Tubulin beta-4B chain
[4]		P68371	TBB4B_HUMAN	TUBB4B	11	36.9	8.27	1.1e-14	848.9210	2	1.0	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-12_FTMSms2hcd	53.953	337	350	29.6	4.1e-10	4.7e-13	7	49831.5	HUMAN	Tubulin beta-4B chain
[4]		P68371	TBB4B_HUMAN	TUBB4B	11	36.9	8.27	1.1e-14	520.3007	2	0.61	YLTVAAVFR	YLTVAAVFR		9	V20130429-12_FTMSms2hcd	48.117	310	318	43.6	1.5e-8	5.7e-11	3	49831.5	HUMAN	Tubulin beta-4B chain
[4]		P68371	TBB4B_HUMAN	TUBB4B	11	36.9	8.27	1.1e-14	690.3503	3	-0.74	MREIVHLQAGQCGNQIGAK	M(Oxidation)REIVHLQAGQCGNQIGAK	Oxidation@1	19	V20130429-12_FTMSms2hcd	27.408	1	19	21.6	1.3e-7	1.4e-10	6	49831.5	HUMAN	Tubulin beta-4B chain
[4]		P68371	TBB4B_HUMAN	TUBB4B	11	36.9	8.27	1.1e-14	539.2700	2	0.35	IREEYPDR	IREEYPDR		8	V20130429-12_FTMSms2hcd	12.040	155	162	39.7	1.3e-6	2.2e-9	8	49831.5	HUMAN	Tubulin beta-4B chain
[4-1]	1	P07437	TBB5_HUMAN	TUBB	11	36.9	8.27	1.1e-14	933.4544	3	1.9	SGPFGQIFRPDNFVFGQSGAGNNWAK	SGPFGQIFRPDNFVFGQSGAGNNWAK		26	V20130429-12_FTMSms2hcd	61.271	78	103	47.1	1.1e-14	1.0e-17	5	49671.3	HUMAN	Tubulin beta chain
[4-1]	1	P07437	TBB5_HUMAN	TUBB	11	36.9	8.27	1.1e-14	1021.5493	2	8.5	MAVTFIGNSTAIQELFKR	M(Oxidation)AVTFIGNSTAIQELFKR	Oxidation@363	18	V20130429-12_FTMSms2hcd	59.006	363	380	32.3	9.5e-14	2.1e-16	1	49671.3	HUMAN	Tubulin beta chain
[4-1]	1	P07437	TBB5_HUMAN	TUBB	11	36.9	8.27	1.1e-14	818.9185	2	-0.44	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-12_FTMSms2hcd	51.611	263	276	43.0	2.7e-13	3.3e-16	9	49671.3	HUMAN	Tubulin beta chain
[4-1]	1	P07437	TBB5_HUMAN	TUBB	11	36.9	8.27	1.1e-14	883.4559	2	1.8	EIVHIQAGQCGNQIGAK	EIVHIQAGQCGNQIGAK		17	V20130429-12_FTMSms2hcd	29.797	3	19	42.3	5.1e-12	6.8e-15	6	49671.3	HUMAN	Tubulin beta chain
[4-1]	1	P07437	TBB5_HUMAN	TUBB	11	36.9	8.27	1.1e-14	889.7793	3	4.4	LTTPTYGDLNHLVSATMSGVTTCLR	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLR	Oxidation@233	25	V20130429-12_FTMSms2hcd	60.063	217	241	38.2	6.8e-12	7.7e-15	5	49671.3	HUMAN	Tubulin beta chain
[4-1]	1	P07437	TBB5_HUMAN	TUBB	11	36.9	8.27	1.1e-14	696.3642	3	0.62	GHYTEGAELVDSVLDVVRK	GHYTEGAELVDSVLDVVRK		19	V20130429-12_FTMSms2hcd	57.975	104	122	43.0	2.6e-11	3.6e-14	5	49671.3	HUMAN	Tubulin beta chain
[4-1]	1	P07437	TBB5_HUMAN	TUBB	11	36.9	8.27	1.1e-14	668.3527	2	0.32	IMNTFSVVPSPK	IM(Oxidation)NTFSVVPSPK	Oxidation@164	12	V20130429-12_FTMSms2hcd	36.212	163	174	32.1	2.6e-11	4.2e-14	4	49671.3	HUMAN	Tubulin beta chain
[4-1]	1	P07437	TBB5_HUMAN	TUBB	11	36.9	8.27	1.1e-14	848.9210	2	1.0	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-12_FTMSms2hcd	53.953	337	350	29.6	4.1e-10	4.7e-13	7	49671.3	HUMAN	Tubulin beta chain
[4-1]	1	P07437	TBB5_HUMAN	TUBB	11	36.9	8.27	1.1e-14	520.3007	2	0.61	YLTVAAVFR	YLTVAAVFR		9	V20130429-12_FTMSms2hcd	48.117	310	318	43.6	1.5e-8	5.7e-11	3	49671.3	HUMAN	Tubulin beta chain
[4-1]	1	P07437	TBB5_HUMAN	TUBB	11	36.9	8.27	1.1e-14	690.3503	3	-0.74	MREIVHIQAGQCGNQIGAK	M(Oxidation)REIVHIQAGQCGNQIGAK	Oxidation@1	19	V20130429-12_FTMSms2hcd	27.408	1	19	21.6	1.3e-7	1.4e-10	6	49671.3	HUMAN	Tubulin beta chain
[4-1]	1	P07437	TBB5_HUMAN	TUBB	11	36.9	8.27	1.1e-14	539.2700	2	0.35	IREEYPDR	IREEYPDR		8	V20130429-12_FTMSms2hcd	12.040	155	162	39.7	1.3e-6	2.2e-9	8	49671.3	HUMAN	Tubulin beta chain
[4-2]	0	Q13885	TBB2A_HUMAN	TUBB2A	9	32.1	8.27	1.1e-14	933.4544	3	1.9	SGPFGQIFRPDNFVFGQSGAGNNWAK	SGPFGQIFRPDNFVFGQSGAGNNWAK		26	V20130429-12_FTMSms2hcd	61.271	78	103	47.1	1.1e-14	1.0e-17	5	49907.4	HUMAN	Tubulin beta-2A chain
[4-2]	0	Q13885	TBB2A_HUMAN	TUBB2A	9	32.1	8.27	1.1e-14	677.3528	3	3.1	MSATFIGNSTAIQELFKR	M(Oxidation)SATFIGNSTAIQELFKR	Oxidation@363	18	V20130429-12_FTMSms2hcd	55.992	363	380	38.1	9.1e-14	1.2e-16	3	49907.4	HUMAN	Tubulin beta-2A chain
[4-2]	0	Q13885	TBB2A_HUMAN	TUBB2A	9	32.1	8.27	1.1e-14	818.9185	2	-0.44	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-12_FTMSms2hcd	51.611	263	276	43.0	2.7e-13	3.3e-16	9	49907.4	HUMAN	Tubulin beta-2A chain
[4-2]	0	Q13885	TBB2A_HUMAN	TUBB2A	9	32.1	8.27	1.1e-14	883.4559	2	1.8	EIVHIQAGQCGNQIGAK	EIVHIQAGQCGNQIGAK		17	V20130429-12_FTMSms2hcd	29.797	3	19	42.3	5.1e-12	6.8e-15	6	49907.4	HUMAN	Tubulin beta-2A chain
[4-2]	0	Q13885	TBB2A_HUMAN	TUBB2A	9	32.1	8.27	1.1e-14	889.7793	3	4.4	LTTPTYGDLNHLVSATMSGVTTCLR	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLR	Oxidation@233	25	V20130429-12_FTMSms2hcd	60.063	217	241	38.2	6.8e-12	7.7e-15	5	49907.4	HUMAN	Tubulin beta-2A chain
[4-2]	0	Q13885	TBB2A_HUMAN	TUBB2A	9	32.1	8.27	1.1e-14	696.3642	3	0.62	GHYTEGAELVDSVLDVVRK	GHYTEGAELVDSVLDVVRK		19	V20130429-12_FTMSms2hcd	57.975	104	122	43.0	2.6e-11	3.6e-14	5	49907.4	HUMAN	Tubulin beta-2A chain
[4-2]	0	Q13885	TBB2A_HUMAN	TUBB2A	9	32.1	8.27	1.1e-14	848.9210	2	1.0	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-12_FTMSms2hcd	53.953	337	350	29.6	4.1e-10	4.7e-13	7	49907.4	HUMAN	Tubulin beta-2A chain
[4-2]	0	Q13885	TBB2A_HUMAN	TUBB2A	9	32.1	8.27	1.1e-14	690.3503	3	-0.74	MREIVHIQAGQCGNQIGAK	M(Oxidation)REIVHIQAGQCGNQIGAK	Oxidation@1	19	V20130429-12_FTMSms2hcd	27.408	1	19	21.6	1.3e-7	1.4e-10	6	49907.4	HUMAN	Tubulin beta-2A chain
[4-2]	0	Q13885	TBB2A_HUMAN	TUBB2A	9	32.1	8.27	1.1e-14	539.2700	2	0.35	IREEYPDR	IREEYPDR		8	V20130429-12_FTMSms2hcd	12.040	155	162	39.7	1.3e-6	2.2e-9	8	49907.4	HUMAN	Tubulin beta-2A chain
[4-3]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	9	32.1	8.27	1.1e-14	933.4544	3	1.9	SGPFGQIFRPDNFVFGQSGAGNNWAK	SGPFGQIFRPDNFVFGQSGAGNNWAK		26	V20130429-12_FTMSms2hcd	61.271	78	103	47.1	1.1e-14	1.0e-17	5	49953.5	HUMAN	Tubulin beta-2B chain
[4-3]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	9	32.1	8.27	1.1e-14	677.3528	3	3.1	MSATFIGNSTAIQELFKR	M(Oxidation)SATFIGNSTAIQELFKR	Oxidation@363	18	V20130429-12_FTMSms2hcd	55.992	363	380	38.1	9.1e-14	1.2e-16	3	49953.5	HUMAN	Tubulin beta-2B chain
[4-3]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	9	32.1	8.27	1.1e-14	818.9185	2	-0.44	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-12_FTMSms2hcd	51.611	263	276	43.0	2.7e-13	3.3e-16	9	49953.5	HUMAN	Tubulin beta-2B chain
[4-3]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	9	32.1	8.27	1.1e-14	883.4559	2	1.8	EIVHIQAGQCGNQIGAK	EIVHIQAGQCGNQIGAK		17	V20130429-12_FTMSms2hcd	29.797	3	19	42.3	5.1e-12	6.8e-15	6	49953.5	HUMAN	Tubulin beta-2B chain
[4-3]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	9	32.1	8.27	1.1e-14	889.7793	3	4.4	LTTPTYGDLNHLVSATMSGVTTCLR	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLR	Oxidation@233	25	V20130429-12_FTMSms2hcd	60.063	217	241	38.2	6.8e-12	7.7e-15	5	49953.5	HUMAN	Tubulin beta-2B chain
[4-3]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	9	32.1	8.27	1.1e-14	696.3642	3	0.62	GHYTEGAELVDSVLDVVRK	GHYTEGAELVDSVLDVVRK		19	V20130429-12_FTMSms2hcd	57.975	104	122	43.0	2.6e-11	3.6e-14	5	49953.5	HUMAN	Tubulin beta-2B chain
[4-3]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	9	32.1	8.27	1.1e-14	848.9210	2	1.0	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-12_FTMSms2hcd	53.953	337	350	29.6	4.1e-10	4.7e-13	7	49953.5	HUMAN	Tubulin beta-2B chain
[4-3]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	9	32.1	8.27	1.1e-14	690.3503	3	-0.74	MREIVHIQAGQCGNQIGAK	M(Oxidation)REIVHIQAGQCGNQIGAK	Oxidation@1	19	V20130429-12_FTMSms2hcd	27.408	1	19	21.6	1.3e-7	1.4e-10	6	49953.5	HUMAN	Tubulin beta-2B chain
[4-3]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	9	32.1	8.27	1.1e-14	539.2700	2	0.35	IREEYPDR	IREEYPDR		8	V20130429-12_FTMSms2hcd	12.040	155	162	39.7	1.3e-6	2.2e-9	8	49953.5	HUMAN	Tubulin beta-2B chain
[4-4]	0	P04350	TBB4A_HUMAN	TUBB4A	8	26.8	8.27	1.1e-14	933.4544	3	1.9	SGPFGQIFRPDNFVFGQSGAGNNWAK	SGPFGQIFRPDNFVFGQSGAGNNWAK		26	V20130429-12_FTMSms2hcd	61.271	78	103	47.1	1.1e-14	1.0e-17	5	49586.2	HUMAN	Tubulin beta-4A chain
[4-4]	0	P04350	TBB4A_HUMAN	TUBB4A	8	26.8	8.27	1.1e-14	818.9185	2	-0.44	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-12_FTMSms2hcd	51.611	263	276	43.0	2.7e-13	3.3e-16	9	49586.2	HUMAN	Tubulin beta-4A chain
[4-4]	0	P04350	TBB4A_HUMAN	TUBB4A	8	26.8	8.27	1.1e-14	883.4559	2	1.8	EIVHLQAGQCGNQIGAK	EIVHLQAGQCGNQIGAK		17	V20130429-12_FTMSms2hcd	29.797	3	19	42.3	5.1e-12	6.8e-15	6	49586.2	HUMAN	Tubulin beta-4A chain
[4-4]	0	P04350	TBB4A_HUMAN	TUBB4A	8	26.8	8.27	1.1e-14	889.7793	3	4.4	LTTPTYGDLNHLVSATMSGVTTCLR	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLR	Oxidation@233	25	V20130429-12_FTMSms2hcd	60.063	217	241	38.2	6.8e-12	7.7e-15	5	49586.2	HUMAN	Tubulin beta-4A chain
[4-4]	0	P04350	TBB4A_HUMAN	TUBB4A	8	26.8	8.27	1.1e-14	668.3527	2	0.32	IMNTFSVVPSPK	IM(Oxidation)NTFSVVPSPK	Oxidation@164	12	V20130429-12_FTMSms2hcd	36.212	163	174	32.1	2.6e-11	4.2e-14	4	49586.2	HUMAN	Tubulin beta-4A chain
[4-4]	0	P04350	TBB4A_HUMAN	TUBB4A	8	26.8	8.27	1.1e-14	848.9210	2	1.0	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-12_FTMSms2hcd	53.953	337	350	29.6	4.1e-10	4.7e-13	7	49586.2	HUMAN	Tubulin beta-4A chain
[4-4]	0	P04350	TBB4A_HUMAN	TUBB4A	8	26.8	8.27	1.1e-14	520.3007	2	0.61	YLTVAAVFR	YLTVAAVFR		9	V20130429-12_FTMSms2hcd	48.117	310	318	43.6	1.5e-8	5.7e-11	3	49586.2	HUMAN	Tubulin beta-4A chain
[4-4]	0	P04350	TBB4A_HUMAN	TUBB4A	8	26.8	8.27	1.1e-14	690.3503	3	-0.74	MREIVHLQAGQCGNQIGAK	M(Oxidation)REIVHLQAGQCGNQIGAK	Oxidation@1	19	V20130429-12_FTMSms2hcd	27.408	1	19	21.6	1.3e-7	1.4e-10	6	49586.2	HUMAN	Tubulin beta-4A chain
[4-5]	0	Q13509	TBB3_HUMAN	TUBB3	5	14.2	6.82	5.1e-12	883.4559	2	1.8	EIVHIQAGQCGNQIGAK	EIVHIQAGQCGNQIGAK		17	V20130429-12_FTMSms2hcd	29.797	3	19	42.3	5.1e-12	6.8e-15	6	50433.2	HUMAN	Tubulin beta-3 chain
[4-5]	0	Q13509	TBB3_HUMAN	TUBB3	5	14.2	6.82	5.1e-12	696.3642	3	0.62	GHYTEGAELVDSVLDVVRK	GHYTEGAELVDSVLDVVRK		19	V20130429-12_FTMSms2hcd	57.975	104	122	43.0	2.6e-11	3.6e-14	5	50433.2	HUMAN	Tubulin beta-3 chain
[4-5]	0	Q13509	TBB3_HUMAN	TUBB3	5	14.2	6.82	5.1e-12	668.3527	2	0.32	IMNTFSVVPSPK	IM(Oxidation)NTFSVVPSPK	Oxidation@164	12	V20130429-12_FTMSms2hcd	36.212	163	174	32.1	2.6e-11	4.2e-14	4	50433.2	HUMAN	Tubulin beta-3 chain
[4-5]	0	Q13509	TBB3_HUMAN	TUBB3	5	14.2	6.82	5.1e-12	848.9210	2	1.0	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-12_FTMSms2hcd	53.953	337	350	29.6	4.1e-10	4.7e-13	7	50433.2	HUMAN	Tubulin beta-3 chain
[4-5]	0	Q13509	TBB3_HUMAN	TUBB3	5	14.2	6.82	5.1e-12	690.3503	3	-0.74	MREIVHIQAGQCGNQIGAK	M(Oxidation)REIVHIQAGQCGNQIGAK	Oxidation@1	19	V20130429-12_FTMSms2hcd	27.408	1	19	21.6	1.3e-7	1.4e-10	6	50433.2	HUMAN	Tubulin beta-3 chain
[4-6]	0	Q9BUF5	TBB6_HUMAN	TUBB6	2	6.3	7.51	2.7e-13	818.9185	2	-0.44	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-12_FTMSms2hcd	51.611	263	276	43.0	2.7e-13	3.3e-16	9	49857.6	HUMAN	Tubulin beta-6 chain
[4-6]	0	Q9BUF5	TBB6_HUMAN	TUBB6	2	6.3	7.51	2.7e-13	848.9210	2	1.0	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-12_FTMSms2hcd	53.953	337	350	29.6	4.1e-10	4.7e-13	7	49857.6	HUMAN	Tubulin beta-6 chain
[4-7]	0	Q3ZCM7	TBB8_HUMAN	TUBB8	2	5.0	7.51	2.7e-13	818.9185	2	-0.44	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-12_FTMSms2hcd	51.611	263	276	43.0	2.7e-13	3.3e-16	9	49776.5	HUMAN	Tubulin beta-8 chain
[4-7]	0	Q3ZCM7	TBB8_HUMAN	TUBB8	2	5.0	7.51	2.7e-13	539.2700	2	0.35	IREEYPDR	IREEYPDR		8	V20130429-12_FTMSms2hcd	12.040	155	162	39.7	1.3e-6	2.2e-9	8	49776.5	HUMAN	Tubulin beta-8 chain
[4-8]	0	A6NKZ8	YI016_HUMAN		2	5.9	7.51	2.7e-13	818.9185	2	-0.44	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@195	14	V20130429-12_FTMSms2hcd	51.611	191	204	43.0	2.7e-13	3.3e-16	9	41775.5	HUMAN	Putative tubulin beta chain-like protein ENSP00000290377
[4-8]	0	A6NKZ8	YI016_HUMAN		2	5.9	7.51	2.7e-13	539.2700	2	0.35	IREEYPDR	IREEYPDR		8	V20130429-12_FTMSms2hcd	12.040	83	90	39.7	1.3e-6	2.2e-9	8	41775.5	HUMAN	Putative tubulin beta chain-like protein ENSP00000290377
[4-9]	0	A6NNZ2	TBB8B_HUMAN		2	5.0	7.51	2.7e-13	818.9185	2	-0.44	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-12_FTMSms2hcd	51.611	263	276	43.0	2.7e-13	3.3e-16	9	49573.1	HUMAN	Tubulin beta-8 chain B
[4-9]	0	A6NNZ2	TBB8B_HUMAN		2	5.0	7.51	2.7e-13	539.2700	2	0.35	IREEYPDR	IREEYPDR		8	V20130429-12_FTMSms2hcd	12.040	155	162	39.7	1.3e-6	2.2e-9	8	49573.1	HUMAN	Tubulin beta-8 chain B
[4-10]	0	Q9H4B7	TBB1_HUMAN	TUBB1	1	1.8	3.87	1.3e-6	539.2700	2	0.35	IREEYPDR	IREEYPDR		8	V20130429-12_FTMSms2hcd	12.040	155	162	39.7	1.3e-6	2.2e-9	8	50327.4	HUMAN	Tubulin beta-1 chain
[5]		P06733	ENOA_HUMAN	ENO1	12	44.5	7.94	4.2e-14	731.9090	2	1.4	FGANAILGVSLAVCK	FGANAILGVSLAVCK		15	V20130429-12_FTMSms2hcd	60.050	106	120	38.2	4.2e-14	1.0e-16	3	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	12	44.5	7.94	4.2e-14	726.0298	3	0.24	AGYTDKVVIGMDVAASEFFR	AGYTDKVVIGMDVAASEFFR		20	V20130429-12_FTMSms2hcd	64.260	234	253	34.1	1.3e-12	1.4e-15	1	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	12	44.5	7.94	4.2e-14	995.8040	3	1.1	SFIKDYPVVSIEDPFDQDDWGAWQK	SFIKDYPVVSIEDPFDQDDWGAWQK		25	V20130429-12_FTMSms2hcd	65.479	282	306	50.4	2.9e-12	2.9e-15	1	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	12	44.5	7.94	4.2e-14	753.6508	4	3.9	HIADLAGNSEVILPVPAFNVINGGSHAGNK	HIADLAGNSEVILPVPAFNVINGGSHAGNK		30	V20130429-12_FTMSms2hcd	58.416	133	162	46.9	6.7e-12	1.4e-14	1	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	12	44.5	7.94	4.2e-14	1148.5773	2	4.2	SGETEDTFIADLVVGLCTGQIK	SGETEDTFIADLVVGLCTGQIK		22	V20130429-12_FTMSms2hcd	77.792	373	394	27.9	1.0e-10	1.3e-13	3	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	12	44.5	7.94	4.2e-14	731.3608	3	-0.63	AGYTDKVVIGMDVAASEFFR	AGYTDKVVIGM(Oxidation)DVAASEFFR	Oxidation@244	20	V20130429-12_FTMSms2hcd	50.986	234	253	35.3	3.4e-10	3.6e-13	1	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	12	44.5	7.94	4.2e-14	788.9040	2	0.50	VNQIGSVTESLQACK	VNQIGSVTESLQACK		15	V20130429-12_FTMSms2hcd	39.360	344	358	40.5	4.0e-10	5.7e-13	2	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	12	44.5	7.94	4.2e-14	703.8622	2	0.67	GNPTVEVDLFTSK	GNPTVEVDLFTSK		13	V20130429-12_FTMSms2hcd	44.325	16	28	32.0	1.2e-9	1.6e-12	1	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	12	44.5	7.94	4.2e-14	915.1292	3	-2.0	DATNVGDEGGFAPNILENKEGLELLK	DATNVGDEGGFAPNILENKEGLELLK		26	V20130429-12_FTMSms2hcd	58.389	203	228	34.2	1.2e-9	1.5e-12	1	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	12	44.5	7.94	4.2e-14	450.2824	2	1.6	TIAPALVSK	TIAPALVSK		9	V20130429-12_FTMSms2hcd	26.685	72	80	30.6	4.1e-7	1.5e-9	1	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	12	44.5	7.94	4.2e-14	572.3121	2	1.1	IGAEVYHNLK	IGAEVYHNLK		10	V20130429-12_FTMSms2hcd	23.065	184	193	31.7	9.0e-6	1.5e-8	1	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	12	44.5	7.94	4.2e-14	452.7347	2	-0.088	IEEELGSK	IEEELGSK		8	V20130429-12_FTMSms2hcd	14.229	413	420	32.3	2.3e-4	3.9e-7	1	47169.4	HUMAN	Alpha-enolase
[5-1]	0	P13929	ENOB_HUMAN	ENO3	3	12.0	7.94	4.2e-14	731.9090	2	1.4	FGANAILGVSLAVCK	FGANAILGVSLAVCK		15	V20130429-12_FTMSms2hcd	60.050	106	120	38.2	4.2e-14	1.0e-16	3	46932.2	HUMAN	Beta-enolase
[5-1]	0	P13929	ENOB_HUMAN	ENO3	3	12.0	7.94	4.2e-14	1148.5773	2	4.2	SGETEDTFIADLVVGLCTGQIK	SGETEDTFIADLVVGLCTGQIK		22	V20130429-12_FTMSms2hcd	77.792	373	394	27.9	1.0e-10	1.3e-13	3	46932.2	HUMAN	Beta-enolase
[5-1]	0	P13929	ENOB_HUMAN	ENO3	3	12.0	7.94	4.2e-14	788.9040	2	0.50	VNQIGSVTESIQACK	VNQIGSVTESIQACK		15	V20130429-12_FTMSms2hcd	39.360	344	358	40.5	4.0e-10	5.7e-13	2	46932.2	HUMAN	Beta-enolase
[5-2]	0	P09104	ENOG_HUMAN	ENO2	2	8.5	7.76	4.2e-14	731.9090	2	1.4	FGANAILGVSLAVCK	FGANAILGVSLAVCK		15	V20130429-12_FTMSms2hcd	60.050	106	120	38.2	4.2e-14	1.0e-16	3	47269.0	HUMAN	Gamma-enolase
[5-2]	0	P09104	ENOG_HUMAN	ENO2	2	8.5	7.76	4.2e-14	1148.5773	2	4.2	SGETEDTFIADLVVGLCTGQIK	SGETEDTFIADLVVGLCTGQIK		22	V20130429-12_FTMSms2hcd	77.792	373	394	27.9	1.0e-10	1.3e-13	3	47269.0	HUMAN	Gamma-enolase
[6]		P14618	KPYM_HUMAN	PKM2	10	32.2	9.45	6.9e-17	1006.5378	3	1.5	TATESFASDPILYRPVAVALDTKGPEIR	TATESFASDPILYRPVAVALDTKGPEIR		28	V20130429-12_FTMSms2hcd	56.489	93	120	59.6	6.9e-17	1.8e-19	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[6]		P14618	KPYM_HUMAN	PKM2	10	32.2	9.45	6.9e-17	1088.0670	2	4.0	LAPITSDPTEATAVGAVEASFK	LAPITSDPTEATAVGAVEASFK		22	V20130429-12_FTMSms2hcd	55.246	401	422	55.6	5.2e-16	7.4e-19	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[6]		P14618	KPYM_HUMAN	PKM2	10	32.2	9.45	6.9e-17	834.0941	3	5.5	GIFPVLCKDPVQEAWAEDVDLR	GIFPVLCKDPVQEAWAEDVDLR		22	V20130429-12_FTMSms2hcd	64.393	468	489	33.5	2.0e-15	2.7e-18	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[6]		P14618	KPYM_HUMAN	PKM2	10	32.2	9.45	6.9e-17	803.0900	3	0.15	KGDVVIVLTGWRPGSGFTNTMR	KGDVVIVLTGWRPGSGFTNTM(Oxidation)R	Oxidation@525	22	V20130429-12_FTMSms2hcd	50.053	505	526	43.1	1.7e-12	3.0e-15	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[6]		P14618	KPYM_HUMAN	PKM2	10	32.2	9.45	6.9e-17	883.4114	4	-0.34	MSKPHSEAGTAFIQTQQLHAAMADTFLEHMCR	M(Met-loss+Acetyl)SKPHSEAGTAFIQTQQLHAAM(Oxidation)ADTFLEHM(Oxidation)CR	Met-loss+Acetyl@1;Oxidation@22;Oxidation@30	32	V20130429-12_FTMSms2hcd	45.133	1	32	43.2	8.1e-12	8.3e-15	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[6]		P14618	KPYM_HUMAN	PKM2	10	32.2	9.45	6.9e-17	722.3829	4	0.50	GFFKKGDVVIVLTGWRPGSGFTNTMR	GFFKKGDVVIVLTGWRPGSGFTNTM(Oxidation)R	Oxidation@525	26	V20130429-12_FTMSms2hcd	54.793	501	526	35.2	1.7e-10	3.6e-13	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[6]		P14618	KPYM_HUMAN	PKM2	10	32.2	9.45	6.9e-17	696.7005	3	-0.15	EAEAAIYHLQLFEELRR	EAEAAIYHLQLFEELRR		17	V20130429-12_FTMSms2hcd	53.340	384	400	38.5	1.2e-8	1.9e-11	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[6]		P14618	KPYM_HUMAN	PKM2	10	32.2	9.45	6.9e-17	651.8400	2	-8.2	NTGIICTIGPASR	NTGIICTIGPASR		13	V20130429-12_FTMSms2hcd	36.884	44	56	35.9	7.6e-8	1.1e-10	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[6]		P14618	KPYM_HUMAN	PKM2	10	32.2	9.45	6.9e-17	599.3284	2	1.8	LDIDSPPITAR	LDIDSPPITAR		11	V20130429-12_FTMSms2hcd	35.855	33	43	36.0	1.8e-7	4.2e-10	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[6]		P14618	KPYM_HUMAN	PKM2	10	32.2	9.45	6.9e-17	1193.5442	3	4.6	MSKPHSEAGTAFIQTQQLHAAMADTFLEHMCR	M(Met-loss+Acetyl)SKPHSEAGTAFIQT(Phospho)QQLHAAMADTFLEHMCR	Met-loss+Acetyl@1;Phospho@15=12	32	V20130429-12_FTMSms2hcd	44.723	1	32	11.3	6.7e-4	7.1e-7	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[7]		P08670	VIME_HUMAN	VIM	12	34.1	6.80	5.4e-12	457.7324	2	-0.29	SYVTTSTR	SYVTTSTR		8	V20130429-12_FTMSms2hcd	11.313	29	36	26.2	5.4e-12	1.1e-14	1	53652.1	HUMAN	Vimentin
[7]		P08670	VIME_HUMAN	VIM	12	34.1	6.80	5.4e-12	748.3967	2	-0.14	TYSLGSALRPSTSR	TYSLGSALRPSTSR		14	V20130429-12_FTMSms2hcd	30.478	37	50	41.4	1.5e-9	2.3e-12	1	53652.1	HUMAN	Vimentin
[7]		P08670	VIME_HUMAN	VIM	12	34.1	6.80	5.4e-12	794.4038	2	1.9	TNEKVELQELNDR	TNEKVELQELNDR		13	V20130429-12_FTMSms2hcd	26.710	101	113	54.9	2.6e-9	3.2e-12	2	53652.1	HUMAN	Vimentin
[7]		P08670	VIME_HUMAN	VIM	12	34.1	6.80	5.4e-12	785.9512	2	-0.019	ISLPLPNFSSLNLR	ISLPLPNFSSLNLR		14	V20130429-12_FTMSms2hcd	65.547	411	424	42.8	4.0e-9	1.4e-11	1	53652.1	HUMAN	Vimentin
[7]		P08670	VIME_HUMAN	VIM	12	34.1	6.80	5.4e-12	774.0538	3	0.83	QVQSLTCEVDALKGTNESLER	QVQSLTCEVDALKGTNESLER		21	V20130429-12_FTMSms2hcd	43.589	322	342	33.5	4.5e-9	5.0e-12	1	53652.1	HUMAN	Vimentin
[7]		P08670	VIME_HUMAN	VIM	12	34.1	6.80	5.4e-12	589.6068	3	0.62	LQDEIQNMKEEMAR	LQDEIQNM(Oxidation)KEEM(Oxidation)AR	Oxidation@372;Oxidation@376	14	V20130429-12_FTMSms2hcd	16.308	365	378	28.1	6.1e-9	6.9e-12	1	53652.1	HUMAN	Vimentin
[7]		P08670	VIME_HUMAN	VIM	12	34.1	6.80	5.4e-12	513.9744	3	-1.2	ILLAELEQLKGQGK	ILLAELEQLKGQGK		14	V20130429-12_FTMSms2hcd	45.362	130	143	46.0	2.7e-8	2.0e-10	1	53652.1	HUMAN	Vimentin
[7]		P08670	VIME_HUMAN	VIM	12	34.1	6.80	5.4e-12	592.9610	3	3.4	FADLSEAANRNNDALR	FADLSEAANRNNDALR		16	V20130429-12_FTMSms2hcd	30.531	295	310	26.9	1.8e-6	2.0e-9	1	53652.1	HUMAN	Vimentin
[7]		P08670	VIME_HUMAN	VIM	12	34.1	6.80	5.4e-12	512.2587	2	-0.42	QQYESVAAK	QQYESVAAK		9	V20130429-12_FTMSms2hcd	11.249	274	282	20.8	4.3e-5	7.2e-8	1	53652.1	HUMAN	Vimentin
[7]		P08670	VIME_HUMAN	VIM	12	34.1	6.80	5.4e-12	755.8572	2	0.28	MFGGPGTASRPSSSR	M(Oxidation)FGGPGTASRPSSSR	Oxidation@14	15	V20130429-12_FTMSms2hcd	14.559	14	28	11.0	6.3e-4	8.6e-7	1	53652.1	HUMAN	Vimentin
[7]		P08670	VIME_HUMAN	VIM	12	34.1	6.80	5.4e-12	509.9487	3	2.5	HLREYQDLLNVK	HLREYQDLLNVK		12	V20130429-12_FTMSms2hcd	34.536	379	390	15.7	9.8e-4	2.0e-6	4	53652.1	HUMAN	Vimentin
[7]		P08670	VIME_HUMAN	VIM	12	34.1	6.80	5.4e-12	563.3068	2	1.1	FANYIDKVR	FANYIDKVR		9	V20130429-12_FTMSms2hcd	57.049	114	122	16.9	0.0025	5.2e-6	1	53652.1	HUMAN	Vimentin
[7-1]	0	P17661	DESM_HUMAN	DES	2	5.3	5.36	2.6e-9	794.4038	2	1.9	TNEKVELQELNDR	TNEKVELQELNDR		13	V20130429-12_FTMSms2hcd	26.710	106	118	54.9	2.6e-9	3.2e-12	2	53536.2	HUMAN	Desmin
[7-1]	0	P17661	DESM_HUMAN	DES	2	5.3	5.36	2.6e-9	509.9487	3	2.5	HLREYQDLLNVK	HLREYQDLLNVK		12	V20130429-12_FTMSms2hcd	34.536	384	395	15.7	9.8e-4	2.0e-6	4	53536.2	HUMAN	Desmin
[8]		P11142	HSP7C_HUMAN	HSPA8	6	14.6	9.15	2.4e-16	821.7505	3	1.3	MSKGPAVGIDLGTTYSCVGVFQHGK	M(Met-loss+Acetyl)SKGPAVGIDLGTTYSCVGVFQHGK	Met-loss+Acetyl@1	25	V20130429-12_FTMSms2hcd	53.832	1	25	47.4	2.4e-16	2.8e-19	1	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[8]		P11142	HSP7C_HUMAN	HSPA8	6	14.6	9.15	2.4e-16	991.5108	2	8.3	TVTNAVVTVPAYFNDSQR	TVTNAVVTVPAYFNDSQR		18	V20130429-12_FTMSms2hcd	46.122	138	155	40.2	6.7e-13	9.0e-16	1	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[8]		P11142	HSP7C_HUMAN	HSPA8	6	14.6	9.15	2.4e-16	744.3553	2	1.4	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-12_FTMSms2hcd	34.696	37	49	41.0	9.1e-12	1.1e-14	6	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[8]		P11142	HSP7C_HUMAN	HSPA8	6	14.6	9.15	2.4e-16	596.6684	3	0.26	IINEPTAAAIAYGLDKK	IINEPTAAAIAYGLDKK		17	V20130429-12_FTMSms2hcd	43.064	172	188	34.2	5.5e-11	1.7e-13	2	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[8]		P11142	HSP7C_HUMAN	HSPA8	6	14.6	9.15	2.4e-16	627.3116	2	-0.12	FEELNADLFR	FEELNADLFR		10	V20130429-12_FTMSms2hcd	48.513	302	311	26.2	3.3e-8	3.8e-11	2	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[8]		P11142	HSP7C_HUMAN	HSPA8	6	14.6	9.15	2.4e-16	614.8172	2	-0.75	VEIIANDQGNR	VEIIANDQGNR		11	V20130429-12_FTMSms2hcd	20.587	26	36	45.9	5.6e-8	8.6e-11	7	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[8-1]	0	P54652	HSP72_HUMAN	HSPA2	4	8.0	6.68	9.1e-12	744.3553	2	1.4	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-12_FTMSms2hcd	34.696	38	50	41.0	9.1e-12	1.1e-14	6	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[8-1]	0	P54652	HSP72_HUMAN	HSPA2	4	8.0	6.68	9.1e-12	596.6684	3	0.26	IINEPTAAAIAYGLDKK	IINEPTAAAIAYGLDKK		17	V20130429-12_FTMSms2hcd	43.064	173	189	34.2	5.5e-11	1.7e-13	2	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[8-1]	0	P54652	HSP72_HUMAN	HSPA2	4	8.0	6.68	9.1e-12	627.3116	2	-0.12	FEELNADLFR	FEELNADLFR		10	V20130429-12_FTMSms2hcd	48.513	305	314	26.2	3.3e-8	3.8e-11	2	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[8-1]	0	P54652	HSP72_HUMAN	HSPA2	4	8.0	6.68	9.1e-12	614.8172	2	-0.75	VEIIANDQGNR	VEIIANDQGNR		11	V20130429-12_FTMSms2hcd	20.587	27	37	45.9	5.6e-8	8.6e-11	7	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[8-2]	2	P08107	HSP71_HUMAN	HSPA1A	4	9.8	6.68	9.1e-12	744.3553	2	1.4	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-12_FTMSms2hcd	34.696	37	49	41.0	9.1e-12	1.1e-14	6	70052.8	HUMAN	Heat shock 70 kDa protein 1A/1B
[8-2]	2	P08107	HSP71_HUMAN	HSPA1A	4	9.8	6.68	9.1e-12	1000.1747	3	12	ELEQVCNPIISGLYQGAGGPGPGGFGAQGPK	ELEQVCNPIISGLYQGAGGPGPGGFGAQGPK		31	V20130429-12_FTMSms2hcd	60.438	598	628	39.1	3.7e-10	4.8e-13	1	70052.8	HUMAN	Heat shock 70 kDa protein 1A/1B
[8-2]	2	P08107	HSP71_HUMAN	HSPA1A	4	9.8	6.68	9.1e-12	614.8172	2	-0.75	VEIIANDQGNR	VEIIANDQGNR		11	V20130429-12_FTMSms2hcd	20.587	26	36	45.9	5.6e-8	8.6e-11	7	70052.8	HUMAN	Heat shock 70 kDa protein 1A/1B
[8-2]	2	P08107	HSP71_HUMAN	HSPA1A	4	9.8	6.68	9.1e-12	502.2744	2	-0.33	LSKEEIER	LSKEEIER		8	V20130429-12_FTMSms2hcd	12.345	510	517	15.5	0.0015	2.5e-6	2	70052.8	HUMAN	Heat shock 70 kDa protein 1A/1B
[8-3]	1	P34931	HS71L_HUMAN	HSPA1L	3	5.0	6.68	9.1e-12	744.3553	2	1.4	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-12_FTMSms2hcd	34.696	39	51	41.0	9.1e-12	1.1e-14	6	70375.6	HUMAN	Heat shock 70 kDa protein 1-like
[8-3]	1	P34931	HS71L_HUMAN	HSPA1L	3	5.0	6.68	9.1e-12	614.8172	2	-0.75	VEIIANDQGNR	VEIIANDQGNR		11	V20130429-12_FTMSms2hcd	20.587	28	38	45.9	5.6e-8	8.6e-11	7	70375.6	HUMAN	Heat shock 70 kDa protein 1-like
[8-3]	1	P34931	HS71L_HUMAN	HSPA1L	3	5.0	6.68	9.1e-12	502.2744	2	-0.33	LSKEEIER	LSKEEIER		8	V20130429-12_FTMSms2hcd	12.345	512	519	15.5	0.0015	2.5e-6	2	70375.6	HUMAN	Heat shock 70 kDa protein 1-like
[8-4]	1	P17066	HSP76_HUMAN	HSPA6	3	6.4	6.68	9.1e-12	744.3553	2	1.4	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-12_FTMSms2hcd	34.696	39	51	41.0	9.1e-12	1.1e-14	6	71028.7	HUMAN	Heat shock 70 kDa protein 6
[8-4]	1	P17066	HSP76_HUMAN	HSPA6	3	6.4	6.68	9.1e-12	614.8172	2	-0.75	VEILANDQGNR	VEILANDQGNR		11	V20130429-12_FTMSms2hcd	20.587	28	38	45.9	5.6e-8	8.6e-11	7	71028.7	HUMAN	Heat shock 70 kDa protein 6
[8-4]	1	P17066	HSP76_HUMAN	HSPA6	3	6.4	6.68	9.1e-12	922.5228	2	19	IINEPTAAAIAYGLDRR	IINEPTAAAIAYGLDRR		17	V20130429-12_FTMSms2hcd	75.382	174	190	13.5	0.019	7.7e-5	1	71028.7	HUMAN	Heat shock 70 kDa protein 6
[8-5]	0	P48741	HSP77_HUMAN	HSPA7	2	6.5	6.68	9.1e-12	744.3553	2	1.4	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-12_FTMSms2hcd	34.696	39	51	41.0	9.1e-12	1.1e-14	6	40244.8	HUMAN	Putative heat shock 70 kDa protein 7
[8-5]	0	P48741	HSP77_HUMAN	HSPA7	2	6.5	6.68	9.1e-12	614.8172	2	-0.75	VEILANDQGNR	VEILANDQGNR		11	V20130429-12_FTMSms2hcd	20.587	28	38	45.9	5.6e-8	8.6e-11	7	40244.8	HUMAN	Putative heat shock 70 kDa protein 7
[8-6]	0	P11021	GRP78_HUMAN	HSPA5	1	1.7	4.63	5.6e-8	614.8172	2	-0.75	VEIIANDQGNR	VEIIANDQGNR		11	V20130429-12_FTMSms2hcd	20.587	50	60	45.9	5.6e-8	8.6e-11	7	72333.5	HUMAN	78 kDa glucose-regulated protein
[9]		P08238	HS90B_HUMAN	HSP90AB1	5	7.2	7.94	4.2e-14	973.3983	2	-0.87	IEDVGSDEEDDSGKDKK	IEDVGS(Phospho)DEEDDSGKDKK	Phospho@255=63	17	V20130429-12_FTMSms2hcd	11.985	250	266	45.1	4.2e-14	6.7e-17	2	83264.9	HUMAN	Heat shock protein HSP 90-beta
[9]		P08238	HS90B_HUMAN	HSP90AB1	5	7.2	7.94	4.2e-14	594.9880	3	-0.15	HLEINPDHPIVETLR	HLEINPDHPIVETLR		15	V20130429-12_FTMSms2hcd	38.219	625	639	45.0	4.6e-14	8.1e-17	1	83264.9	HUMAN	Heat shock protein HSP 90-beta
[9]		P08238	HS90B_HUMAN	HSP90AB1	5	7.2	7.94	4.2e-14	571.2832	2	-0.44	LGIHEDSTNR	LGIHEDSTNR		10	V20130429-12_FTMSms2hcd	12.759	439	448	53.0	3.0e-11	4.9e-14	1	83264.9	HUMAN	Heat shock protein HSP 90-beta
[9]		P08238	HS90B_HUMAN	HSP90AB1	5	7.2	7.94	4.2e-14	478.5169	4	0.58	KHLEINPDHPIVETLR	KHLEINPDHPIVETLR		16	V20130429-12_FTMSms2hcd	33.481	624	639	22.6	2.6e-10	7.6e-13	1	83264.9	HUMAN	Heat shock protein HSP 90-beta
[9]		P08238	HS90B_HUMAN	HSP90AB1	5	7.2	7.94	4.2e-14	576.2819	2	-1.2	YIDQEELNK	YIDQEELNK		9	V20130429-12_FTMSms2hcd	20.651	276	284	22.9	1.7e-7	2.6e-10	4	83264.9	HUMAN	Heat shock protein HSP 90-beta
[9-1]	0	Q58FF8	H90B2_HUMAN	HSP90AB2P	2	6.8	7.94	4.2e-14	973.3983	2	-0.87	IEDVGSDEEDDSGKDKK	IEDVGS(Phospho)DEEDDSGKDKK	Phospho@177=63	17	V20130429-12_FTMSms2hcd	11.985	172	188	45.1	4.2e-14	6.7e-17	2	44349.3	HUMAN	Putative heat shock protein HSP 90-beta 2
[9-1]	0	Q58FF8	H90B2_HUMAN	HSP90AB2P	2	6.8	7.94	4.2e-14	576.2819	2	-1.2	YIDQEELNK	YIDQEELNK		9	V20130429-12_FTMSms2hcd	20.651	198	206	22.9	1.7e-7	2.6e-10	4	44349.3	HUMAN	Putative heat shock protein HSP 90-beta 2
[9-2]	0	P07900	HS90A_HUMAN	HSP90AA1	1	1.2	2.67	1.7e-7	576.2819	2	-1.2	YIDQEELNK	YIDQEELNK		9	V20130429-12_FTMSms2hcd	20.651	284	292	22.9	1.7e-7	2.6e-10	4	84660.4	HUMAN	Heat shock protein HSP 90-alpha
[9-3]	0	Q14568	HS902_HUMAN	HSP90AA2	1	2.6	2.67	1.7e-7	576.2819	2	-1.2	YIDQEELNK	YIDQEELNK		9	V20130429-12_FTMSms2hcd	20.651	283	291	22.9	1.7e-7	2.6e-10	4	39365.1	HUMAN	Putative heat shock protein HSP 90-alpha A2
[10]		P10809	CH60_HUMAN	HSPD1	6	18.7	9.06	3.5e-16	715.7168	3	3.0	ALMLQGVDLLADAVAVTMGPK	ALM(Oxidation)LQGVDLLADAVAVTM(Oxidation)GPK	Oxidation@40;Oxidation@55	21	V20130429-12_FTMSms2hcd	70.208	38	58	54.4	3.5e-16	6.5e-19	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[10]		P10809	CH60_HUMAN	HSPD1	6	18.7	9.06	3.5e-16	524.9728	3	0.58	GVMLAVDAVIAELKK	GVM(Oxidation)LAVDAVIAELKK	Oxidation@145	15	V20130429-12_FTMSms2hcd	59.182	143	157	37.1	8.2e-11	3.6e-13	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[10]		P10809	CH60_HUMAN	HSPD1	6	18.7	9.06	3.5e-16	577.0058	3	-0.70	RGVMLAVDAVIAELKK	RGVM(Oxidation)LAVDAVIAELKK	Oxidation@145	16	V20130429-12_FTMSms2hcd	53.699	142	157	39.6	1.6e-9	8.1e-12	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[10]		P10809	CH60_HUMAN	HSPD1	6	18.7	9.06	3.5e-16	672.8629	2	2.0	TVIIEQSWGSPK	TVIIEQSWGSPK		12	V20130429-12_FTMSms2hcd	36.802	61	72	28.2	5.5e-9	8.9e-12	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[10]		P10809	CH60_HUMAN	HSPD1	6	18.7	9.06	3.5e-16	385.2603	3	-0.31	LKVGLQVVAVK	LKVGLQVVAVK		11	V20130429-12_FTMSms2hcd	37.401	291	301	16.6	1.0e-4	4.2e-6	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[10]		P10809	CH60_HUMAN	HSPD1	6	18.7	9.06	3.5e-16	921.6509	5	16	TALLDAAGVASLLTTAEVVVTEIPKEEKDPGMGAMGGMGGGMGGGMF	TALLDAAGVASLLTTAEVVVT(Phospho)EIPKEEKDPGMGAMGGMGGGMGGGMF	Phospho@537|540|547	47	V20130429-12_FTMSms2hcd	77.458	527	573	12.1	4.9e-4	7.6e-7	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[11]		P62937	PPIA_HUMAN	PPIA	6	55.8	7.80	7.7e-14	917.4396	3	0.64	HTGPGILSMANAGPNTNGSQFFICTAK	HTGPGILSM(Oxidation)ANAGPNTNGSQFFICTAK	Oxidation@100	27	V20130429-12_FTMSms2hcd	47.850	92	118	57.0	7.7e-14	7.2e-17	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[11]		P62937	PPIA_HUMAN	PPIA	6	55.8	7.80	7.7e-14	779.3642	2	1.5	IIPGFMCQGGDFTR	IIPGFM(Oxidation)CQGGDFTR	Oxidation@61	14	V20130429-12_FTMSms2hcd	42.876	56	69	53.2	9.3e-13	1.1e-15	2	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[11]		P62937	PPIA_HUMAN	PPIA	6	55.8	7.80	7.7e-14	758.4021	2	0.98	TEWLDGKHVVFGK	TEWLDGKHVVFGK		13	V20130429-12_FTMSms2hcd	36.708	119	131	37.1	3.5e-11	5.7e-14	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[11]		P62937	PPIA_HUMAN	PPIA	6	55.8	7.80	7.7e-14	595.8093	2	2.3	KITIADCGQLE	KITIADCGQLE		11	V20130429-12_FTMSms2hcd	36.994	155	165	20.0	7.5e-6	1.1e-8	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[11]		P62937	PPIA_HUMAN	PPIA	6	55.8	7.80	7.7e-14	460.5898	3	-1.5	VSFELFADKVPK	VSFELFADKVPK		12	V20130429-12_FTMSms2hcd	47.380	20	31	24.6	2.7e-5	5.4e-8	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[11]		P62937	PPIA_HUMAN	PPIA	6	55.8	7.80	7.7e-14	611.3100	3	2.3	SIYGEKFEDENFILK	SIYGEKFEDENFILK		15	V20130429-12_FTMSms2hcd	46.495	77	91	14.9	6.1e-5	7.2e-8	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[11-1]	0	Q9Y536	PAL4A_HUMAN	PPIAL4A	1	8.5	7.22	9.3e-13	779.3642	2	1.5	IIPGFMCQGGDFTR	IIPGFM(Oxidation)CQGGDFTR	Oxidation@61	14	V20130429-12_FTMSms2hcd	42.876	56	69	53.2	9.3e-13	1.1e-15	2	18182.0	HUMAN	Peptidyl-prolyl cis-trans isomerase A-like 4A/B/C
[12]		O43707	ACTN4_HUMAN	ACTN4	4	5.6	8.39	6.4e-15	685.0815	4	0.11	AIMTYVSSFYHAFSGAQKAETAANR	AIM(Oxidation)TYVSSFYHAFSGAQKAETAANR	Oxidation@258	25	V20130429-12_FTMSms2hcd	51.598	256	280	45.7	6.4e-15	6.3e-18	2	104854.9	HUMAN	Alpha-actinin-4
[12]		O43707	ACTN4_HUMAN	ACTN4	4	5.6	8.39	6.4e-15	1012.4843	2	1.5	AIMTYVSSFYHAFSGAQK	AIM(Oxidation)TYVSSFYHAFSGAQK	Oxidation@258	18	V20130429-12_FTMSms2hcd	53.617	256	273	33.9	5.7e-13	5.8e-16	2	104854.9	HUMAN	Alpha-actinin-4
[12]		O43707	ACTN4_HUMAN	ACTN4	4	5.6	8.39	6.4e-15	669.9932	3	0.87	AIMTYVSSFYHAFSGAQK	AIMTYVSSFYHAFSGAQK		18	V20130429-12_FTMSms2hcd	60.980	256	273	32.5	3.3e-12	3.5e-15	2	104854.9	HUMAN	Alpha-actinin-4
[12]		O43707	ACTN4_HUMAN	ACTN4	4	5.6	8.39	6.4e-15	908.8192	3	7.7	ALDFIASKGVKLVSIGAEEIVDGNAK	ALDFIASKGVKLVS(Phospho)IGAEEIVDGNAK	Phospho@128=8	26	V20130429-12_FTMSms2hcd	59.355	115	140	11.0	0.044	9.9e-5	1	104854.9	HUMAN	Alpha-actinin-4
[12-1]	0	P12814	ACTN1_HUMAN	ACTN1	3	2.8	8.39	6.4e-15	685.0815	4	0.11	AIMTYVSSFYHAFSGAQKAETAANR	AIM(Oxidation)TYVSSFYHAFSGAQKAETAANR	Oxidation@239	25	V20130429-12_FTMSms2hcd	51.598	237	261	45.7	6.4e-15	6.3e-18	2	103058.4	HUMAN	Alpha-actinin-1
[12-1]	0	P12814	ACTN1_HUMAN	ACTN1	3	2.8	8.39	6.4e-15	1012.4843	2	1.5	AIMTYVSSFYHAFSGAQK	AIM(Oxidation)TYVSSFYHAFSGAQK	Oxidation@239	18	V20130429-12_FTMSms2hcd	53.617	237	254	33.9	5.7e-13	5.8e-16	2	103058.4	HUMAN	Alpha-actinin-1
[12-1]	0	P12814	ACTN1_HUMAN	ACTN1	3	2.8	8.39	6.4e-15	669.9932	3	0.87	AIMTYVSSFYHAFSGAQK	AIMTYVSSFYHAFSGAQK		18	V20130429-12_FTMSms2hcd	60.980	237	254	32.5	3.3e-12	3.5e-15	2	103058.4	HUMAN	Alpha-actinin-1
[13]		P07737	PROF1_HUMAN	PFN1	5	35.0	6.16	8.4e-11	822.4744	2	2.9	TFVNITPAEVGVLVGK	TFVNITPAEVGVLVGK		16	V20130429-12_FTMSms2hcd	58.631	39	54	36.7	8.4e-11	3.4e-13	1	15054.4	HUMAN	Profilin-1
[13]		P07737	PROF1_HUMAN	PFN1	5	35.0	6.16	8.4e-11	639.0266	3	0.27	TFVNITPAEVGVLVGKDR	TFVNITPAEVGVLVGKDR		18	V20130429-12_FTMSms2hcd	54.513	39	56	47.3	3.6e-10	1.4e-12	1	15054.4	HUMAN	Profilin-1
[13]		P07737	PROF1_HUMAN	PFN1	5	35.0	6.16	8.4e-11	735.8877	2	6.4	SSFYVNGLTLGGQK	SSFYVNGLTLGGQK		14	V20130429-12_FTMSms2hcd	44.084	57	70	38.4	5.5e-9	8.6e-12	1	15054.4	HUMAN	Profilin-1
[13]		P07737	PROF1_HUMAN	PFN1	5	35.0	6.16	8.4e-11	445.7729	2	0.64	TLVLLMGK	TLVLLM(Oxidation)GK	Oxidation@114	8	V20130429-12_FTMSms2hcd	34.842	109	116	21.3	6.2e-7	3.9e-9	1	15054.4	HUMAN	Profilin-1
[13]		P07737	PROF1_HUMAN	PFN1	5	35.0	6.16	8.4e-11	375.8321	3	0.15	CYEMASHLR	CYEM(Oxidation)ASHLR	Oxidation@131	9	V20130429-12_FTMSms2hcd	12.465	128	136	11.2	0.0056	1.2e-5	1	15054.4	HUMAN	Profilin-1
[14]		P23528	COF1_HUMAN	CFL1	4	41.6	7.02	2.1e-12	1021.5389	3	2.9	NIILEEGKEILVGDVGQTVDDPYATFVK	NIILEEGKEILVGDVGQTVDDPYATFVK		28	V20130429-12_FTMSms2hcd	64.436	46	73	47.5	2.1e-12	4.7e-15	1	18502.7	HUMAN	Cofilin-1
[14]		P23528	COF1_HUMAN	CFL1	4	41.6	7.02	2.1e-12	669.3215	2	7.3	YALYDATYETK	YALYDATYETK		11	V20130429-12_FTMSms2hcd	32.402	82	92	37.8	2.3e-9	3.2e-12	2	18502.7	HUMAN	Cofilin-1
[14]		P23528	COF1_HUMAN	CFL1	4	41.6	7.02	2.1e-12	626.8338	2	-0.21	AVLFCLSEDKK	AVLFCLSEDKK		11	V20130429-12_FTMSms2hcd	38.473	35	45	36.8	2.9e-9	4.4e-12	1	18502.7	HUMAN	Cofilin-1
[14]		P23528	COF1_HUMAN	CFL1	4	41.6	7.02	2.1e-12	562.2867	4	0.70	LTGIKHELQANCYEEVKDR	LTGIKHELQANCYEEVKDR		19	V20130429-12_FTMSms2hcd	29.905	128	146	27.0	9.5e-9	1.2e-11	1	18502.7	HUMAN	Cofilin-1
[14-1]	0	Q9Y281	COF2_HUMAN	CFL2	1	6.6	5.16	2.3e-9	669.3215	2	7.3	YALYDATYETK	YALYDATYETK		11	V20130429-12_FTMSms2hcd	32.402	82	92	37.8	2.3e-9	3.2e-12	2	18736.8	HUMAN	Cofilin-2
[15]		P68363	TBA1B_HUMAN	TUBA1B	4	12.9	7.24	8.3e-13	764.3679	2	-1.0	SIQFVDWCPTGFK	SIQFVDWCPTGFK		13	V20130429-12_FTMSms2hcd	59.127	340	352	46.0	8.3e-13	1.0e-15	2	50152.1	HUMAN	Tubulin alpha-1B chain
[15]		P68363	TBA1B_HUMAN	TUBA1B	4	12.9	7.24	8.3e-13	851.4573	2	0.91	AVFVDLEPTVIDEVR	AVFVDLEPTVIDEVR		15	V20130429-12_FTMSms2hcd	57.264	65	79	46.5	5.3e-11	9.5e-14	3	50152.1	HUMAN	Tubulin alpha-1B chain
[15]		P68363	TBA1B_HUMAN	TUBA1B	4	12.9	7.24	8.3e-13	744.4442	2	1.3	LISQIVSSITASLR	LISQIVSSITASLR		14	V20130429-12_FTMSms2hcd	67.427	230	243	46.4	6.0e-10	3.5e-12	5	50152.1	HUMAN	Tubulin alpha-1B chain
[15]		P68363	TBA1B_HUMAN	TUBA1B	4	12.9	7.24	8.3e-13	586.3240	3	-3.3	IHFPLATYAPVISAEK	IHFPLATYAPVISAEK		16	V20130429-12_FTMSms2hcd	52.335	265	280	14.0	5.6e-5	1.3e-7	6	50152.1	HUMAN	Tubulin alpha-1B chain
[15-1]	1	Q9BQE3	TBA1C_HUMAN	TUBA1C	4	12.9	6.27	5.3e-11	851.4573	2	0.91	AVFVDLEPTVIDEVR	AVFVDLEPTVIDEVR		15	V20130429-12_FTMSms2hcd	57.264	65	79	46.5	5.3e-11	9.5e-14	3	49895.8	HUMAN	Tubulin alpha-1C chain
[15-1]	1	Q9BQE3	TBA1C_HUMAN	TUBA1C	4	12.9	6.27	5.3e-11	744.4442	2	1.3	LISQIVSSITASLR	LISQIVSSITASLR		14	V20130429-12_FTMSms2hcd	67.427	230	243	46.4	6.0e-10	3.5e-12	5	49895.8	HUMAN	Tubulin alpha-1C chain
[15-1]	1	Q9BQE3	TBA1C_HUMAN	TUBA1C	4	12.9	6.27	5.3e-11	771.3776	2	1.4	TIQFVDWCPTGFK	TIQFVDWCPTGFK		13	V20130429-12_FTMSms2hcd	59.570	340	352	32.0	7.5e-9	8.6e-12	5	49895.8	HUMAN	Tubulin alpha-1C chain
[15-1]	1	Q9BQE3	TBA1C_HUMAN	TUBA1C	4	12.9	6.27	5.3e-11	586.3240	3	-3.3	IHFPLATYAPVISAEK	IHFPLATYAPVISAEK		16	V20130429-12_FTMSms2hcd	52.335	265	280	14.0	5.6e-5	1.3e-7	6	49895.8	HUMAN	Tubulin alpha-1C chain
[15-2]	0	P68366	TBA4A_HUMAN	TUBA4A	3	9.6	7.24	8.3e-13	764.3679	2	-1.0	SIQFVDWCPTGFK	SIQFVDWCPTGFK		13	V20130429-12_FTMSms2hcd	59.127	340	352	46.0	8.3e-13	1.0e-15	2	49924.9	HUMAN	Tubulin alpha-4A chain
[15-2]	0	P68366	TBA4A_HUMAN	TUBA4A	3	9.6	7.24	8.3e-13	744.4442	2	1.3	LISQIVSSITASLR	LISQIVSSITASLR		14	V20130429-12_FTMSms2hcd	67.427	230	243	46.4	6.0e-10	3.5e-12	5	49924.9	HUMAN	Tubulin alpha-4A chain
[15-2]	0	P68366	TBA4A_HUMAN	TUBA4A	3	9.6	7.24	8.3e-13	586.3240	3	-3.3	IHFPLATYAPVISAEK	IHFPLATYAPVISAEK		16	V20130429-12_FTMSms2hcd	52.335	265	280	14.0	5.6e-5	1.3e-7	6	49924.9	HUMAN	Tubulin alpha-4A chain
[15-3]	1	Q71U36	TBA1A_HUMAN	TUBA1A	3	9.8	6.27	5.3e-11	851.4573	2	0.91	AVFVDLEPTVIDEVR	AVFVDLEPTVIDEVR		15	V20130429-12_FTMSms2hcd	57.264	65	79	46.5	5.3e-11	9.5e-14	3	50136.1	HUMAN	Tubulin alpha-1A chain
[15-3]	1	Q71U36	TBA1A_HUMAN	TUBA1A	3	9.8	6.27	5.3e-11	771.3776	2	1.4	TIQFVDWCPTGFK	TIQFVDWCPTGFK		13	V20130429-12_FTMSms2hcd	59.570	340	352	32.0	7.5e-9	8.6e-12	5	50136.1	HUMAN	Tubulin alpha-1A chain
[15-3]	1	Q71U36	TBA1A_HUMAN	TUBA1A	3	9.8	6.27	5.3e-11	586.3240	3	-3.3	IHFPLATYAPVISAEK	IHFPLATYAPVISAEK		16	V20130429-12_FTMSms2hcd	52.335	265	280	14.0	5.6e-5	1.3e-7	6	50136.1	HUMAN	Tubulin alpha-1A chain
[15-4]	1	Q9NY65	TBA8_HUMAN	TUBA8	2	6.0	5.70	6.0e-10	744.4442	2	1.3	LISQIVSSITASLR	LISQIVSSITASLR		14	V20130429-12_FTMSms2hcd	67.427	230	243	46.4	6.0e-10	3.5e-12	5	50094.0	HUMAN	Tubulin alpha-8 chain
[15-4]	1	Q9NY65	TBA8_HUMAN	TUBA8	2	6.0	5.70	6.0e-10	771.3776	2	1.4	TIQFVDWCPTGFK	TIQFVDWCPTGFK		13	V20130429-12_FTMSms2hcd	59.570	340	352	32.0	7.5e-9	8.6e-12	5	50094.0	HUMAN	Tubulin alpha-8 chain
[15-5]	1	Q13748	TBA3C_HUMAN	TUBA3C	2	6.4	4.31	7.5e-9	771.3776	2	1.4	TIQFVDWCPTGFK	TIQFVDWCPTGFK		13	V20130429-12_FTMSms2hcd	59.570	340	352	32.0	7.5e-9	8.6e-12	5	49960.0	HUMAN	Tubulin alpha-3C/D chain
[15-5]	1	Q13748	TBA3C_HUMAN	TUBA3C	2	6.4	4.31	7.5e-9	586.3240	3	-3.3	IHFPLATYAPVISAEK	IHFPLATYAPVISAEK		16	V20130429-12_FTMSms2hcd	52.335	265	280	14.0	5.6e-5	1.3e-7	6	49960.0	HUMAN	Tubulin alpha-3C/D chain
[15-6]	1	Q6PEY2	TBA3E_HUMAN	TUBA3E	2	6.4	4.31	7.5e-9	771.3776	2	1.4	TIQFVDWCPTGFK	TIQFVDWCPTGFK		13	V20130429-12_FTMSms2hcd	59.570	340	352	32.0	7.5e-9	8.6e-12	5	49859.0	HUMAN	Tubulin alpha-3E chain
[15-6]	1	Q6PEY2	TBA3E_HUMAN	TUBA3E	2	6.4	4.31	7.5e-9	586.3240	3	-3.3	IHFPLATYAPVISAEK	IHFPLATYAPVISAEK		16	V20130429-12_FTMSms2hcd	52.335	265	280	14.0	5.6e-5	1.3e-7	6	49859.0	HUMAN	Tubulin alpha-3E chain
[15-7]	0	Q9H853	TBA4B_HUMAN	TUBA4B	1	5.8	5.70	6.0e-10	744.4442	2	1.3	LISQIVSSITASLR	LISQIVSSITASLR		14	V20130429-12_FTMSms2hcd	67.427	169	182	46.4	6.0e-10	3.5e-12	5	27551.5	HUMAN	Putative tubulin-like protein alpha-4B
[16]		P00558	PGK1_HUMAN	PGK1	3	7.2	6.96	2.8e-12	843.6911	4	0.42	VADKIQLINNMLDKVNEMIIGGGMAFTFLK	VADKIQLINNM(Oxidation)LDKVNEM(Oxidation)IIGGGM(Oxidation)AFTFLK	Oxidation@227;Oxidation@234;Oxidation@240	30	V20130429-12_FTMSms2hcd	63.970	217	246	47.4	2.8e-12	5.6e-15	1	44615.1	HUMAN	Phosphoglycerate kinase 1
[16]		P00558	PGK1_HUMAN	PGK1	3	7.2	6.96	2.8e-12	835.6950	4	2.0	VADKIQLINNMLDKVNEMIIGGGMAFTFLK	VADKIQLINNM(Oxidation)LDKVNEMIIGGGMAFTFLK	Oxidation@227|234	30	V20130429-12_FTMSms2hcd	75.986	217	246	42.9	9.4e-12	2.4e-14	1	44615.1	HUMAN	Phosphoglycerate kinase 1
[16]		P00558	PGK1_HUMAN	PGK1	3	7.2	6.96	2.8e-12	839.6946	4	3.1	VADKIQLINNMLDKVNEMIIGGGMAFTFLK	VADKIQLINNM(Oxidation)LDKVNEM(Oxidation)IIGGGMAFTFLK	Oxidation@227=39;Oxidation@234=36	30	V20130429-12_FTMSms2hcd	69.333	217	246	35.6	7.3e-11	1.8e-13	1	44615.1	HUMAN	Phosphoglycerate kinase 1
[17]		P62805	H4_HUMAN	HIST1H4A	4	41.7	5.44	1.8e-9	494.9389	3	2.5	TVTAMDVVYALKR	TVTAM(Oxidation)DVVYALKR	Oxidation@85	13	V20130429-12_FTMSms2hcd	40.694	81	93	42.1	1.8e-9	4.2e-12	1	11367.4	HUMAN	Histone H4
[17]		P62805	H4_HUMAN	HIST1H4A	4	41.7	5.44	1.8e-9	663.3795	2	-1.4	DNIQGITKPAIR	DNIQGITKPAIR		12	V20130429-12_FTMSms2hcd	27.421	25	36	42.0	2.1e-9	7.4e-12	1	11367.4	HUMAN	Histone H4
[17]		P62805	H4_HUMAN	HIST1H4A	4	41.7	5.44	1.8e-9	567.7752	2	0.48	DAVTYTEHAK	DAVTYTEHAK		10	V20130429-12_FTMSms2hcd	12.267	69	78	29.4	3.0e-7	4.9e-10	1	11367.4	HUMAN	Histone H4
[17]		P62805	H4_HUMAN	HIST1H4A	4	41.7	5.44	1.8e-9	527.0316	4	0.95	VFLENVIRDAVTYTEHAK	VFLENVIRDAVTYTEHAK		18	V20130429-12_FTMSms2hcd	62.954	61	78	17.8	8.1e-7	1.3e-9	1	11367.4	HUMAN	Histone H4
[18]		P05387	RLA2_HUMAN	RPLP2	3	40.9	7.80	7.6e-14	934.9918	2	0.57	YVASYLLAALGGNSSPSAK	YVASYLLAALGGNSSPSAK		19	V20130429-12_FTMSms2hcd	58.282	3	21	46.1	7.6e-14	1.2e-16	1	11665.0	HUMAN	60S acidic ribosomal protein P2
[18]		P05387	RLA2_HUMAN	RPLP2	3	40.9	7.80	7.6e-14	886.9557	2	0.93	ILDSVGIEADDDRLNK	ILDSVGIEADDDRLNK		16	V20130429-12_FTMSms2hcd	35.135	26	41	38.7	1.6e-12	2.1e-15	1	11665.0	HUMAN	60S acidic ribosomal protein P2
[18]		P05387	RLA2_HUMAN	RPLP2	3	40.9	7.80	7.6e-14	628.8463	2	0.66	NIEDVIAQGIGK	NIEDVIAQGIGK		12	V20130429-12_FTMSms2hcd	47.552	50	61	32.7	4.5e-6	8.7e-9	1	11665.0	HUMAN	60S acidic ribosomal protein P2
[19]		Q13268	DHRS2_HUMAN	DHRS2	3	16.7	7.81	7.5e-14	887.5110	3	1.9	RGAVILVSSIAAYNPVVALGVYNVSK	RGAVILVSSIAAYNPVVALGVYNVSK		26	V20130429-12_FTMSms2hcd	68.377	142	167	47.1	7.5e-14	1.1e-15	1	27438.9	HUMAN	Dehydrogenase/reductase SDR family member 2
[19]		Q13268	DHRS2_HUMAN	DHRS2	3	16.7	7.81	7.5e-14	1252.7183	2	6.8	GAVILVSSIAAYNPVVALGVYNVSK	GAVILVSSIAAYNPVVALGVYNVSK		25	V20130429-12_FTMSms2hcd	74.111	143	167	28.6	2.9e-11	2.8e-13	1	27438.9	HUMAN	Dehydrogenase/reductase SDR family member 2
[19]		Q13268	DHRS2_HUMAN	DHRS2	3	16.7	7.81	7.5e-14	803.4485	2	-3.8	VAVVTGSTSGIGFAIAR	VAVVTGSTSGIGFAIAR		17	V20130429-12_FTMSms2hcd	46.577	16	32	25.8	5.7e-6	1.4e-8	1	27438.9	HUMAN	Dehydrogenase/reductase SDR family member 2
[20]		P60174	TPIS_HUMAN	TPI1	4	26.6	5.89	1.6e-10	801.9471	2	-1.3	VVLAYEPVWAIGTGK	VVLAYEPVWAIGTGK		15	V20130429-12_FTMSms2hcd	55.616	198	212	32.1	1.6e-10	3.9e-13	1	30791.3	HUMAN	Triosephosphate isomerase
[20]		P60174	TPIS_HUMAN	TPI1	4	26.6	5.89	1.6e-10	584.3223	3	0.19	VAHALAEGLGVIACIGEK	VAHALAEGLGVIACIGEK		18	V20130429-12_FTMSms2hcd	55.100	151	168	38.8	3.0e-10	7.6e-13	1	30791.3	HUMAN	Triosephosphate isomerase
[20]		P60174	TPIS_HUMAN	TPI1	4	26.6	5.89	1.6e-10	635.3302	2	1.9	IIYGGSVTGATCK	IIYGGSVTGATCK		13	V20130429-12_FTMSms2hcd	27.643	244	256	25.9	5.5e-8	9.7e-11	1	30791.3	HUMAN	Triosephosphate isomerase
[20]		P60174	TPIS_HUMAN	TPI1	4	26.6	5.89	1.6e-10	1053.2229	3	4.0	ELASQPDVDGFLVGGASLKPEFVDIINAKQ	ELASQPDVDGFLVGGASLKPEFVDIINAKQ		30	V20130429-12_FTMSms2hcd	66.202	257	286	10.8	0.025	6.0e-5	1	30791.3	HUMAN	Triosephosphate isomerase
[21]		P02765	FETUA_HUMAN	AHSG	3	3.5	6.06	5.8e-11	640.7563	2	-0.48	CDSSPDSAEDVR	CDSSPDSAEDVR		12	V20130429-12_FTMSms2hcd	13.213	132	143	38.1	5.8e-11	1.4e-13	1	39325.0	HUMAN	Alpha-2-HS-glycoprotein
[21]		P02765	FETUA_HUMAN	AHSG	3	3.5	6.06	5.8e-11	704.8041	2	0.018	CDSSPDSAEDVRK	CDSSPDSAEDVRK		13	V20130429-12_FTMSms2hcd	9.695	132	144	37.1	9.9e-11	1.7e-13	1	39325.0	HUMAN	Alpha-2-HS-glycoprotein
[21]		P02765	FETUA_HUMAN	AHSG	3	3.5	6.06	5.8e-11	744.7872	2	-0.071	CDSSPDSAEDVRK	CDSSPDS(Phospho)AEDVRK	Phospho@134|138	13	V20130429-12_FTMSms2hcd	11.053	132	144	30.6	9.2e-9	2.4e-11	1	39325.0	HUMAN	Alpha-2-HS-glycoprotein
[22]		P21333	FLNA_HUMAN	FLNA	3	2.9	7.21	9.7e-13	603.9339	5	10	TFSVWYVPEVTGTHKVTVLFAGQHIAK	TFSVWYVPEVTGTHKVTVLFAGQHIAK		27	V20130429-12_FTMSms2hcd	56.902	341	367	35.1	9.7e-13	4.7e-15	1	280741.3	HUMAN	Filamin-A
[22]		P21333	FLNA_HUMAN	FLNA	3	2.9	7.21	9.7e-13	966.2700	4	-1.3	VGSAADIPINISETDLSLLTATVVPPSGREEPCLLKR	VGSAADIPINISETDLSLLTATVVPPSGREEPCLLKR		37	V20130429-12_FTMSms2hcd	71.429	1965	2001	40.1	2.3e-12	9.3e-15	1	280741.3	HUMAN	Filamin-A
[22]		P21333	FLNA_HUMAN	FLNA	3	2.9	7.21	9.7e-13	588.7779	2	-1.2	CSGPGLSPGMVR	CSGPGLSPGM(Oxidation)VR	Oxidation@1462	12	V20130429-12_FTMSms2hcd	22.947	1453	1464	18.6	3.1e-4	5.4e-7	1	280741.3	HUMAN	Filamin-A
[23]		P43487	RANG_HUMAN	RANBP1	2	16.9	9.32	1.2e-16	671.3336	4	-0.28	AWVWNTHADFADECPKPELLAIR	AWVWNTHADFADECPKPELLAIR		23	V20130429-12_FTMSms2hcd	59.730	119	141	43.6	1.2e-16	1.3e-19	1	23310.3	HUMAN	Ran-specific GTPase-activating protein
[23]		P43487	RANG_HUMAN	RANBP1	2	16.9	9.32	1.2e-16	691.3223	2	0.28	TLEEDEEELFK	TLEEDEEELFK		11	V20130429-12_FTMSms2hcd	44.153	40	50	37.1	2.1e-9	2.9e-12	1	23310.3	HUMAN	Ran-specific GTPase-activating protein
[24]		P07355	ANXA2_HUMAN	ANXA2	3	12.1	6.75	6.9e-12	550.9979	3	0.16	SALSGHLETVILGLLK	SALSGHLETVILGLLK		16	V20130429-12_FTMSms2hcd	69.575	89	104	46.4	6.9e-12	9.7e-14	2	38604.4	HUMAN	Annexin A2
[24]		P07355	ANXA2_HUMAN	ANXA2	3	12.1	6.75	6.9e-12	536.2794	2	1.1	MSTVHEILCK	M(Met-loss+Acetyl)STVHEILCK	Met-loss+Acetyl@1	10	V20130429-12_FTMSms2hcd	34.099	1	10	37.6	3.7e-10	6.6e-13	2	38604.4	HUMAN	Annexin A2
[24]		P07355	ANXA2_HUMAN	ANXA2	3	12.1	6.75	6.9e-12	828.4000	2	-1.1	TPAQYDASELKASMK	TPAQYDASELKASM(Oxidation)K	Oxidation@118	15	V20130429-12_FTMSms2hcd	21.349	105	119	11.5	0.0037	4.2e-6	2	38604.4	HUMAN	Annexin A2
[24-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	3	12.1	6.75	6.9e-12	550.9979	3	0.16	SALSGHLETVILGLLK	SALSGHLETVILGLLK		16	V20130429-12_FTMSms2hcd	69.575	89	104	46.4	6.9e-12	9.7e-14	2	38659.3	HUMAN	Putative annexin A2-like protein
[24-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	3	12.1	6.75	6.9e-12	536.2794	2	1.1	MSTVHEILCK	M(Met-loss+Acetyl)STVHEILCK	Met-loss+Acetyl@1	10	V20130429-12_FTMSms2hcd	34.099	1	10	37.6	3.7e-10	6.6e-13	2	38659.3	HUMAN	Putative annexin A2-like protein
[24-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	3	12.1	6.75	6.9e-12	828.4000	2	-1.1	TPAQYDASELKASMK	TPAQYDASELKASM(Oxidation)K	Oxidation@118	15	V20130429-12_FTMSms2hcd	21.349	105	119	11.5	0.0037	4.2e-6	2	38659.3	HUMAN	Putative annexin A2-like protein
[25]		P19338	NUCL_HUMAN	NCL	2	6.3	7.70	1.2e-13	1251.1422	2	4.6	TLVLSNLSYSATEETLQEVFEK	TLVLSNLSYSATEETLQEVFEK		22	V20130429-12_FTMSms2hcd	70.834	487	508	48.0	1.2e-13	1.7e-16	1	76615.0	HUMAN	Nucleolin
[25]		P19338	NUCL_HUMAN	NCL	2	6.3	7.70	1.2e-13	653.3126	4	-0.28	GYAFIEFASFEDAKEALNSCNKR	GYAFIEFASFEDAKEALNSCNKR		23	V20130429-12_FTMSms2hcd	59.247	524	546	34.0	3.9e-12	3.7e-15	1	76615.0	HUMAN	Nucleolin
[26]		P07195	LDHB_HUMAN	LDHB	4	16.8	4.26	2.8e-7	1197.9907	3	2.4	LIAPVAEEEATVPNNKITVVGVGQVGMACAISILGK	LIAPVAEEEATVPNNKITVVGVGQVGMACAISILGK		36	V20130429-12_FTMSms2hcd	75.516	8	43	23.6	2.8e-7	1.9e-9	1	36638.8	HUMAN	L-lactate dehydrogenase B chain
[26]		P07195	LDHB_HUMAN	LDHB	4	16.8	4.26	2.8e-7	643.8696	2	0.37	LKDDEVAQLKK	LKDDEVAQLKK		11	V20130429-12_FTMSms2hcd	17.467	309	319	40.4	1.3e-6	3.0e-9	1	36638.8	HUMAN	L-lactate dehydrogenase B chain
[26]		P07195	LDHB_HUMAN	LDHB	4	16.8	4.26	2.8e-7	639.3628	3	1.6	ITVVGVGQVGMACAISILGK	ITVVGVGQVGMACAISILGK		20	V20130429-12_FTMSms2hcd	76.254	24	43	21.0	1.6e-5	6.2e-8	1	36638.8	HUMAN	L-lactate dehydrogenase B chain
[26]		P07195	LDHB_HUMAN	LDHB	4	16.8	4.26	2.8e-7	457.2952	2	0.21	IVVVTAGVR	IVVVTAGVR		9	V20130429-12_FTMSms2hcd	27.799	92	100	14.4	6.9e-4	3.7e-6	1	36638.8	HUMAN	L-lactate dehydrogenase B chain
[27]		P35579	MYH9_HUMAN	MYH9	2	1.5	8.36	7.1e-15	808.0134	2	16	VISGVLQLGNIVFKK	VISGVLQLGNIVFKK		15	V20130429-12_FTMSms2hcd	57.907	342	356	40.8	7.1e-15	1.0e-15	1	226534.2	HUMAN	Myosin-9
[27]		P35579	MYH9_HUMAN	MYH9	2	1.5	8.36	7.1e-15	536.3040	3	1.4	KVIQYLAYVASSHK	KVIQYLAYVASSHK		14	V20130429-12_FTMSms2hcd	37.623	186	199	28.7	4.0e-9	1.2e-11	1	226534.2	HUMAN	Myosin-9
[28]		Q15366	PCBP2_HUMAN	PCBP2	2	10.1	6.51	5.6e-12	1103.1158	2	0.26	QVTITGSAASISLAQYLINVR	QVTITGSAASISLAQYLINVR		21	V20130429-12_FTMSms2hcd	66.405	334	354	33.9	5.6e-12	2.1e-14	1	38580.4	HUMAN	Poly(rC)-binding protein 2
[28]		Q15366	PCBP2_HUMAN	PCBP2	2	10.1	6.51	5.6e-12	828.4744	2	0.89	AITIAGIPQSIIECVK	AITIAGIPQSIIECVK		16	V20130429-12_FTMSms2hcd	67.161	145	160	37.1	5.6e-11	2.0e-13	1	38580.4	HUMAN	Poly(rC)-binding protein 2
[29]		Q15365	PCBP1_HUMAN	PCBP1	2	10.4	7.91	4.9e-14	1089.1001	2	0.21	QVTITGSAASISLAQYLINAR	QVTITGSAASISLAQYLINAR		21	V20130429-12_FTMSms2hcd	63.849	326	346	45.7	4.9e-14	1.6e-16	1	37498.2	HUMAN	Poly(rC)-binding protein 1
[29]		Q15365	PCBP1_HUMAN	PCBP1	2	10.4	7.91	4.9e-14	808.4444	2	5.7	AITIAGVPQSVTECVK	AITIAGVPQSVTECVK		16	V20130429-12_FTMSms2hcd	48.898	145	160	19.9	2.3e-7	4.6e-10	1	37498.2	HUMAN	Poly(rC)-binding protein 1
[30]		P15531	NDKA_HUMAN	NME1	2	13.8	7.50	2.7e-13	672.8854	2	0.083	TFIAIKPDGVQR	TFIAIKPDGVQR		12	V20130429-12_FTMSms2hcd	32.193	7	18	49.5	2.7e-13	6.6e-16	2	17148.9	HUMAN	Nucleoside diphosphate kinase A
[30]		P15531	NDKA_HUMAN	NME1	2	13.8	7.50	2.7e-13	497.7421	2	-0.56	GDFCIQVGR	GDFCIQVGR		9	V20130429-12_FTMSms2hcd	35.083	106	114	30.6	9.1e-8	1.9e-10	3	17148.9	HUMAN	Nucleoside diphosphate kinase A
[30-1]	0	P22392	NDKB_HUMAN	NME2	2	13.8	7.50	2.7e-13	672.8854	2	0.083	TFIAIKPDGVQR	TFIAIKPDGVQR		12	V20130429-12_FTMSms2hcd	32.193	7	18	49.5	2.7e-13	6.6e-16	2	17298.2	HUMAN	Nucleoside diphosphate kinase B
[30-1]	0	P22392	NDKB_HUMAN	NME2	2	13.8	7.50	2.7e-13	497.7421	2	-0.56	GDFCIQVGR	GDFCIQVGR		9	V20130429-12_FTMSms2hcd	35.083	106	114	30.6	9.1e-8	1.9e-10	3	17298.2	HUMAN	Nucleoside diphosphate kinase B
[30-2]	1	O60361	NDK8_HUMAN	NME2P1	2	13.9	3.60	8.5e-8	634.3332	2	1.8	FKPEELVDYK	FKPEELVDYK		10	V20130429-12_FTMSms2hcd	35.669	119	128	28.7	8.5e-8	1.2e-10	1	15529.2	HUMAN	Putative nucleoside diphosphate kinase
[30-2]	1	O60361	NDK8_HUMAN	NME2P1	2	13.9	3.60	8.5e-8	497.7421	2	-0.56	GDFCIQVGR	GDFCIQVGR		9	V20130429-12_FTMSms2hcd	35.083	91	99	30.6	9.1e-8	1.9e-10	3	15529.2	HUMAN	Putative nucleoside diphosphate kinase
[31]		P13639	EF2_HUMAN	EEF2	2	5.4	6.06	1.2e-10	785.0792	3	1.9	GVQYLNEIKDSVVAGFQWATK	GVQYLNEIKDSVVAGFQWATK		21	V20130429-12_FTMSms2hcd	68.347	668	688	38.3	1.2e-10	2.1e-13	1	95339.0	HUMAN	Elongation factor 2
[31]		P13639	EF2_HUMAN	EEF2	2	5.4	6.06	1.2e-10	901.4760	3	0.92	YVEPIEDVPCGNIVGLVGVDQFLVK	YVEPIEDVPCGNIVGLVGVDQFLVK		25	V20130429-12_FTMSms2hcd	74.914	457	481	39.9	9.4e-10	1.8e-12	1	95339.0	HUMAN	Elongation factor 2
[32]		P08865	RSSA_HUMAN	RPSA	2	13.9	7.68	1.3e-13	980.4918	3	1.4	ADHQPLTEASYVNLPTIALCNTDSPLR	ADHQPLTEASYVNLPTIALCNTDSPLR		27	V20130429-12_FTMSms2hcd	59.984	129	155	48.5	1.3e-13	1.6e-16	1	32854.4	HUMAN	40S ribosomal protein SA
[32]		P08865	RSSA_HUMAN	RPSA	2	13.9	7.68	1.3e-13	544.2720	3	2.1	GAHSVGLMWWMLAR	GAHSVGLM(Oxidation)WWMLAR	Oxidation@174=24	14	V20130429-12_FTMSms2hcd	55.070	167	180	23.4	2.7e-6	3.2e-9	1	32854.4	HUMAN	40S ribosomal protein SA
[33]		P09651	ROA1_HUMAN	HNRNPA1	2	9.7	6.49	1.7e-11	892.9576	2	0.79	LFIGGLSFETTDESLR	LFIGGLSFETTDESLR		16	V20130429-12_FTMSms2hcd	58.148	16	31	39.6	1.7e-11	2.3e-14	2	38746.9	HUMAN	Heterogeneous nuclear ribonucleoprotein A1
[33]		P09651	ROA1_HUMAN	HNRNPA1	2	9.7	6.49	1.7e-11	761.0539	3	-1.2	GFAFVTFDDHDSVDKIVIQK	GFAFVTFDDHDSVDKIVIQK		20	V20130429-12_FTMSms2hcd	52.511	147	166	24.7	2.5e-8	3.2e-11	2	38746.9	HUMAN	Heterogeneous nuclear ribonucleoprotein A1
[33-1]	0	Q32P51	RA1L2_HUMAN	HNRNPA1L2	2	11.2	6.49	1.7e-11	892.9576	2	0.79	LFIGGLSFETTDESLR	LFIGGLSFETTDESLR		16	V20130429-12_FTMSms2hcd	58.148	16	31	39.6	1.7e-11	2.3e-14	2	34225.6	HUMAN	Heterogeneous nuclear ribonucleoprotein A1-like 2
[33-1]	0	Q32P51	RA1L2_HUMAN	HNRNPA1L2	2	11.2	6.49	1.7e-11	761.0539	3	-1.2	GFAFVTFDDHDSVDKIVIQK	GFAFVTFDDHDSVDKIVIQK		20	V20130429-12_FTMSms2hcd	52.511	147	166	24.7	2.5e-8	3.2e-11	2	34225.6	HUMAN	Heterogeneous nuclear ribonucleoprotein A1-like 2
[34]		P62081	RS7_HUMAN	RPS7	2	11.9	5.88	1.9e-10	631.6006	4	-0.45	TLTAVHDAILEDLVFPSEIVGKR	TLTAVHDAILEDLVFPSEIVGKR		23	V20130429-12_FTMSms2hcd	65.084	121	143	39.0	1.9e-10	7.8e-13	1	22127.0	HUMAN	40S ribosomal protein S7
[34]		P62081	RS7_HUMAN	RPS7	2	11.9	5.88	1.9e-10	789.7674	3	3.0	TLTAVHDAILEDLVFPSEIVGK	TLTAVHDAILEDLVFPSEIVGK		22	V20130429-12_FTMSms2hcd	68.571	121	142	21.1	1.4e-7	4.0e-10	1	22127.0	HUMAN	40S ribosomal protein S7
[35]		P31949	S10AB_HUMAN	S100A11	2	23.8	5.92	2.4e-10	933.4669	2	15	TEFLSFMNTELAAFTK	TEFLSFM(Oxidation)NTELAAFTK	Oxidation@43	16	V20130429-12_FTMSms2hcd	60.330	37	52	41.7	2.4e-10	2.7e-13	1	11740.6	HUMAN	Protein S100-A11
[35]		P31949	S10AB_HUMAN	S100A11	2	23.8	5.92	2.4e-10	510.2539	2	0.14	ISSPTETER	ISSPTETER		9	V20130429-12_FTMSms2hcd	12.185	4	12	29.2	4.3e-7	7.0e-10	1	11740.6	HUMAN	Protein S100-A11
[36]		O60814	H2B1K_HUMAN	HIST1H2BK	2	20.6	7.92	2.0e-14	888.4088	2	0.68	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-12_FTMSms2hcd	55.031	59	73	38.0	2.0e-14	2.0e-17	14	13890.3	HUMAN	Histone H2B type 1-K
[36]		O60814	H2B1K_HUMAN	HIST1H2BK	2	20.6	7.92	2.0e-14	576.2939	2	9.9	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-12_FTMSms2hcd	18.519	48	58	15.7	0.0025	3.6e-6	15	13890.3	HUMAN	Histone H2B type 1-K
[36-1]	0	P06899	H2B1J_HUMAN	HIST1H2BJ	2	20.6	7.92	2.0e-14	888.4088	2	0.68	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-12_FTMSms2hcd	55.031	59	73	38.0	2.0e-14	2.0e-17	14	13904.3	HUMAN	Histone H2B type 1-J
[36-1]	0	P06899	H2B1J_HUMAN	HIST1H2BJ	2	20.6	7.92	2.0e-14	576.2939	2	9.9	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-12_FTMSms2hcd	18.519	48	58	15.7	0.0025	3.6e-6	15	13904.3	HUMAN	Histone H2B type 1-J
[36-2]	0	P23527	H2B1O_HUMAN	HIST1H2BO	2	20.6	7.92	2.0e-14	888.4088	2	0.68	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-12_FTMSms2hcd	55.031	59	73	38.0	2.0e-14	2.0e-17	14	13906.3	HUMAN	Histone H2B type 1-O
[36-2]	0	P23527	H2B1O_HUMAN	HIST1H2BO	2	20.6	7.92	2.0e-14	576.2939	2	9.9	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-12_FTMSms2hcd	18.519	48	58	15.7	0.0025	3.6e-6	15	13906.3	HUMAN	Histone H2B type 1-O
[36-3]	0	P33778	H2B1B_HUMAN	HIST1H2BB	2	20.6	7.92	2.0e-14	888.4088	2	0.68	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-12_FTMSms2hcd	55.031	59	73	38.0	2.0e-14	2.0e-17	14	13950.3	HUMAN	Histone H2B type 1-B
[36-3]	0	P33778	H2B1B_HUMAN	HIST1H2BB	2	20.6	7.92	2.0e-14	576.2939	2	9.9	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-12_FTMSms2hcd	18.519	48	58	15.7	0.0025	3.6e-6	15	13950.3	HUMAN	Histone H2B type 1-B
[36-4]	0	P57053	H2BFS_HUMAN	H2BFS	2	20.6	7.92	2.0e-14	888.4088	2	0.68	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-12_FTMSms2hcd	55.031	59	73	38.0	2.0e-14	2.0e-17	14	13944.3	HUMAN	Histone H2B type F-S
[36-4]	0	P57053	H2BFS_HUMAN	H2BFS	2	20.6	7.92	2.0e-14	576.2939	2	9.9	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-12_FTMSms2hcd	18.519	48	58	15.7	0.0025	3.6e-6	15	13944.3	HUMAN	Histone H2B type F-S
[36-5]	0	P58876	H2B1D_HUMAN	HIST1H2BD	2	20.6	7.92	2.0e-14	888.4088	2	0.68	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-12_FTMSms2hcd	55.031	59	73	38.0	2.0e-14	2.0e-17	14	13936.3	HUMAN	Histone H2B type 1-D
[36-5]	0	P58876	H2B1D_HUMAN	HIST1H2BD	2	20.6	7.92	2.0e-14	576.2939	2	9.9	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-12_FTMSms2hcd	18.519	48	58	15.7	0.0025	3.6e-6	15	13936.3	HUMAN	Histone H2B type 1-D
[36-6]	0	P62807	H2B1C_HUMAN	HIST1H2BC	2	20.6	7.92	2.0e-14	888.4088	2	0.68	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-12_FTMSms2hcd	55.031	59	73	38.0	2.0e-14	2.0e-17	14	13906.3	HUMAN	Histone H2B type 1-C/E/F/G/I
[36-6]	0	P62807	H2B1C_HUMAN	HIST1H2BC	2	20.6	7.92	2.0e-14	576.2939	2	9.9	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-12_FTMSms2hcd	18.519	48	58	15.7	0.0025	3.6e-6	15	13906.3	HUMAN	Histone H2B type 1-C/E/F/G/I
[36-7]	0	Q16778	H2B2E_HUMAN	HIST2H2BE	2	20.6	7.92	2.0e-14	888.4088	2	0.68	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-12_FTMSms2hcd	55.031	59	73	38.0	2.0e-14	2.0e-17	14	13920.3	HUMAN	Histone H2B type 2-E
[36-7]	0	Q16778	H2B2E_HUMAN	HIST2H2BE	2	20.6	7.92	2.0e-14	576.2939	2	9.9	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-12_FTMSms2hcd	18.519	48	58	15.7	0.0025	3.6e-6	15	13920.3	HUMAN	Histone H2B type 2-E
[36-8]	0	Q5QNW6	H2B2F_HUMAN	HIST2H2BF	2	20.6	7.92	2.0e-14	888.4088	2	0.68	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-12_FTMSms2hcd	55.031	59	73	38.0	2.0e-14	2.0e-17	14	13920.3	HUMAN	Histone H2B type 2-F
[36-8]	0	Q5QNW6	H2B2F_HUMAN	HIST2H2BF	2	20.6	7.92	2.0e-14	576.2939	2	9.9	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-12_FTMSms2hcd	18.519	48	58	15.7	0.0025	3.6e-6	15	13920.3	HUMAN	Histone H2B type 2-F
[36-9]	0	Q8N257	H2B3B_HUMAN	HIST3H2BB	2	20.6	7.92	2.0e-14	888.4088	2	0.68	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-12_FTMSms2hcd	55.031	59	73	38.0	2.0e-14	2.0e-17	14	13908.2	HUMAN	Histone H2B type 3-B
[36-9]	0	Q8N257	H2B3B_HUMAN	HIST3H2BB	2	20.6	7.92	2.0e-14	576.2939	2	9.9	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-12_FTMSms2hcd	18.519	48	58	15.7	0.0025	3.6e-6	15	13908.2	HUMAN	Histone H2B type 3-B
[36-10]	0	Q93079	H2B1H_HUMAN	HIST1H2BH	2	20.6	7.92	2.0e-14	888.4088	2	0.68	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-12_FTMSms2hcd	55.031	59	73	38.0	2.0e-14	2.0e-17	14	13892.2	HUMAN	Histone H2B type 1-H
[36-10]	0	Q93079	H2B1H_HUMAN	HIST1H2BH	2	20.6	7.92	2.0e-14	576.2939	2	9.9	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-12_FTMSms2hcd	18.519	48	58	15.7	0.0025	3.6e-6	15	13892.2	HUMAN	Histone H2B type 1-H
[36-11]	0	Q99877	H2B1N_HUMAN	HIST1H2BN	2	20.6	7.92	2.0e-14	888.4088	2	0.68	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-12_FTMSms2hcd	55.031	59	73	38.0	2.0e-14	2.0e-17	14	13922.3	HUMAN	Histone H2B type 1-N
[36-11]	0	Q99877	H2B1N_HUMAN	HIST1H2BN	2	20.6	7.92	2.0e-14	576.2939	2	9.9	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-12_FTMSms2hcd	18.519	48	58	15.7	0.0025	3.6e-6	15	13922.3	HUMAN	Histone H2B type 1-N
[36-12]	0	Q99879	H2B1M_HUMAN	HIST1H2BM	2	20.6	7.92	2.0e-14	888.4088	2	0.68	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-12_FTMSms2hcd	55.031	59	73	38.0	2.0e-14	2.0e-17	14	13989.4	HUMAN	Histone H2B type 1-M
[36-12]	0	Q99879	H2B1M_HUMAN	HIST1H2BM	2	20.6	7.92	2.0e-14	576.2939	2	9.9	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-12_FTMSms2hcd	18.519	48	58	15.7	0.0025	3.6e-6	15	13989.4	HUMAN	Histone H2B type 1-M
[36-13]	0	Q99880	H2B1L_HUMAN	HIST1H2BL	2	20.6	7.92	2.0e-14	888.4088	2	0.68	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-12_FTMSms2hcd	55.031	59	73	38.0	2.0e-14	2.0e-17	14	13952.3	HUMAN	Histone H2B type 1-L
[36-13]	0	Q99880	H2B1L_HUMAN	HIST1H2BL	2	20.6	7.92	2.0e-14	576.2939	2	9.9	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-12_FTMSms2hcd	18.519	48	58	15.7	0.0025	3.6e-6	15	13952.3	HUMAN	Histone H2B type 1-L
[37]		O75531	BAF_HUMAN	BANF1	2	14.6	5.17	1.1e-9	493.3091	3	-0.91	AYVVLGQFLVLKK	AYVVLGQFLVLKK		13	V20130429-12_FTMSms2hcd	55.846	42	54	35.4	1.1e-9	3.8e-11	1	10058.7	HUMAN	Barrier-to-autointegration factor
[37]		O75531	BAF_HUMAN	BANF1	2	14.6	5.17	1.1e-9	675.4136	2	0.58	AYVVLGQFLVLK	AYVVLGQFLVLK		12	V20130429-12_FTMSms2hcd	64.087	42	53	36.1	2.1e-8	3.8e-10	1	10058.7	HUMAN	Barrier-to-autointegration factor
[38]		P04075	ALDOA_HUMAN	ALDOA	2	11.5	8.22	1.3e-14	1040.5369	3	4.2	YASICQQNGIVPIVEPEILPDGDHDLKR	YASICQQNGIVPIVEPEILPDGDHDLKR		28	V20130429-12_FTMSms2hcd	54.578	174	201	44.5	1.3e-14	2.1e-17	2	39420.4	HUMAN	Fructose-bisphosphate aldolase A
[38]		P04075	ALDOA_HUMAN	ALDOA	2	11.5	8.22	1.3e-14	823.9102	2	2.4	LQSIGTENTEENRR	LQSIGTENTEENRR		14	V20130429-12_FTMSms2hcd	16.201	44	57	10.4	0.054	6.3e-5	1	39420.4	HUMAN	Fructose-bisphosphate aldolase A
[38-1]	0	P09972	ALDOC_HUMAN	ALDOC	1	7.7	8.22	1.3e-14	1040.5369	3	4.2	YASICQQNGIVPIVEPEILPDGDHDLKR	YASICQQNGIVPIVEPEILPDGDHDLKR		28	V20130429-12_FTMSms2hcd	54.578	174	201	44.5	1.3e-14	2.1e-17	2	39456.2	HUMAN	Fructose-bisphosphate aldolase C
[39]		P20700	LMNB1_HUMAN	LMNB1	1	5.1	9.51	5.2e-17	1137.8687	3	6.0	TTIPEEEEEEEEAAGVVVEEELFHQQGTPR	TTIPEEEEEEEEAAGVVVEEELFHQQGTPR		30	V20130429-12_FTMSms2hcd	61.150	548	577	48.7	5.2e-17	5.1e-20	1	66408.9	HUMAN	Lamin-B1
[40]		P46776	RL27A_HUMAN	RPL27A	2	22.3	5.13	3.4e-10	556.3272	2	0.12	TGAAPIIDVVR	TGAAPIIDVVR		11	V20130429-12_FTMSms2hcd	39.024	95	105	33.0	3.4e-10	1.7e-12	1	16561.5	HUMAN	60S ribosomal protein L27a
[40]		P46776	RL27A_HUMAN	RPL27A	2	22.3	5.13	3.4e-10	860.4368	3	1.4	NQSFCPTVNLDKLWTLVSEQTR	NQSFCPTVNLDKLWTLVSEQTR		22	V20130429-12_FTMSms2hcd	71.778	66	87	32.0	8.8e-9	1.1e-11	1	16561.5	HUMAN	60S ribosomal protein L27a
[41]		P09382	LEG1_HUMAN	LGALS1	2	14.8	5.59	1.3e-11	572.7956	4	0.054	SFVLNLGKDSNNLCLHFNPR	SFVLNLGKDSNNLCLHFNPR		20	V20130429-12_FTMSms2hcd	53.392	30	49	29.8	1.3e-11	1.5e-14	1	14715.8	HUMAN	Galectin-1
[41]		P09382	LEG1_HUMAN	LGALS1	2	14.8	5.59	1.3e-11	477.2272	3	2.1	DSNNLCLHFNPR	DSNNLCLHFNPR		12	V20130429-12_FTMSms2hcd	36.040	38	49	27.7	2.5e-8	3.3e-11	1	14715.8	HUMAN	Galectin-1
[42]		P0C0S8	H2A1_HUMAN	HIST1H2AG	3	35.4	4.97	5.4e-10	966.0900	2	2.0	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-12_FTMSms2hcd	65.427	101	119	32.5	5.4e-10	1.6e-11	10	14091.6	HUMAN	Histone H2A type 1
[42]		P0C0S8	H2A1_HUMAN	HIST1H2AG	3	35.4	4.97	5.4e-10	526.8021	4	-0.35	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-12_FTMSms2hcd	45.708	83	100	27.9	5.0e-6	2.8e-8	7	14091.6	HUMAN	Histone H2A type 1
[42]		P0C0S8	H2A1_HUMAN	HIST1H2AG	3	35.4	4.97	5.4e-10	472.7694	2	0.31	AGLQFPVGR	AGLQFPVGR		9	V20130429-12_FTMSms2hcd	36.694	22	30	23.4	0.0028	4.6e-6	15	14091.6	HUMAN	Histone H2A type 1
[42-1]	0	P20671	H2A1D_HUMAN	HIST1H2AD	3	35.4	4.97	5.4e-10	966.0900	2	2.0	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-12_FTMSms2hcd	65.427	101	119	32.5	5.4e-10	1.6e-11	10	14107.6	HUMAN	Histone H2A type 1-D
[42-1]	0	P20671	H2A1D_HUMAN	HIST1H2AD	3	35.4	4.97	5.4e-10	526.8021	4	-0.35	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-12_FTMSms2hcd	45.708	83	100	27.9	5.0e-6	2.8e-8	7	14107.6	HUMAN	Histone H2A type 1-D
[42-1]	0	P20671	H2A1D_HUMAN	HIST1H2AD	3	35.4	4.97	5.4e-10	472.7694	2	0.31	AGLQFPVGR	AGLQFPVGR		9	V20130429-12_FTMSms2hcd	36.694	22	30	23.4	0.0028	4.6e-6	15	14107.6	HUMAN	Histone H2A type 1-D
[42-2]	0	Q16777	H2A2C_HUMAN	HIST2H2AC	3	35.7	4.97	5.4e-10	966.0900	2	2.0	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-12_FTMSms2hcd	65.427	101	119	32.5	5.4e-10	1.6e-11	10	13988.5	HUMAN	Histone H2A type 2-C
[42-2]	0	Q16777	H2A2C_HUMAN	HIST2H2AC	3	35.7	4.97	5.4e-10	526.8021	4	-0.35	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-12_FTMSms2hcd	45.708	83	100	27.9	5.0e-6	2.8e-8	7	13988.5	HUMAN	Histone H2A type 2-C
[42-2]	0	Q16777	H2A2C_HUMAN	HIST2H2AC	3	35.7	4.97	5.4e-10	472.7694	2	0.31	AGLQFPVGR	AGLQFPVGR		9	V20130429-12_FTMSms2hcd	36.694	22	30	23.4	0.0028	4.6e-6	15	13988.5	HUMAN	Histone H2A type 2-C
[42-3]	0	Q6FI13	H2A2A_HUMAN	HIST2H2AA3	3	35.4	4.97	5.4e-10	966.0900	2	2.0	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-12_FTMSms2hcd	65.427	101	119	32.5	5.4e-10	1.6e-11	10	14095.6	HUMAN	Histone H2A type 2-A
[42-3]	0	Q6FI13	H2A2A_HUMAN	HIST2H2AA3	3	35.4	4.97	5.4e-10	526.8021	4	-0.35	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-12_FTMSms2hcd	45.708	83	100	27.9	5.0e-6	2.8e-8	7	14095.6	HUMAN	Histone H2A type 2-A
[42-3]	0	Q6FI13	H2A2A_HUMAN	HIST2H2AA3	3	35.4	4.97	5.4e-10	472.7694	2	0.31	AGLQFPVGR	AGLQFPVGR		9	V20130429-12_FTMSms2hcd	36.694	22	30	23.4	0.0028	4.6e-6	15	14095.6	HUMAN	Histone H2A type 2-A
[42-4]	0	Q96KK5	H2A1H_HUMAN	HIST1H2AH	3	35.9	4.97	5.4e-10	966.0900	2	2.0	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-12_FTMSms2hcd	65.427	101	119	32.5	5.4e-10	1.6e-11	10	13906.4	HUMAN	Histone H2A type 1-H
[42-4]	0	Q96KK5	H2A1H_HUMAN	HIST1H2AH	3	35.9	4.97	5.4e-10	526.8021	4	-0.35	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-12_FTMSms2hcd	45.708	83	100	27.9	5.0e-6	2.8e-8	7	13906.4	HUMAN	Histone H2A type 1-H
[42-4]	0	Q96KK5	H2A1H_HUMAN	HIST1H2AH	3	35.9	4.97	5.4e-10	472.7694	2	0.31	AGLQFPVGR	AGLQFPVGR		9	V20130429-12_FTMSms2hcd	36.694	22	30	23.4	0.0028	4.6e-6	15	13906.4	HUMAN	Histone H2A type 1-H
[42-5]	0	Q99878	H2A1J_HUMAN	HIST1H2AJ	3	35.9	4.97	5.4e-10	966.0900	2	2.0	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-12_FTMSms2hcd	65.427	101	119	32.5	5.4e-10	1.6e-11	10	13936.4	HUMAN	Histone H2A type 1-J
[42-5]	0	Q99878	H2A1J_HUMAN	HIST1H2AJ	3	35.9	4.97	5.4e-10	526.8021	4	-0.35	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-12_FTMSms2hcd	45.708	83	100	27.9	5.0e-6	2.8e-8	7	13936.4	HUMAN	Histone H2A type 1-J
[42-5]	0	Q99878	H2A1J_HUMAN	HIST1H2AJ	3	35.9	4.97	5.4e-10	472.7694	2	0.31	AGLQFPVGR	AGLQFPVGR		9	V20130429-12_FTMSms2hcd	36.694	22	30	23.4	0.0028	4.6e-6	15	13936.4	HUMAN	Histone H2A type 1-J
[42-6]	0	Q9BTM1	H2AJ_HUMAN	H2AFJ	3	35.7	4.97	5.4e-10	966.0900	2	2.0	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-12_FTMSms2hcd	65.427	101	119	32.5	5.4e-10	1.6e-11	10	14019.5	HUMAN	Histone H2A.J
[42-6]	0	Q9BTM1	H2AJ_HUMAN	H2AFJ	3	35.7	4.97	5.4e-10	526.8021	4	-0.35	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-12_FTMSms2hcd	45.708	83	100	27.9	5.0e-6	2.8e-8	7	14019.5	HUMAN	Histone H2A.J
[42-6]	0	Q9BTM1	H2AJ_HUMAN	H2AFJ	3	35.7	4.97	5.4e-10	472.7694	2	0.31	AGLQFPVGR	AGLQFPVGR		9	V20130429-12_FTMSms2hcd	36.694	22	30	23.4	0.0028	4.6e-6	15	14019.5	HUMAN	Histone H2A.J
[42-7]	0	P04908	H2A1B_HUMAN	HIST1H2AB	2	21.5	4.97	5.4e-10	966.0900	2	2.0	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-12_FTMSms2hcd	65.427	101	119	32.5	5.4e-10	1.6e-11	10	14135.6	HUMAN	Histone H2A type 1-B/E
[42-7]	0	P04908	H2A1B_HUMAN	HIST1H2AB	2	21.5	4.97	5.4e-10	472.7694	2	0.31	AGLQFPVGR	AGLQFPVGR		9	V20130429-12_FTMSms2hcd	36.694	22	30	23.4	0.0028	4.6e-6	15	14135.6	HUMAN	Histone H2A type 1-B/E
[42-8]	0	Q7L7L0	H2A3_HUMAN	HIST3H2A	2	21.5	4.97	5.4e-10	966.0900	2	2.0	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-12_FTMSms2hcd	65.427	101	119	32.5	5.4e-10	1.6e-11	10	14121.6	HUMAN	Histone H2A type 3
[42-8]	0	Q7L7L0	H2A3_HUMAN	HIST3H2A	2	21.5	4.97	5.4e-10	472.7694	2	0.31	AGLQFPVGR	AGLQFPVGR		9	V20130429-12_FTMSms2hcd	36.694	22	30	23.4	0.0028	4.6e-6	15	14121.6	HUMAN	Histone H2A type 3
[42-9]	0	Q93077	H2A1C_HUMAN	HIST1H2AC	2	21.5	4.97	5.4e-10	966.0900	2	2.0	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-12_FTMSms2hcd	65.427	101	119	32.5	5.4e-10	1.6e-11	10	14105.6	HUMAN	Histone H2A type 1-C
[42-9]	0	Q93077	H2A1C_HUMAN	HIST1H2AC	2	21.5	4.97	5.4e-10	472.7694	2	0.31	AGLQFPVGR	AGLQFPVGR		9	V20130429-12_FTMSms2hcd	36.694	22	30	23.4	0.0028	4.6e-6	15	14105.6	HUMAN	Histone H2A type 1-C
[42-10]	1	P16104	H2AX_HUMAN	H2AFX	2	27.3	4.32	1.8e-10	1038.6064	3	15	NDEELNKLLGGVTIAQGGVLPNIQAVLLPK	NDEELNKLLGGVTIAQGGVLPNIQAVLLPK		30	V20130429-12_FTMSms2hcd	75.421	90	119	22.6	1.8e-10	5.0e-12	3	15144.7	HUMAN	Histone H2A.x
[42-10]	1	P16104	H2AX_HUMAN	H2AFX	2	27.3	4.32	1.8e-10	472.7694	2	0.31	AGLQFPVGR	AGLQFPVGR		9	V20130429-12_FTMSms2hcd	36.694	22	30	23.4	0.0028	4.6e-6	15	15144.7	HUMAN	Histone H2A.x
[42-11]	1	Q8IUE6	H2A2B_HUMAN	HIST2H2AB	2	30.0	4.32	1.8e-10	1038.6064	3	15	NDEELNKLLGGVTIAQGGVLPNIQAVLLPK	NDEELNKLLGGVTIAQGGVLPNIQAVLLPK		30	V20130429-12_FTMSms2hcd	75.421	90	119	22.6	1.8e-10	5.0e-12	3	13995.4	HUMAN	Histone H2A type 2-B
[42-11]	1	Q8IUE6	H2A2B_HUMAN	HIST2H2AB	2	30.0	4.32	1.8e-10	472.7694	2	0.31	AGLQFPVGR	AGLQFPVGR		9	V20130429-12_FTMSms2hcd	36.694	22	30	23.4	0.0028	4.6e-6	15	13995.4	HUMAN	Histone H2A type 2-B
[42-12]	1	Q96QV6	H2A1A_HUMAN	HIST1H2AA	2	29.8	4.32	1.8e-10	1038.6064	3	15	NDEELNKLLGGVTIAQGGVLPNIQAVLLPK	NDEELNKLLGGVTIAQGGVLPNIQAVLLPK		30	V20130429-12_FTMSms2hcd	75.421	90	119	22.6	1.8e-10	5.0e-12	3	14233.6	HUMAN	Histone H2A type 1-A
[42-12]	1	Q96QV6	H2A1A_HUMAN	HIST1H2AA	2	29.8	4.32	1.8e-10	472.7694	2	0.31	AGLQFPVGR	AGLQFPVGR		9	V20130429-12_FTMSms2hcd	36.694	22	30	23.4	0.0028	4.6e-6	15	14233.6	HUMAN	Histone H2A type 1-A
[42-13]	0	P0C0S5	H2AZ_HUMAN	H2AFZ	1	7.0	0.44	0.0028	472.7694	2	0.31	AGLQFPVGR	AGLQFPVGR		9	V20130429-12_FTMSms2hcd	36.694	24	32	23.4	0.0028	4.6e-6	15	13552.8	HUMAN	Histone H2A.Z
[42-14]	0	Q71UI9	H2AV_HUMAN	H2AFV	1	7.0	0.44	0.0028	472.7694	2	0.31	AGLQFPVGR	AGLQFPVGR		9	V20130429-12_FTMSms2hcd	36.694	24	32	23.4	0.0028	4.6e-6	15	13508.8	HUMAN	Histone H2A.V
[43]		P30101	PDIA3_HUMAN	PDIA3	1	4.8	9.08	1.7e-16	859.1180	3	14	TFSHELSDFGLESTAGEIPVVAIR	TFSHELSDFGLESTAGEIPVVAIR		24	V20130429-12_FTMSms2hcd	60.265	306	329	38.4	1.7e-16	2.7e-19	1	56782.9	HUMAN	Protein disulfide-isomerase A3
[44]		P31947	1433S_HUMAN	SFN	2	13.7	6.27	5.4e-11	945.1644	3	0.56	LGLALNFSVFHYEIANSPEEAISLAK	LGLALNFSVFHYEIANSPEEAISLAK		26	V20130429-12_FTMSms2hcd	70.182	170	195	41.6	5.4e-11	1.0e-13	1	27774.3	HUMAN	14-3-3 protein sigma
[44]		P31947	1433S_HUMAN	SFN	2	13.7	6.27	5.4e-11	454.2667	2	1.5	NLLSVAYK	NLLSVAYK		8	V20130429-12_FTMSms2hcd	35.735	42	49	21.2	1.9e-4	6.5e-7	7	27774.3	HUMAN	14-3-3 protein sigma
[44-1]	1	P63104	1433Z_HUMAN	YWHAZ	2	9.0	5.96	1.9e-10	774.8603	2	-0.19	SVTEQGAELSNEER	SVTEQGAELSNEER		14	V20130429-12_FTMSms2hcd	20.785	28	41	46.6	1.9e-10	2.4e-13	1	27745.3	HUMAN	14-3-3 protein zeta/delta
[44-1]	1	P63104	1433Z_HUMAN	YWHAZ	2	9.0	5.96	1.9e-10	454.2667	2	1.5	NLLSVAYK	NLLSVAYK		8	V20130429-12_FTMSms2hcd	35.735	42	49	21.2	1.9e-4	6.5e-7	7	27745.3	HUMAN	14-3-3 protein zeta/delta
[44-2]	0	P27348	1433T_HUMAN	YWHAQ	1	3.3	0.85	1.9e-4	454.2667	2	1.5	NLLSVAYK	NLLSVAYK		8	V20130429-12_FTMSms2hcd	35.735	42	49	21.2	1.9e-4	6.5e-7	7	27764.5	HUMAN	14-3-3 protein theta
[44-3]	0	P31946	1433B_HUMAN	YWHAB	1	3.3	0.85	1.9e-4	454.2667	2	1.5	NLLSVAYK	NLLSVAYK		8	V20130429-12_FTMSms2hcd	35.735	44	51	21.2	1.9e-4	6.5e-7	7	28082.6	HUMAN	14-3-3 protein beta/alpha
[44-4]	0	P61981	1433G_HUMAN	YWHAG	1	3.2	0.85	1.9e-4	454.2667	2	1.5	NLLSVAYK	NLLSVAYK		8	V20130429-12_FTMSms2hcd	35.735	43	50	21.2	1.9e-4	6.5e-7	7	28302.8	HUMAN	14-3-3 protein gamma
[44-5]	0	P62258	1433E_HUMAN	YWHAE	1	3.1	0.85	1.9e-4	454.2667	2	1.5	NLLSVAYK	NLLSVAYK		8	V20130429-12_FTMSms2hcd	35.735	43	50	21.2	1.9e-4	6.5e-7	7	29174.2	HUMAN	14-3-3 protein epsilon
[44-6]	0	Q04917	1433F_HUMAN	YWHAH	1	3.3	0.85	1.9e-4	454.2667	2	1.5	NLLSVAYK	NLLSVAYK		8	V20130429-12_FTMSms2hcd	35.735	43	50	21.2	1.9e-4	6.5e-7	7	28219.0	HUMAN	14-3-3 protein eta
[45]		P62829	RL23_HUMAN	RPL23	1	14.3	8.99	4.8e-16	957.0121	2	0.44	ISLGLPVGAVINCADNTGAK	ISLGLPVGAVINCADNTGAK		20	V20130429-12_FTMSms2hcd	58.980	16	35	50.0	4.8e-16	9.1e-19	1	14865.6	HUMAN	60S ribosomal protein L23
[46]		Q16658	FSCN1_HUMAN	FSCN1	1	4.9	8.62	2.3e-15	873.4490	3	3.1	VGKDELFALEQSCAQVVLQAANER	VGKDELFALEQSCAQVVLQAANER		24	V20130429-12_FTMSms2hcd	73.188	248	271	52.6	2.3e-15	3.3e-18	1	54530.4	HUMAN	Fascin
[47]		P11766	ADHX_HUMAN	ADH5	1	7.5	8.47	4.5e-15	948.1775	3	-1.1	GWGVSVVVGVAASGEEIATRPFQLVTGR	GWGVSVVVGVAASGEEIATRPFQLVTGR		28	V20130429-12_FTMSms2hcd	76.335	285	312	47.0	4.5e-15	1.4e-17	1	39724.6	HUMAN	Alcohol dehydrogenase class-3
[48]		Q96DA6	TIM14_HUMAN	DNAJC19	1	17.2	8.46	3.4e-15	887.4926	2	-4.4	MASTVVAVGLTIAAAGFAGR	M(Met-loss+Acetyl)ASTVVAVGLTIAAAGFAGR	Met-loss+Acetyl@1	20	V20130429-12_FTMSms2hcd	78.161	1	20	39.2	3.4e-15	9.1e-18	1	12498.7	HUMAN	Mitochondrial import inner membrane translocase subunit TIM14
[49]		P09429	HMGB1_HUMAN	HMGB1	1	5.6	8.45	4.8e-15	728.3235	2	0.13	MSSYAFFVQTCR	M(Oxidation)SSYAFFVQTCR	Oxidation@13	12	V20130429-12_FTMSms2hcd	44.540	13	24	44.7	4.8e-15	7.0e-18	3	24894.0	HUMAN	High mobility group protein B1
[49-1]	0	P26583	HMGB2_HUMAN	HMGB2	1	5.7	8.45	4.8e-15	728.3235	2	0.13	MSSYAFFVQTCR	M(Oxidation)SSYAFFVQTCR	Oxidation@13	12	V20130429-12_FTMSms2hcd	44.540	13	24	44.7	4.8e-15	7.0e-18	3	24034.0	HUMAN	High mobility group protein B2
[49-2]	0	B2RPK0	HGB1A_HUMAN	HMGB1P1	1	5.7	8.45	4.8e-15	728.3235	2	0.13	MSSYAFFVQTCR	M(Oxidation)SSYAFFVQTCR	Oxidation@13	12	V20130429-12_FTMSms2hcd	44.540	13	24	44.7	4.8e-15	7.0e-18	3	24238.2	HUMAN	Putative high mobility group protein B1-like 1
[50]		P42025	ACTY_HUMAN	ACTR1B	1	5.1	7.87	2.4e-14	700.7183	3	1.3	LYSTWIGGSILASLDTFKK	LYSTWIGGSILASLDTFKK		19	V20130429-12_FTMSms2hcd	70.342	337	355	37.9	2.4e-14	5.8e-17	2	42293.8	HUMAN	Beta-centractin
[50-1]	0	P61163	ACTZ_HUMAN	ACTR1A	1	5.1	7.87	2.4e-14	700.7183	3	1.3	LYSTWIGGSILASLDTFKK	LYSTWIGGSILASLDTFKK		19	V20130429-12_FTMSms2hcd	70.342	337	355	37.9	2.4e-14	5.8e-17	2	42614.1	HUMAN	Alpha-centractin
[51]		P61604	CH10_HUMAN	HSPE1	2	20.6	5.69	6.2e-10	658.3824	2	-0.36	VLQATVVAVGSGSK	VLQATVVAVGSGSK		14	V20130429-12_FTMSms2hcd	30.012	41	54	47.5	6.2e-10	1.8e-12	1	10931.8	HUMAN	10 kDa heat shock protein, mitochondrial
[51]		P61604	CH10_HUMAN	HSPE1	2	20.6	5.69	6.2e-10	454.2558	2	0.78	FLPLFDR	FLPLFDR		7	V20130429-12_FTMSms2hcd	49.140	9	15	21.9	0.0024	5.7e-6	1	10931.8	HUMAN	10 kDa heat shock protein, mitochondrial
[52]		Q15843	NEDD8_HUMAN	NEDD8	1	17.3	7.57	2.0e-13	730.9698	2	0.81	ILGGSVLHLVLALR	ILGGSVLHLVLALR		14	V20130429-12_FTMSms2hcd	67.466	61	74	50.1	2.0e-13	1.8e-14	1	9071.6	HUMAN	NEDD8
[53]		P35232	PHB_HUMAN	PHB	1	8.8	7.42	3.9e-13	791.0901	3	1.7	FGLALAVAGGVVNSALYNVDAGHR	FGLALAVAGGVVNSALYNVDAGHR		24	V20130429-12_FTMSms2hcd	66.793	12	35	41.0	3.9e-13	8.3e-16	1	29804.3	HUMAN	Prohibitin
[54]		P78371	TCPB_HUMAN	CCT2	1	2.8	7.37	3.5e-13	759.4506	2	0.11	LTSFIGAIAIGDLVK	LTSFIGAIAIGDLVK		15	V20130429-12_FTMSms2hcd	67.560	26	40	39.3	3.5e-13	2.6e-15	1	57488.7	HUMAN	T-complex protein 1 subunit beta
[55]		Q99832	TCPH_HUMAN	CCT7	1	4.6	7.34	5.6e-13	867.1305	3	0.37	INALTAASEAACLIVSVDETIKNPR	INALTAASEAACLIVSVDETIKNPR		25	V20130429-12_FTMSms2hcd	77.114	500	524	43.4	5.6e-13	1.3e-15	1	59367.2	HUMAN	T-complex protein 1 subunit eta
[56]		P10412	H14_HUMAN	HIST1H1E	1	6.8	7.33	5.8e-13	789.8972	2	0.040	ALAAAGYDVEKNNSR	ALAAAGYDVEKNNSR		15	V20130429-12_FTMSms2hcd	21.254	65	79	41.6	5.8e-13	7.5e-16	5	21865.4	HUMAN	Histone H1.4
[56-1]	0	P16402	H13_HUMAN	HIST1H1D	1	6.8	7.33	5.8e-13	789.8972	2	0.040	ALAAAGYDVEKNNSR	ALAAAGYDVEKNNSR		15	V20130429-12_FTMSms2hcd	21.254	66	80	41.6	5.8e-13	7.5e-16	5	22350.1	HUMAN	Histone H1.3
[56-2]	0	P16403	H12_HUMAN	HIST1H1C	1	7.0	7.33	5.8e-13	789.8972	2	0.040	ALAAAGYDVEKNNSR	ALAAAGYDVEKNNSR		15	V20130429-12_FTMSms2hcd	21.254	65	79	41.6	5.8e-13	7.5e-16	5	21364.9	HUMAN	Histone H1.2
[56-3]	0	P22492	H1T_HUMAN	HIST1H1T	1	7.2	7.33	5.8e-13	789.8972	2	0.040	ALAAAGYDVEKNNSR	ALAAAGYDVEKNNSR		15	V20130429-12_FTMSms2hcd	21.254	69	83	41.6	5.8e-13	7.5e-16	5	22019.2	HUMAN	Histone H1t
[56-4]	0	Q02539	H11_HUMAN	HIST1H1A	1	7.0	7.33	5.8e-13	789.8972	2	0.040	ALAAAGYDVEKNNSR	ALAAAGYDVEKNNSR		15	V20130429-12_FTMSms2hcd	21.254	68	82	41.6	5.8e-13	7.5e-16	5	21842.3	HUMAN	Histone H1.1
[57]		P52272	HNRPM_HUMAN	HNRNPM	1	4.5	7.29	6.9e-13	924.7218	4	2.5	GIGTVTFEQSIEAVQAISMFNGQLLFDRPMHVK	GIGTVTFEQSIEAVQAISM(Oxidation)FNGQLLFDRPM(Oxidation)HVK	Oxidation@263;Oxidation@274	33	V20130429-12_FTMSms2hcd	76.055	245	277	40.5	6.9e-13	1.2e-15	1	77516.4	HUMAN	Heterogeneous nuclear ribonucleoprotein M
[58]		P22626	ROA2_HUMAN	HNRNPA2B1	2	9.1	4.71	2.6e-9	740.6968	3	2.3	DYFEEYGKIDTIEIITDR	DYFEEYGKIDTIEIITDR		18	V20130429-12_FTMSms2hcd	56.794	130	147	33.6	2.6e-9	2.7e-12	1	37430.0	HUMAN	Heterogeneous nuclear ribonucleoproteins A2/B1
[58]		P22626	ROA2_HUMAN	HNRNPA2B1	2	9.1	4.71	2.6e-9	402.4565	4	0.12	LTDCVVMRDPASKR	LTDCVVM(Oxidation)RDPASKR	Oxidation@53	14	V20130429-12_FTMSms2hcd	18.530	47	60	16.9	4.7e-5	5.9e-8	1	37430.0	HUMAN	Heterogeneous nuclear ribonucleoproteins A2/B1
[59]		P50991	TCPD_HUMAN	CCT4	1	4.8	6.94	6.8e-13	855.4299	3	-0.33	AQDIEAGDGTTSVVIIAGSLLDSCTK	AQDIEAGDGTTSVVIIAGSLLDSCTK		26	V20130429-12_FTMSms2hcd	73.602	97	122	36.5	6.8e-13	8.0e-16	1	57924.8	HUMAN	T-complex protein 1 subunit delta
[60]		P61978	HNRPK_HUMAN	HNRNPK	1	3.7	6.81	9.5e-13	615.0309	3	-0.28	ILSISADIETIGEILKK	ILSISADIETIGEILKK		17	V20130429-12_FTMSms2hcd	71.036	87	103	36.0	9.5e-13	1.1e-14	1	50976.7	HUMAN	Heterogeneous nuclear ribonucleoprotein K
[61]		Q9Y262	EIF3L_HUMAN	EIF3L	1	3.9	6.61	7.5e-12	640.1042	4	-1.9	IWNVHSVLNVLHSLVDKSNINR	IWNVHSVLNVLHSLVDKSNINR		22	V20130429-12_FTMSms2hcd	69.145	221	242	38.8	7.5e-12	2.7e-14	1	66727.6	HUMAN	Eukaryotic translation initiation factor 3 subunit L
[62]		P11940	PABP1_HUMAN	PABPC1	1	2.5	6.41	2.0e-13	875.4276	2	-2.1	ALYDTFSAFGNILSCK	ALYDTFSAFGNILSCK		16	V20130429-12_FTMSms2hcd	67.969	114	129	28.3	2.0e-13	2.2e-16	2	70671.5	HUMAN	Polyadenylate-binding protein 1
[62-1]	0	Q13310	PABP4_HUMAN	PABPC4	1	2.5	6.41	2.0e-13	875.4276	2	-2.1	ALYDTFSAFGNILSCK	ALYDTFSAFGNILSCK		16	V20130429-12_FTMSms2hcd	67.969	114	129	28.3	2.0e-13	2.2e-16	2	70783.5	HUMAN	Polyadenylate-binding protein 4
[63]		P62316	SMD2_HUMAN	SNRPD2	2	16.9	3.66	5.9e-8	554.3267	4	2.6	MFLRGDSVIVVLRNPLIAGK	M(Oxidation)FLRGDSVIVVLRNPLIAGK	Oxidation@99	20	V20130429-12_FTMSms2hcd	56.673	99	118	30.4	5.9e-8	8.5e-10	1	13527.0	HUMAN	Small nuclear ribonucleoprotein Sm D2
[63]		P62316	SMD2_HUMAN	SNRPD2	2	16.9	3.66	5.9e-8	507.6317	3	12	MFLRGDSVIVVLR	M(Oxidation)FLRGDSVIVVLR	Oxidation@99	13	V20130429-12_FTMSms2hcd	46.913	99	111	29.0	3.5e-6	1.8e-8	1	13527.0	HUMAN	Small nuclear ribonucleoprotein Sm D2
[64]		P46782	RS5_HUMAN	RPS5	1	7.4	6.35	3.8e-11	787.9092	2	1.1	TIAECLADELINAAK	TIAECLADELINAAK		15	V20130429-12_FTMSms2hcd	66.030	168	182	43.7	3.8e-11	5.1e-14	1	22876.6	HUMAN	40S ribosomal protein S5
[65]		P55072	TERA_HUMAN	VCP	1	4.3	6.29	2.9e-11	904.7039	4	6.4	LADDVDLEQVANETHGHVGADLAALCSEAALQAIR	LADDVDLEQVANETHGHVGADLAALCSEAALQAIR		35	V20130429-12_FTMSms2hcd	70.113	390	424	38.8	2.9e-11	4.0e-14	1	89322.6	HUMAN	Transitional endoplasmic reticulum ATPase
[66]		P09211	GSTP1_HUMAN	GSTP1	1	12.4	6.25	6.5e-12	1003.1613	3	-0.79	MLLADQGQSWKEEVVTVETWQEGSLK	M(Oxidation)LLADQGQSWKEEVVTVETWQEGSLK	Oxidation@20	26	V20130429-12_FTMSms2hcd	57.571	20	45	34.9	6.5e-12	6.7e-15	1	23356.0	HUMAN	Glutathione S-transferase P
[67]		P46060	RAGP1_HUMAN	RANGAP1	1	4.1	6.15	5.4e-12	840.4641	3	3.5	ALAPLLLAFVTKPNSALESCSFAR	ALAPLLLAFVTKPNSALESCSFAR		24	V20130429-12_FTMSms2hcd	74.819	554	577	33.5	5.4e-12	2.1e-14	1	63542.5	HUMAN	Ran GTPase-activating protein 1
[68]		P14174	MIF_HUMAN	MIF	2	18.3	3.31	1.4e-5	652.3500	2	7.7	MPMFIVNTNVPR	M(Met-loss)PM(Oxidation)FIVNTNVPR	Met-loss@1;Oxidation@3	12	V20130429-12_FTMSms2hcd	36.858	1	12	22.3	1.4e-5	2.1e-8	1	12476.4	HUMAN	Macrophage migration inhibitory factor
[68]		P14174	MIF_HUMAN	MIF	2	18.3	3.31	1.4e-5	494.2871	2	1.4	LLCGLLAER	LLCGLLAER		9	V20130429-12_FTMSms2hcd	46.646	79	87	39.7	1.1e-4	2.3e-7	1	12476.4	HUMAN	Macrophage migration inhibitory factor
[69]		P10768	ESTD_HUMAN	ESD	1	7.4	6.06	5.4e-11	648.0668	4	1.7	LQEGYDHSYYFIATFITDHIR	LQEGYDHSYYFIATFITDHIR		21	V20130429-12_FTMSms2hcd	67.746	254	274	37.9	5.4e-11	5.6e-14	1	31463.1	HUMAN	S-formylglutathione hydrolase
[70]		P06732	KCRM_HUMAN	CKM	2	5.5	4.29	6.3e-9	754.4048	2	1.4	LSVEALNSLTGEFK	LSVEALNSLTGEFK		14	V20130429-12_FTMSms2hcd	55.285	157	170	31.4	6.3e-9	9.6e-12	1	43101.5	HUMAN	Creatine kinase M-type
[70]		P06732	KCRM_HUMAN	CKM	2	5.5	4.29	6.3e-9	454.2481	2	0.62	FEEILTR	FEEILTR		7	V20130429-12_FTMSms2hcd	30.159	308	314	28.1	8.0e-4	1.6e-6	1	43101.5	HUMAN	Creatine kinase M-type
[71]		P13804	ETFA_HUMAN	ETFA	1	7.8	5.80	6.7e-11	675.1210	4	-0.83	IVAPELYIAVGISGAIQHLAGMKDSK	IVAPELYIAVGISGAIQHLAGM(Oxidation)KDSK	Oxidation@290	26	V20130429-12_FTMSms2hcd	74.555	269	294	35.9	6.7e-11	2.0e-13	1	35079.9	HUMAN	Electron transfer flavoprotein subunit alpha, mitochondrial
[72]		P06744	G6PI_HUMAN	GPI	1	2.7	5.62	8.0e-11	860.4775	2	0.88	ILLANFLAQTEALMR	ILLANFLAQTEALM(Oxidation)R	Oxidation@437	15	V20130429-12_FTMSms2hcd	65.655	424	438	34.5	8.0e-11	1.8e-13	1	63147.7	HUMAN	Glucose-6-phosphate isomerase
[73]		P06753	TPM3_HUMAN	TPM3	1	4.6	5.61	4.6e-10	492.8984	3	-0.41	LEEAEKAADESER	LEEAEKAADESER		13	V20130429-12_FTMSms2hcd	13.341	113	125	38.5	4.6e-10	5.4e-13	4	32819.1	HUMAN	Tropomyosin alpha-3 chain
[73-1]	0	P07951	TPM2_HUMAN	TPM2	1	4.6	5.61	4.6e-10	492.8984	3	-0.41	LEEAEKAADESER	LEEAEKAADESER		13	V20130429-12_FTMSms2hcd	13.341	113	125	38.5	4.6e-10	5.4e-13	4	32851.0	HUMAN	Tropomyosin beta chain
[73-2]	0	P09493	TPM1_HUMAN	TPM1	1	4.6	5.61	4.6e-10	492.8984	3	-0.41	LEEAEKAADESER	LEEAEKAADESER		13	V20130429-12_FTMSms2hcd	13.341	113	125	38.5	4.6e-10	5.4e-13	4	32708.8	HUMAN	Tropomyosin alpha-1 chain
[73-3]	0	P67936	TPM4_HUMAN	TPM4	1	5.2	5.61	4.6e-10	492.8984	3	-0.41	LEEAEKAADESER	LEEAEKAADESER		13	V20130429-12_FTMSms2hcd	13.341	77	89	38.5	4.6e-10	5.4e-13	4	28522.0	HUMAN	Tropomyosin alpha-4 chain
[74]		P25705	ATPA_HUMAN	ATP5A1	1	2.4	5.16	2.5e-10	720.3370	2	-1.1	TGTAEMSSILEER	TGTAEM(Oxidation)SSILEER	Oxidation@51	13	V20130429-12_FTMSms2hcd	26.267	46	58	32.5	2.5e-10	3.2e-13	1	59751.1	HUMAN	ATP synthase subunit alpha, mitochondrial
[75]		P62847	RS24_HUMAN	RPS24	1	9.0	4.98	2.8e-10	699.8744	2	-0.064	TTPDVIFVFGFR	TTPDVIFVFGFR		12	V20130429-12_FTMSms2hcd	65.573	50	61	31.0	2.8e-10	5.0e-13	1	15423.3	HUMAN	40S ribosomal protein S24
[76]		P23284	PPIB_HUMAN	PPIB	1	6.0	4.80	5.9e-9	682.8567	2	0.37	TVDNFVALATGEK	TVDNFVALATGEK		13	V20130429-12_FTMSms2hcd	45.427	72	84	36.4	5.9e-9	7.9e-12	1	23742.7	HUMAN	Peptidyl-prolyl cis-trans isomerase B
[77]		P07237	PDIA1_HUMAN	P4HB	2	3.5	2.42	1.2e-6	533.7628	2	1.8	TVIDYNGER	TVIDYNGER		9	V20130429-12_FTMSms2hcd	21.094	453	461	25.1	1.2e-6	2.1e-9	1	57116.8	HUMAN	Protein disulfide-isomerase
[77]		P07237	PDIA1_HUMAN	P4HB	2	3.5	2.42	1.2e-6	541.3423	2	0.46	THILLFLPK	THILLFLPK		9	V20130429-12_FTMSms2hcd	47.190	255	263	17.9	3.0e-6	5.3e-8	1	57116.8	HUMAN	Protein disulfide-isomerase
[78]		O00299	CLIC1_HUMAN	CLIC1	1	3.3	4.54	1.3e-9	533.3123	2	0.74	LFMVLWLK	LFM(Oxidation)VLWLK	Oxidation@32	8	V20130429-12_FTMSms2hcd	60.171	30	37	30.2	1.3e-9	5.2e-12	1	26923.0	HUMAN	Chloride intracellular channel protein 1
[79]		P14406	CX7A2_HUMAN	COX7A2	1	28.9	4.53	8.9e-10	835.1105	3	0.67	ATMILTVGGTAYAIYELAVASFPK	ATM(Oxidation)ILTVGGTAYAIYELAVASFPK	Oxidation@59	24	V20130429-12_FTMSms2hcd	77.750	57	80	29.2	8.9e-10	1.8e-12	1	9396.1	HUMAN	Cytochrome c oxidase subunit 7A2, mitochondrial
[80]		P62701	RS4X_HUMAN	RPS4X	1	3.8	4.48	1.1e-7	608.8601	2	0.57	ECLPLIIFLR	ECLPLIIFLR		10	V20130429-12_FTMSms2hcd	72.946	40	49	40.4	1.1e-7	3.6e-10	1	29598.0	HUMAN	40S ribosomal protein S4, X isoform
[81]		P46777	RL5_HUMAN	RPL5	1	6.1	4.23	3.1e-7	624.0018	3	0.92	VGLTNYAAAYCTGLLLAR	VGLTNYAAAYCTGLLLAR		18	V20130429-12_FTMSms2hcd	67.440	90	107	41.5	3.1e-7	5.6e-10	1	34362.9	HUMAN	60S ribosomal protein L5
[82]		Q6UXB4	CLC4G_HUMAN	CLEC4G	1	3.8	4.18	2.1e-8	597.3417	2	10	AALLDGHDLLR	AALLDGHDLLR		11	V20130429-12_FTMSms2hcd	37.177	61	71	33.1	2.1e-8	6.7e-11	1	32562.0	HUMAN	C-type lectin domain family 4 member G
[83]		Q9UQ80	PA2G4_HUMAN	PA2G4	1	4.6	3.95	3.8e-10	919.3838	2	1.8	TAENATSGETLEENEAGD	TAENATSGETLEENEAGD		18	V20130429-12_FTMSms2hcd	22.960	377	394	21.4	3.8e-10	5.4e-13	1	43787.3	HUMAN	Proliferation-associated protein 2G4
[84]		P37802	TAGL2_HUMAN	TAGLN2	1	5.5	3.81	4.2e-8	640.2991	2	-0.31	NFSDNQLQEGK	NFSDNQLQEGK		11	V20130429-12_FTMSms2hcd	20.678	161	171	31.1	4.2e-8	6.6e-11	1	22391.7	HUMAN	Transgelin-2
[85]		P26599	PTBP1_HUMAN	PTBP1	1	3.4	3.80	3.1e-9	680.3707	3	0.74	VTPQSLFILFGVYGDVQR	VTPQSLFILFGVYGDVQR		18	V20130429-12_FTMSms2hcd	74.797	349	366	24.9	3.1e-9	7.1e-12	1	57221.8	HUMAN	Polypyrimidine tract-binding protein 1
[86]		P00338	LDHA_HUMAN	LDHA	2	5.7	2.92	4.7e-8	567.7800	2	-9.7	VTLTSEEEAR	VTLTSEEEAR		10	V20130429-12_FTMSms2hcd	19.044	306	315	22.4	4.7e-8	6.8e-11	1	36689.1	HUMAN	L-lactate dehydrogenase A chain
[86]		P00338	LDHA_HUMAN	LDHA	2	5.7	2.92	4.7e-8	457.3000	2	11	LVIITAGAR	LVIITAGAR		9	V20130429-12_FTMSms2hcd	31.373	91	99	19.8	3.8e-4	2.8e-6	1	36689.1	HUMAN	L-lactate dehydrogenase A chain
[87]		P68431	H31_HUMAN	HIST1H3A	1	6.6	3.71	9.1e-8	516.8008	2	-0.55	YRPGTVALR	YRPGTVALR		9	V20130429-12_FTMSms2hcd	20.349	42	50	31.9	9.1e-8	2.6e-10	5	15404.2	HUMAN	Histone H3.1
[87-1]	0	P84243	H33_HUMAN	H3F3A	1	6.6	3.71	9.1e-8	516.8008	2	-0.55	YRPGTVALR	YRPGTVALR		9	V20130429-12_FTMSms2hcd	20.349	42	50	31.9	9.1e-8	2.6e-10	5	15328.0	HUMAN	Histone H3.3
[87-2]	0	Q16695	H31T_HUMAN	HIST3H3	1	6.6	3.71	9.1e-8	516.8008	2	-0.55	YRPGTVALR	YRPGTVALR		9	V20130429-12_FTMSms2hcd	20.349	42	50	31.9	9.1e-8	2.6e-10	5	15508.4	HUMAN	Histone H3.1t
[87-3]	0	Q6NXT2	H3C_HUMAN	H3F3C	1	6.7	3.71	9.1e-8	516.8008	2	-0.55	YRPGTVALR	YRPGTVALR		9	V20130429-12_FTMSms2hcd	20.349	41	49	31.9	9.1e-8	2.6e-10	5	15213.9	HUMAN	Histone H3.3C
[87-4]	0	Q71DI3	H32_HUMAN	HIST2H3A	1	6.6	3.71	9.1e-8	516.8008	2	-0.55	YRPGTVALR	YRPGTVALR		9	V20130429-12_FTMSms2hcd	20.349	42	50	31.9	9.1e-8	2.6e-10	5	15388.2	HUMAN	Histone H3.2
[88]		P04792	HSPB1_HUMAN	HSPB1	1	4.9	3.68	5.2e-7	582.3140	2	-0.040	LFDQAFGLPR	LFDQAFGLPR		10	V20130429-12_FTMSms2hcd	48.631	28	37	35.6	5.2e-7	8.6e-10	1	22782.7	HUMAN	Heat shock protein beta-1
[89]		P49006	MRP_HUMAN	MARCKSL1	1	4.1	3.54	8.0e-8	494.2547	2	-0.19	LSGLSFKR	LSGLS(Phospho)FKR	Phospho@104=19	8	V20130429-12_FTMSms2hcd	30.107	100	107	29.9	8.0e-8	1.4e-10	1	19528.9	HUMAN	MARCKS-related protein
[90]		P02768	ALBU_HUMAN	ALB	3	4.3	2.22	3.5e-6	693.8132	2	-1.0	YICENQDSISSK	YICENQDSISSK		12	V20130429-12_FTMSms2hcd	22.137	287	298	21.2	3.5e-6	5.2e-9	1	69367.4	HUMAN	Serum albumin
[90]		P02768	ALBU_HUMAN	ALB	3	4.3	2.22	3.5e-6	464.2505	2	0.30	YLYEIAR	YLYEIAR		7	V20130429-12_FTMSms2hcd	31.214	162	168	23.2	0.0017	4.1e-6	1	69367.4	HUMAN	Serum albumin
[90]		P02768	ALBU_HUMAN	ALB	3	4.3	2.22	3.5e-6	395.2398	2	0.86	LVTDLTK	LVTDLTK		7	V20130429-12_FTMSms2hcd	22.042	258	264	25.6	0.0052	1.5e-5	1	69367.4	HUMAN	Serum albumin
[91]		P05783	K1C18_HUMAN	KRT18	1	5.3	3.48	5.8e-8	896.1459	3	14	YALQMEQLNGILLHLESELAQTR	YALQM(Oxidation)EQLNGILLHLESELAQTR	Oxidation@335	23	V20130429-12_FTMSms2hcd	72.783	331	353	28.5	5.8e-8	1.3e-10	1	48058.2	HUMAN	Keratin, type I cytoskeletal 18
[92]		P62280	RS11_HUMAN	RPS11	1	11.4	3.38	1.2e-7	643.6762	3	1.6	DVQIGDIVTVGECRPLSK	DVQIGDIVTVGECRPLSK		18	V20130429-12_FTMSms2hcd	49.946	119	136	29.3	1.2e-7	2.2e-10	1	18430.9	HUMAN	40S ribosomal protein S11
[93]		P06748	NPM_HUMAN	NPM1	2	15.6	1.87	5.8e-6	565.8068	2	1.0	GPSSVEDIKAK	GPSSVEDIKAK		11	V20130429-12_FTMSms2hcd	14.917	240	250	23.2	5.8e-6	9.2e-9	1	32575.3	HUMAN	Nucleophosmin
[93]		P06748	NPM_HUMAN	NPM1	2	15.6	1.87	5.8e-6	918.7230	4	-14	TVSLGAGAKDELHIVEAEAMNYEGSPIKVTLATLK	TVSLGAGAKDELHIVEAEAM(Oxidation)NYEGSPIKVTLATLK	Oxidation@65	35	V20130429-12_FTMSms2hcd	62.579	46	80	16.9	1.0e-4	2.0e-7	1	32575.3	HUMAN	Nucleophosmin
[94]		P25398	RS12_HUMAN	RPS12	1	6.8	2.86	1.3e-6	502.7658	2	0.96	LGEWVGLCK	LGEWVGLCK		9	V20130429-12_FTMSms2hcd	42.824	85	93	29.7	1.3e-6	2.1e-9	1	14515.1	HUMAN	40S ribosomal protein S12
[95]		O60812	HNRCL_HUMAN	HNRNPCL1	1	4.1	2.83	2.9e-7	658.9005	2	0.057	VFIGNLNTLVVK	VFIGNLNTLVVK		12	V20130429-12_FTMSms2hcd	51.852	18	29	25.8	2.9e-7	2.4e-9	2	32142.6	HUMAN	Heterogeneous nuclear ribonucleoprotein C-like 1
[95-1]	0	P07910	HNRPC_HUMAN	HNRNPC	1	3.9	2.83	2.9e-7	658.9005	2	0.057	VFIGNLNTLVVK	VFIGNLNTLVVK		12	V20130429-12_FTMSms2hcd	51.852	18	29	25.8	2.9e-7	2.4e-9	2	33670.3	HUMAN	Heterogeneous nuclear ribonucleoproteins C1/C2
[96]		P13010	XRCC5_HUMAN	XRCC5	1	1.2	2.55	3.2e-6	516.3109	2	0.93	TLFPLIEAK	TLFPLIEAK		9	V20130429-12_FTMSms2hcd	50.866	535	543	28.7	3.2e-6	1.4e-8	1	82705.3	HUMAN	X-ray repair cross-complementing protein 5
[97]		P63313	TYB10_HUMAN	TMSB10	1	34.1	2.48	1.3e-7	791.3604	2	2.2	MADKPDMGEIASFDK	M(Met-loss+Acetyl)ADKPDM(Oxidation)GEIASFDK	Met-loss+Acetyl@1;Oxidation@7	15	V20130429-12_FTMSms2hcd	31.145	1	15	20.4	1.3e-7	1.7e-10	1	5025.7	HUMAN	Thymosin beta-10
[98]		Q8N187	AL2S8_HUMAN	ALS2CR8	1	1.0	2.43	4.1e-8	464.2018	2	3.4	VETNQTR	VETNQT(Phospho)R	Phospho@536=39	7	V20130429-12_FTMSms2hcd	14.109	531	537	17.2	4.1e-8	1.0e-10	1	80698.6	HUMAN	Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 8 protein
[99]		Q12882	DPYD_HUMAN	DPYD	2	1.5	1.45	4.2e-4	920.4292	2	16	SLSVNEMTLSTLKEK	SLSVNEMT(Phospho)LS(Phospho)TLKEK	Phospho@267&269|267&270|269&270	15	V20130429-12_FTMSms2hcd	28.440	260	274	29.1	4.2e-4	4.6e-7	1	111402.5	HUMAN	Dihydropyrimidine dehydrogenase [NADP(+)]
[99]		Q12882	DPYD_HUMAN	DPYD	2	1.5	1.45	4.2e-4	928.4097	2	-2.1	SLSVNEMTLSTLKEK	S(Phospho)LSVNEM(Oxidation)T(Phospho)LSTLKEK	Oxidation@266;Phospho@260&262|260&267|260&269|260&270|262&267|262&269|262&270|267&269|267&270|269&270	15	V20130429-12_FTMSms2hcd	28.624	260	274	19.1	0.0035	4.1e-6	1	111402.5	HUMAN	Dihydropyrimidine dehydrogenase [NADP(+)]
[100]		P07305	H10_HUMAN	H1F0	1	5.2	2.23	2.8e-6	530.7677	2	1.1	VGENADSQIK	VGENADSQIK		10	V20130429-12_FTMSms2hcd	11.327	60	69	25.1	2.8e-6	3.9e-9	1	20863.1	HUMAN	Histone H1.0
[101]		P17844	DDX5_HUMAN	DDX5	1	1.5	2.19	9.1e-7	519.2707	2	0.51	LIDFLECGK	LIDFLECGK		9	V20130429-12_FTMSms2hcd	49.247	228	236	22.1	9.1e-7	1.5e-9	1	69148.7	HUMAN	Probable ATP-dependent RNA helicase DDX5
[102]		P05141	ADT2_HUMAN	SLC25A5	1	6.0	2.06	9.2e-7	674.0206	3	0.63	GMGGAFVLVLYDEIKKYT	GM(Oxidation)GGAFVLVLYDEIKKYT	Oxidation@282	18	V20130429-12_FTMSms2hcd	75.022	281	298	20.8	9.2e-7	1.3e-9	1	32852.5	HUMAN	ADP/ATP translocase 2
[103]		Q9Y520	PRC2C_HUMAN	PRRC2C	3	1.3	1.34	9.2e-4	556.3087	2	9.7	LPDLSPVENK	LPDLSPVENK		10	V20130429-12_FTMSms2hcd	20.044	2101	2110	29.8	9.2e-4	2.6e-6	1	316913.6	HUMAN	Protein PRRC2C
[103]		Q9Y520	PRC2C_HUMAN	PRRC2C	3	1.3	1.34	9.2e-4	547.6022	3	15	EGFIRSSEGPKPEK	EGFIRS(Phospho)SEGPKPEK	Phospho@975|976	14	V20130429-12_FTMSms2hcd	40.098	970	983	12.8	0.077	8.9e-5	1	316913.6	HUMAN	Protein PRRC2C
[103]		Q9Y520	PRC2C_HUMAN	PRRC2C	3	1.3	1.34	9.2e-4	710.3697	2	-1.3	LNGQQAALASQYR	LNGQQAALASQYR		13	V20130429-12_FTMSms2hcd	25.490	230	242	13.8	0.095	1.3e-4	1	316913.6	HUMAN	Protein PRRC2C
[104]		Q9HC16	ABC3G_HUMAN	APOBEC3G	1	3.4	1.62	6.6e-5	776.8740	2	15	IYDDQGRCQEGLR	IYDDQGRCQEGLR		13	V20130429-12_FTMSms2hcd	19.548	314	326	26.4	6.6e-5	7.9e-8	1	46408.4	HUMAN	DNA dC->dU-editing enzyme APOBEC-3G
[105]		O95067	CCNB2_HUMAN	CCNB2	1	5.8	1.57	3.0e-6	836.4215	3	-0.070	MALLRRPTVSSDLENIDTGVNSK	M(Met-loss+Acetyl)ALLRRPT(Phospho)VSSDLENIDTGVNSK	Met-loss+Acetyl@1;Phospho@8=8	23	V20130429-12_FTMSms2hcd	49.838	1	23	18.7	3.0e-6	3.6e-9	1	45282.0	HUMAN	G2/mitotic-specific cyclin-B2
[106]		P08754	GNAI3_HUMAN	GNAI3	1	4.5	1.57	8.2e-7	895.0350	2	2.5	VVVYSNTIQSIIAIIR	VVVYSNTIQSIIAIIR		16	V20130429-12_FTMSms2hcd	73.132	71	86	15.6	8.2e-7	1.3e-8	1	40532.6	HUMAN	Guanine nucleotide-binding protein G(k) subunit alpha
[107]		Q9BZ72	PITM2_HUMAN	PITPNM2	1	0.5	1.40	0.0021	435.2584	2	0.49	LEPLLER	LEPLLER		7	V20130429-12_FTMSms2hcd	30.699	769	775	32.4	0.0021	9.3e-6	1	148934.5	HUMAN	Membrane-associated phosphatidylinositol transfer protein 2
[108]		P40227	TCPZ_HUMAN	CCT6A	1	3.2	1.28	3.4e-5	884.5231	2	1.2	AQLGVQAFADALLIIPK	AQLGVQAFADALLIIPK		17	V20130429-12_FTMSms2hcd	75.585	433	449	21.5	3.4e-5	3.7e-7	1	58024.7	HUMAN	T-complex protein 1 subunit zeta
[109]		Q6ZQQ6	WDR87_HUMAN	WDR87	1	0.3	1.28	1.9e-5	610.8145	2	2.1	EEKALNLEMK	EEKALNLEM(Oxidation)K	Oxidation@1967	10	V20130429-12_FTMSms2hcd	37.468	1959	1968	20.1	1.9e-5	2.7e-8	1	333188.0	HUMAN	WD repeat-containing protein 87
[110]		Q15417	CNN3_HUMAN	CNN3	1	4.0	1.16	2.9e-6	666.7851	2	-3.1	CASQAGMTAYGTR	CASQAGM(Oxidation)TAYGTR	Oxidation@179	13	V20130429-12_FTMSms2hcd	10.595	173	185	14.5	2.9e-6	5.8e-9	1	36414.0	HUMAN	Calponin-3
[111]		A6NHP6	YR011_HUMAN		1	3.1	1.09	9.7e-7	727.2896	2	-7.9	LDMKEIHTYK	LDM(Oxidation)KEIHT(Phospho)Y(Phospho)K	Oxidation@175;Phospho@180;Phospho@181	10	V20130429-12_FTMSms2hcd	29.079	173	182	11.2	9.7e-7	2.5e-9	2	37918.4	HUMAN	NPIP-like protein LOC729602
[111-1]	0	A8MZ50	NPIL4_HUMAN		1	3.0	1.09	9.7e-7	727.2896	2	-7.9	LDMKEIHTYK	LDM(Oxidation)KEIHT(Phospho)Y(Phospho)K	Oxidation@175;Phospho@180;Phospho@181	10	V20130429-12_FTMSms2hcd	29.079	173	182	11.2	9.7e-7	2.5e-9	2	38380.9	HUMAN	Putative NPIP-like protein ENSP00000381263
[112]		Q4G0P3	HYDIN_HUMAN	HYDIN	1	0.2	0.88	3.4e-5	649.8401	2	4.8	LPPELYEYFK	LPPELYEYFK		10	V20130429-12_FTMSms2hcd	43.963	1898	1907	17.4	3.4e-5	5.3e-8	1	575897.1	HUMAN	Hydrocephalus-inducing protein homolog
[113]		Q8IU53	CASC2_HUMAN	CASC2	1	14.5	0.87	7.0e-5	642.4020	2	-18	KLPQGIIIVFR	KLPQGIIIVFR		11	V20130429-12_FTMSms2hcd	56.781	39	49	19.1	7.0e-5	5.8e-7	1	8607.3	HUMAN	Protein CASC2, isoforms 1/2
[114]		Q86UP3	ZFHX4_HUMAN	ZFHX4	1	0.3	0.80	1.8e-5	723.3564	2	0.41	LQIHSQYHAIR	LQIHSQY(Phospho)HAIR	Phospho@1373=13	11	V20130429-12_FTMSms2hcd	42.850	1367	1377	15.1	1.8e-5	2.1e-8	1	393733.1	HUMAN	Zinc finger homeobox protein 4
[115]		Q5VVM6	CCD30_HUMAN	CCDC30	1	1.5	0.74	6.8e-4	695.3224	2	1.6	EGQKEEGSQQNR	EGQKEEGSQQNR		12	V20130429-12_FTMSms2hcd	23.767	166	177	23.1	6.8e-4	9.0e-7	1	91334.1	HUMAN	Coiled-coil domain-containing protein 30
[116]		P21815	SIAL_HUMAN	IBSP	1	3.5	0.63	4.6e-5	613.8123	2	2.7	KAGDITNKATK	KAGDITNKAT(Phospho)K	Phospho@144=8	11	V20130429-12_FTMSms2hcd	30.832	135	145	15.7	4.6e-5	6.0e-8	1	35147.8	HUMAN	Bone sialoprotein 2
[117]		Q0D2J5	ZN763_HUMAN	ZNF763	1	2.8	0.59	1.6e-4	668.3313	2	16	ALSYKFSNTPK	ALSYKFS(Phospho)NTPK	Phospho@382|384	11	V20130429-12_FTMSms2hcd	29.425	376	386	18.2	1.6e-4	2.3e-7	1	46099.6	HUMAN	Zinc finger protein 763
[118]		Q86UQ4	ABCAD_HUMAN	ABCA13	1	0.1	0.58	0.0018	426.2716	2	1.2	HILDIIK	HILDIIK		7	V20130429-12_FTMSms2hcd	36.375	994	1000	23.8	0.0018	2.6e-5	1	576164.4	HUMAN	ATP-binding cassette sub-family A member 13
[119]		Q9NR33	DPOE4_HUMAN	POLE4	1	9.4	0.57	4.1e-5	636.3234	2	8.8	AAELFVETIAK	AAELFVET(Phospho)IAK	Phospho@77	11	V20130429-12_FTMSms2hcd	35.178	70	80	14.8	4.1e-5	6.0e-8	1	12208.9	HUMAN	DNA polymerase epsilon subunit 4
[120]		Q9NXG0	CNTLN_HUMAN	CNTLN	1	0.7	0.54	0.0025	376.5477	3	0.50	RQVAEANALR	RQVAEANALR		10	V20130429-12_FTMSms2hcd	15.924	776	785	24.1	0.0025	7.5e-6	1	161604.6	HUMAN	Centlein
[121]		O95466	FMNL_HUMAN	FMNL1	1	0.9	0.52	0.0019	569.2684	2	-0.40	RDSELGPGVK	RDS(Phospho)ELGPGVK	Phospho@624	10	V20130429-12_FTMSms2hcd	16.757	622	631	23.4	0.0019	3.6e-6	1	121854.6	HUMAN	Formin-like protein 1
[122]		O95747	OXSR1_HUMAN	OXSR1	1	1.7	0.43	3.1e-4	536.2746	2	-0.92	IVEEPQSNR	IVEEPQSNR		9	V20130429-12_FTMSms2hcd	14.255	489	497	18.2	3.1e-4	5.5e-7	1	58022.7	HUMAN	Serine/threonine-protein kinase OSR1
[123]		Q9UKZ4	TEN1_HUMAN	ODZ1	1	0.3	0.41	2.4e-4	535.8159	2	-10	RVLYKYTK	RVLYKYTK		8	V20130429-12_FTMSms2hcd	44.987	1967	1974	17.3	2.4e-4	8.0e-7	1	305014.0	HUMAN	Teneurin-1
[124]		Q9UPN9	TRI33_HUMAN	TRIM33	1	1.2	0.37	6.7e-4	742.9129	2	0.38	KGKTAQGLSPVDQR	KGKTAQGLSPVDQR		14	V20130429-12_FTMSms2hcd	14.865	951	964	19.4	6.7e-4	1.5e-6	1	122534.3	HUMAN	E3 ubiquitin-protein ligase TRIM33
[125]		Q96MH6	TMM68_HUMAN	TMEM68	1	3.7	0.30	0.056	665.3596	2	-5.7	IPGNIMSALLER	IPGNIM(Oxidation)SALLER	Oxidation@316	12	V20130429-12_FTMSms2hcd	19.682	311	322	29.0	0.056	9.6e-5	1	37425.1	HUMAN	Transmembrane protein 68
[126]		Q8NG11	TSN14_HUMAN	TSPAN14	1	3.0	0.25	0.0068	416.7425	2	0.32	GVLSDLTK	GVLSDLTK		8	V20130429-12_FTMSms2hcd	44.842	45	52	23.6	0.0068	1.3e-5	1	30691.1	HUMAN	Tetraspanin-14
[127]		Q8WVB6	CTF18_HUMAN	CHTF18	1	1.2	0.19	0.0020	691.3512	2	5.5	VSKEATAPGKWK	VSKEAT(Phospho)APGKWK	Phospho@339=33	12	V20130429-12_FTMSms2hcd	15.038	334	345	20.1	0.0020	2.4e-6	1	107383.9	HUMAN	Chromosome transmission fidelity protein 18 homolog
[128]		O14744	ANM5_HUMAN	PRMT5	1	3.3	0.16	5.7e-4	775.7691	3	-2.3	AAILPTSIFLTNKKGFPVLSK	AAILPTSIFLTNKKGFPVLS(Phospho)K	Phospho@238|247	21	V20130429-12_FTMSms2hcd	59.773	228	248	16.9	5.7e-4	2.7e-6	1	72684.5	HUMAN	Protein arginine N-methyltransferase 5
[129]		Q9UHC7	MKRN1_HUMAN	MKRN1	1	2.3	0.16	4.5e-4	720.8006	2	-14	VGTSSRYRAQR	VGT(Phospho)SSRY(Phospho)RAQR	Phospho@407=17;Phospho@411=17	11	V20130429-12_FTMSms2hcd	11.223	405	415	16.3	4.5e-4	9.6e-7	1	53350.0	HUMAN	E3 ubiquitin-protein ligase makorin-1
[130]		Q9Y5S1	TRPV2_HUMAN	TRPV2	1	1.4	0.16	0.0082	643.8451	2	4.4	LCPTVQLEDIR	LCPTVQLEDIR		11	V20130429-12_FTMSms2hcd	15.301	280	290	23.1	0.0082	1.3e-5	1	85981.9	HUMAN	Transient receptor potential cation channel subfamily V member 2
[131]		Q96J92	WNK4_HUMAN	WNK4	1	0.9	0.15	0.0044	658.3348	2	8.0	LSKGSFPTSRR	LSKGS(Phospho)FPTSRR	Phospho@1193|1196|1197	11	V20130429-12_FTMSms2hcd	17.989	1189	1199	21.6	0.0044	5.7e-6	1	134740.4	HUMAN	Serine/threonine-protein kinase WNK4
[132]		O00571	DDX3X_HUMAN	DDX3X	1	2.0	0.14	0.019	735.3895	2	-4.3	IVEQDTMPPKGVR	IVEQDTMPPKGVR		13	V20130429-12_FTMSms2hcd	23.647	364	376	24.9	0.019	2.9e-5	2	73244.0	HUMAN	ATP-dependent RNA helicase DDX3X
[132-1]	0	O15523	DDX3Y_HUMAN	DDX3Y	1	2.0	0.14	0.019	735.3895	2	-4.3	IVEQDTMPPKGVR	IVEQDTMPPKGVR		13	V20130429-12_FTMSms2hcd	23.647	362	374	24.9	0.019	2.9e-5	2	73154.2	HUMAN	ATP-dependent RNA helicase DDX3Y
[133]		Q9H2D6	TARA_HUMAN	TRIOBP	1	0.3	0.12	0.0017	488.2707	2	-1.6	LSEEIEKK	LSEEIEKK		8	V20130429-12_FTMSms2hcd	28.663	2022	2029	19.1	0.0017	2.9e-6	1	261377.7	HUMAN	TRIO and F-actin-binding protein
[134]		Q8IUG5	MY18B_HUMAN	MYO18B	1	0.3	0.12	0.0038	442.7365	2	-0.14	QMVLHEK	QMVLHEK		7	V20130429-12_FTMSms2hcd	34.019	1769	1775	20.9	0.0038	1.0e-5	1	285187.1	HUMAN	Unconventional myosin-XVIIIb
[135]		Q5TEJ8	THMS2_HUMAN	THEMIS2	1	1.4	0.11	0.0036	470.2724	2	12	ALDPASLPR	ALDPASLPR		9	V20130429-12_FTMSms2hcd	17.934	12	20	20.7	0.0036	1.5e-5	1	72049.3	HUMAN	Protein THEMIS2
[136]		Q9Y2H9	MAST1_HUMAN	MAST1	1	1.1	0.11	5.1e-5	615.3160	3	15	AVAKAALSPVQEHETGR	AVAKAALSPVQEHET(Phospho)GR	Phospho@1420=63	17	V20130429-12_FTMSms2hcd	46.767	1406	1422	10.7	5.1e-5	6.0e-8	1	170678.4	HUMAN	Microtubule-associated serine/threonine-protein kinase 1
[137]		Q9NSB8	HOME2_HUMAN	HOMER2	1	2.8	0.09	0.0035	410.8821	3	20	DNQNLEDKVR	DNQNLEDKVR		10	V20130429-12_FTMSms2hcd	25.581	297	306	20.4	0.0035	5.2e-6	1	40627.6	HUMAN	Homer protein homolog 2
[138]		Q9UFP1	F198A_HUMAN	FAM198A	1	1.9	0.06	2.6e-4	718.8124	2	-2.1	HNLTLFRDEDP	HNLT(Phospho)LFRDEDP	Phospho@568	11	V20130429-12_FTMSms2hcd	23.819	565	575	14.1	2.6e-4	4.5e-7	1	63637.9	HUMAN	Protein FAM198A
[139]		Q96JB1	DYH8_HUMAN	DNAH8	1	0.1	0.05	0.0022	401.2515	2	-17	RLLFPR	RLLFPR		6	V20130429-12_FTMSms2hcd	61.525	1577	1582	18.9	0.0022	4.6e-6	1	514668.4	HUMAN	Dynein heavy chain 8, axonemal
[140]		Q96FQ7	CR018_HUMAN	LINC00526	1	16.8	0.02	0.0014	622.9507	3	18	SAAYTDIGATKPVEQR	S(Phospho)AAYTDIGAT(Phospho)KPVEQR	Phospho@85=35;Phospho@76|79|80	16	V20130429-12_FTMSms2hcd	14.947	76	91	17.6	0.0014	1.6e-6	1	10201.5	HUMAN	Putative uncharacterized protein encoded LINC00526
[141]		Q8NDV7	TNR6A_HUMAN	TNRC6A	1	1.0	0.02	7.5e-5	1136.9774	2	16	MEIDDGTSAWGDPSKYNYK	M(Oxidation)EIDDGTSAWGDPSKY(Phospho)NYK	Oxidation@999;Phospho@1014|1016	19	V20130429-12_FTMSms2hcd	43.464	999	1017	10.7	7.5e-5	9.4e-8	1	210298.9	HUMAN	Trinucleotide repeat-containing gene 6A protein
[142]		Q9Y4B5	CC165_HUMAN	CCDC165	1	1.5	0.00	9.1e-4	928.4304	3	6.6	GSGVTSSPHKCLTPKAGGGATPVSSPSR	GSGVTSSPHKCLT(Phospho)PKAGGGATPVS(Phospho)SPSR	Phospho@1658=20;Phospho@1666|1669|1670|1672	28	V20130429-12_FTMSms2hcd	37.883	1646	1673	16.4	9.1e-4	8.6e-7	1	208750.8	HUMAN	Coiled-coil domain-containing protein 165
